Document:

Purchasing Agreement

 Exhibit 10.3 
 *** Text Omitted and Filed Separately 
 Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 230.406 
 

 
 PURCHASING AGREEMENT 
 HealthTrust Purchasing Group 
 Products 
  

			
	Vendor:	  	Masimo Americas, Inc.
		
	Products:	  	Pulse Oximetry
		
	Effective Date:	  	February 1, 2008
		
	Agreement Number:	  	HPG-1331

 *Confidential Treatment Requested 

 TABLE OF CONTENTS 
  

					
	1.0	  	Definitions	  	3
	2.0	  	General Purchasing Provisions	  	5
	3.0	  	GPO Fees, Rebates, Reporting, Prices, Payments	  	7
	4.0	  	EDI and E-Commerce	  	9
	5.0	  	Price Warranty	  	10
	6.0	  	State Sales or Use Taxes	  	10
	7.0	  	Vendor Delivery Performance; Customer Service	  	11
	8.0	  	Shipment, Risk of Loss, Freight Charges	  	12
	9.0	  	Warranties and Disclaimer of Liability	  	13
	10.0	  	Inspection	  	17
	11.0	  	Indemnity	  	18
	12.0	  	Confidentiality; Software License & Use Restrictions.	  	19
	13.0	  	Publicity	  	21
	14.0	  	Insurance	  	21
	15.0	  	Order Cancellation	  	22
	16.0	  	Termination of Agreement	  	22
	17.0	  	Books, Records and Compliance Requirements	  	23
	18.0	  	Reports	  	27
	19.0	  	Assignment	  	27
	20.0	  	Merger of Terms and Amendments	  	27
	21.0	  	Partial Invalidity	  	28
	22.0	  	Other Documents	  	28
	23.0	  	Personal Inducements	  	28
	24.0	  	Vendor Relations Policy	  	28
	25.0	  	Controlling Law	  	29
	26.0	  	Legal Fees	  	29
	27.0	  	Product Bar Coding	  	29
	28.0	  	Minority and Women Owned Business Enterprises	  	29
	29.0	  	Notices	  	30
	30.0	  	New Technology	  	30
		
	Exhibits A-F	  	

 PURCHASING AGREEMENT 
 HealthTrust Purchasing Group 
 This Purchasing Agreement, dated February 1, 2008, is
entered into by HealthTrust Purchasing Group, L.P., a Delaware limited partnership, having its principal place of business at 155 Franklin Road, Suite 400, Brentwood, TN 37027 (hereinafter referred to as “HPG”), and the following
entity: 
 Masimo Americas, Inc., a Delaware corporation, 
  

			
	Address:	 	40 Parker
		 	Irvine, CA 92618

 (hereinafter referred to as “Vendor”), for the primary purpose of establishing the terms and
conditions pursuant to which members of HPG may purchase certain products and services from Vendor. 
 WHEREAS, HPG is organized as a
group purchasing organization with various healthcare providers belonging to HPG as Participants (as hereinafter defined); 
 WHEREAS,
Participants have entered into Participation Agreements (as hereinafter defined) with HPG, which permit Participants and their Affiliates (as hereinafter defined) to obtain products and services under purchasing agreements between HPG and its
vendors, provided Participants comply with the purchaser obligations stated in the purchasing agreements and Participants’ obligations under the Participation Agreements; and 
 WHEREAS, Vendor desires to offer certain of its products and/or services to Participants. 
 NOW, THEREFORE, HPG and Vendor hereby agree that Vendor shall provide the products and/or services described herein to Participants in accordance
with the terms and conditions set forth herein: 
  

	 	1.0	Definitions 

  

	 	1.1	“Affiliates” as applied to any particular entity, is defined as those entities, businesses, facilities, and enterprises, that are controlled by, controlling, or
under common control with a stated entity, including, without limitation, all parent corporations and their respective subsidiaries and affiliates, joint ventures, limited liability companies and partnerships, together with any and all entities and
businesses to which any of the above-described entities provide management services or purchasing services. “Control” as used herein means control through ownership of more than a majority interest in an entity, or control by
contract. 

  

	 	1.2	“Agreement” shall be defined as this purchasing agreement, including the Exhibits and attachments referenced herein. 

  

	 	1.3	“Distributor(s)” shall be defined as any product distributor designated by HPG, as described in Exhibit B, to distribute Products to Purchasers.

  

 Page 3 of 32 

	 	1.4	“Dual Source Award” shall be defined as an agreement by HPG not to contract with more than one alternative supplier pursuant to which Participants can purchase
products and services comparable to those listed in Exhibit A during the Term. 

  

	 	1.5	“EDI” shall be defined as Electronic Data Interchange. 

  

	 	1.6	“Effective Date” shall be defined as the date first stated in the opening paragraph to this Agreement. 

  

	 	1.7	“Expiration Date” shall be defined as the date this Agreement terminates and is designated in Exhibit B. 

  

	 	1.8	“Facility Agreement” shall be defined as the template agreement available for Purchasers to contract with Vendor to obtain certain products under this Agreement,
and which is titled: “Deferred Equipment Purchase Agreement”. 

  

	 	1.9	“GPOID” shall be defined as the unique identification number assigned by HPG to each Purchaser. 

  

	 	1.10	“Multi-Source Award” shall be defined as Vendor being designated as an approved source of Products and/or Services, with no limitation on HPG contracting for
Participants to purchase comparable products and services from alternative suppliers pursuant to their contracts with HPG. 

  

	 	1.11	“Optional/Preferred Source Award” shall be defined as Vendor being designated as an approved source of the Products and/or Services listed in Exhibit A, with
no limitation on HPG or Participants contracting for purchasing comparable products and services from alternative suppliers or on Participants purchasing comparable products and services from alternative suppliers on a non-contract basis.

  

	 	1.12	“Participant(s)” shall be defined as member(s) of HPG who have entered into a Participation Agreement. 

  

	 	1.13	“Participation Agreement” shall be defined as a written member agreement with HPG that permits Participants and their Affiliates to purchase products and services
from various vendors having purchasing agreements with HPG; and which designates HPG as such Participant’s exclusive GPO for the product category that covers Products available hereunder. 

  

	 	1.14	“Party” and “Parties” shall be defined as Vendor and/or HPG. 

  

	 	1.15	“Products” shall be defined as those goods listed in Exhibit A to this Agreement. 

  

	 	1.16	“Purchaser” shall be defined as any Participant obtaining Products and/or Services from Vendor under this Agreement. 

  

	 	1.17	“Services” shall be defined as those services listed in Exhibit A to this Agreement as well as any services provided by Vendor, its subcontractors, and
agents in connection with any Purchaser’s purchase and/or use of Products. 

  

 Page 4 of 32 

	 	1.18	“Sole Source Award” shall be defined as an agreement by HPG not to contract with any alternative supplier pursuant to which Participants can purchase products and
services comparable to those listed in Exhibit A during the Term. 

  

	 	1.19	“Term” shall be defined, subject to the provisions of Section 16, as the period this Agreement is in effect, commencing on the Effective Date and expiring on
the Expiration Date specified in Exhibit B to this Agreement, or as extended pursuant to a written agreement signed by both Parties. 

  

	 	2.0	General Purchasing Provisions 

  

	 	2.1	GPO Laws and Regulations. HPG represents and Vendor recognizes that HPG is a group purchasing organization. The Parties acknowledge that it is their intent to establish a
business relationship in which payments by Vendor to HPG and Purchasers comply with the exceptions to the Medicare and Medicaid Anti-Kickback statute set forth at 42 U.S.C. § 1320a-7b(b)(3) (A) and (C), the “safe harbor”
regulations regarding discounts set forth in 42 C.F.R. § 1001.952(h), and the “safe harbor” regulations regarding payments to group purchasing organizations set forth in 42 C.F.R. § 1001.952(j); and the Parties believe that the
relationship contemplated by this Agreement is in compliance with those requirements. 

  

	 	2.2	Award Basis. HPG and Vendor hereby agree that they are entering into this Agreement pursuant to the award basis designated in Exhibit B to this Agreement.

  

	 	2.3	Eligible Purchasers. Commencing on the Effective Date, all Participants located in the United States or its territories shall be eligible to obtain Products and/or Services
from Vendor under this Agreement, including but not limited to acute care facilities, hospitals, ambulatory surgery centers, imaging centers, alternate site entities, physician practices, rehabilitation facilities, psychiatric centers, clinics or
any other kind of healthcare providers, as well as any Participant distribution centers qualifying as a Participant and servicing other Participants and Purchasers. In addition to being able to obtain Products from Vendor pursuant to the terms of
this Agreement, Purchasers shall be able to obtain Products from Vendor pursuant to the terms of the Facility Agreement. HPG shall update its list of eligible Purchasers on HPG’s secured website for its vendors twice monthly. Vendor agrees to
check the updated list, located at: 

 https://scrubs.healthtrustpg.com/Source/vendors/mm_listings/mm_vendor.xls

 within five (5) business days following the 7th and the 21st of each month, and to update its list of
eligible Purchasers within such 5-day period to accurately reflect the name, address, GPOID, and any other assigned identification code for each eligible Purchaser. Purchasers obtaining Products and/or Services from Vendor under this Agreement shall
be considered third party beneficiaries hereunder. In the event Vendor’s records show that a Purchaser is listed as a member of another GPO in addition to HPG, Vendor shall notify HPG and HPG will contact the Purchaser and obtain appropriate
documentation from the Purchaser that indicates HPG is such Purchaser’s exclusive GPO for the product category that covers Products available hereunder. Until such documentation is furnished, Vendor shall withhold payment of fees to any GPO for
purchases by the 

  

 Page 5 of 32 

 
Purchaser in question, and upon presentation of the appropriate documentation, Vendor shall pay the withheld GPO Fees as appropriate. 
  

	 	2.4	Purchaser Obligations. Payment for purchases made by Purchasers under this Agreement shall be the sole responsibility of the Purchaser, and Vendor agrees that HPG shall have
no responsibility or obligation for such payments or any other obligations of Purchasers under this Agreement. 

  

	 	2.5	Direct Purchases. If purchases are to be directly from the Vendor, as noted in Exhibit B, then upon receipt of an order from Purchaser (regardless of form or media used, or
whether reference is made to this Agreement) Vendor agrees to sell and deliver to Purchaser the Products and/or Services listed in the order at the prices set forth in Exhibit A (including any discounts or rebates stated in Exhibit A),
subject to and in accordance with the terms and conditions stated in this Agreement. No minimum quantity or dollar amount shall apply to any order unless expressly stated in Exhibit B to this Agreement. In the event Vendor charges a Purchaser
a price higher than that stated in Exhibit A, upon discovery of such overcharge and payment thereof by the Purchaser, Vendor shall issue Purchaser a refund (not a credit) in the amount of such overcharge/over payment. If Vendor charges a
Purchaser a price lower than that stated in Exhibit A, Vendor shall have the right to set-off the undercharge against any refund due for an overcharge/over payment. Vendor agrees that it will not refuse to honor any credit balance or
refund obligation for any Purchaser based on such Purchaser’s non-payment or short payment of an invoice on an unrelated purchase where the amount owed is not in dispute. No Purchaser may refuse to honor any payment obligation to Vendor based
on an unrelated purchase by such Purchaser where the amount owed is not in dispute or by any other Purchaser. Vendor shall provide regular statements (at least quarterly) to Purchasers which list unapplied credits, and upon a Purchaser request,
shall promptly refund the amount of the unapplied credits. 

  

	 	2.6	Purchases Through Distributors. If any Product is available through a Distributor, as designated in Exhibit B, then the terms and conditions of this Agreement which
apply to shipment directly from Vendor to a Purchaser shall not be applicable to purchases of such Products through a Distributor; and unless otherwise designated herein, the prices listed in Exhibit A shall be the prices Vendor charges the
Distributor, with the ultimate price paid by Purchaser determined by HPG and the Distributor. Vendor shall provide Product pricing and related information to HPG and Distributors, which is consistent with Exhibit A, any amendments to Exhibit
A, and corresponding pricing files for EDI and Internet e-commerce transactions. Otherwise, with respect to purchases of Products through Distributors, all other terms and conditions of this Agreement shall apply to each purchase transaction by a
Purchaser. Vendor shall assume total responsibility for obtaining from Distributors purchase information for each Purchaser so that Vendors accurately pay and report on GPO fees and rebates (if any). 

  

	 	2.7	 Term. Subject to the termination provisions of Section 16, this Agreement shall have a Term commencing on the Effective Date and expiring on the
Expiration Date specified in Exhibit B to this Agreement, with the obligation of Vendor to first make Products and/or Services available hereunder beginning as of the Effective Date. Except as otherwise provided herein, the provisions of this
Agreement, including prices, shall be 

  

 Page 6 of 32 

	 	 
effective from the Effective Date through the Expiration Date. If Products and/or Services by Purchaser after the Effective Date are provided by Vendor at a
price higher than that provided by this Agreement, then Vendor shall issue refunds for all purchases of Products and/or Services, such that the net purchase price will equal that stated in this Agreement. Prices for Products and/or Services may not
be increased except pursuant to a written amendment to this Agreement that has been signed by both Parties, except as otherwise expressly stated in Section 20.3 or Exhibit B. 

  

	 	2.8	Independent Contractor Relationship. The Parties agree that Vendor is an independent contractor and that this Agreement does not create any agency, employment, or joint
venture relationship, or any right of either Party to obligate the other Party to any legal or financial obligation. 

  

	 	2.9	Capital Investments. Vendor assumes the full and complete risk of any capital investments Vendor makes to enable or enhance its capabilities to serve HPG and to provide
Products and Services to Purchasers under this Agreement. In no event will HPG, any Participant, or any Purchaser assume any financial or other risk associated with capital investments made by Vendor as a result of or related to this Agreement.

  

	 	2.10	Orders. The terms set forth in this Agreement shall apply to each order by a Purchaser, whether such order is communicated by Purchaser’s purchase order form, EDI,
internet e-commerce, facsimile, orally, or any other method, or whether reference is made to this Agreement. 

  

	 	2.11	Multiple Product Purchasing Arrangements. The parties acknowledge that vital signs monitoring products such as pulse oximeters may be considered as Clinical Preference
Products as defined in the HIGPA Code of Conduct adopted July 24, 2002. 

  

	 	3.0	GPO Fees, Rebates, Reporting, Prices, Payments 

  

	 	3.1	 GPO Fees. In consideration for the administrative and other services HPG shall perform in connection with purchases of Products and Services under this
Agreement by Purchasers, Vendor agrees to pay HPG GPO fees as provided in Exhibit B to this Agreement (“GPO Fees”) for all purchases of Products and Services under this Agreement, whether such purchases are made directly
from Vendor or through a Distributor, or whether such purchases are made at prices other than those stated in Exhibit A. If a percentage is listed in Exhibit B for the GPO Fee, the percentage shall be applied against the net dollar
volume of purchases (excluding any added freight charges) of Products and Services by Purchasers during the applicable time period (i.e., total sales less refunds and credits on returns, rebates and discounts). The payment of such GPO Fees is
intended to be in compliance with the exception to the Medicare and Medicaid Anti-Kickback Statute set forth at 42 USC § 1320a-7b(b)(3)(C) and the “safe harbor” regulations set forth in 42 C.F.R. § 1001.952(j). The GPO Fees for
purchases under this Agreement during each calendar quarter during the Term shall be paid by Vendor to HPG within thirty (30) days after the end of each calendar quarter. However, information on sales through distributors may be substantially
delayed due to the distributors’ delay in providing timely sales information. Vendor shall provide 

  

 Page 7 of 32 

	 	 
electronic reports with each GPO Fee payment that accurately list purchases upon which GPO Fees are based by each Purchaser for the applicable quarter and
any other information that may be required to enable HPG to comply with 42 C.F.R. § 1001.952(j). Electronic reports shall be in a format and have content that is mutually acceptable by HPG and Vendor. 

  

	 	3.2	Rebates. If any rebates are to be paid under this Agreement, Vendor agrees to pay rebates based on purchases of Products and/or Services by Purchasers in the amounts stated
in Exhibit A to this Agreement. If a percentage is stated for the rebate, then the rebate shall be determined by multiplying the stated percentage against the dollar amount actually paid by the Purchaser (excluding any added taxes, duties,
freight, packaging and insurance charges) for Products and Services purchased hereunder. Unless otherwise agreed in writing by Vendor and the Participant/Purchaser (in which event Vendor shall disclose the existence and amounts of such rebates to
HPG), rebates shall be payable directly to HPG for payment to Participants/Purchasers, shall be based on purchases by Purchasers under this Agreement made during each calendar quarter during the Term, and shall be paid within thirty (30) days
after the end of each calendar quarter. The payment of rebates is intended to be in compliance with the exception to the Medicaid and Medicare Anti-Kickback Statute set for at 42 U.S.C.A. §1320a-7b(b)(3)(A) and the “safe harbor”
regulations set forth in 42 CFR §1001.952(h). For rebate payments made directly to HPG, Vendor shall provide electronic reports with each rebate payment that contain sufficient detail to permit HPG to accurately allocate the appropriate amounts
to each Participant/Purchaser. For rebate payments made directly to Participants/Purchasers, Vendor shall provide electronic reports with each rebate payment that contain sufficient detail to permit the Participant/Purchaser to accurately account
for the rebates on its accounting records and its cost reports under any government healthcare plan, and provide a copy of such report to HPG at the time payment is made to the Participant/Purchaser. 

  

	 	3.3	Vendor Reports. The Vendor reports submitted pursuant to Sections 3.1 and 3.2 shall include a listing of each Purchaser by the Purchaser “GPOID” number supplied
with HPG’s list of eligible Purchasers. If Vendor uses its own customer identification number, then Vendor shall also provide the GPOID for each Purchaser. The Vendor reports shall be sent by e-mail to: 

 vendorbackup@healthtrustpg.com 
 If Vendor
does not have internet access, then Vendor shall save the required reports on diskettes or compact disks and send them to HPG along with the GPO Fee and rebate payments to the address listed in Section 3.6. 
  

	 	3.4	Prompt Payment Acknowledgement. Vendor acknowledges that failure to promptly pay rebates and GPO Fees, or to submit accurate reports will delay HPG’s payment and/or
reporting of rebates and/or GPO Fees to Participants and Purchasers, thereby potentially causing Participants and Purchasers to be unable to accurately complete cost reports required under United States government reimbursed healthcare programs.

  

 Page 8 of 32 

	 	3.5	Payment Terms and Late Fees. HPG shall have the right to charge, and Vendor agrees to pay, a late fee equal to one percent (1%) per month (or the maximum allowed by law,
whichever is less) of the amount of any GPO Fees, rebates, or other fees not paid by Vendor in accordance with the payment terms stated herein or, if not otherwise stated herein, within thirty (30) days from receipt of an invoice therefor and
that remain unpaid for ten (10) days after HPG provides written notice of delinquency. Timely payment without the required reports shall be considered as non-payment until reports meeting the above requirements have been delivered to HPG.

  

	 	3.6	Addresses for Payments. GPO Fees and Rebates shall be sent to HPG as follows: 

  

			
	For delivery of checks that require proof of delivery:
		
		 	 HealthTrust Purchasing Group
 c/o Wachovia
Bank
 Attn: Wholesale Lockbox- P. O. Box 751576
 Building
2C2-NC0802
 1525 West WT Harris Blvd
 Charlotte, NC
28262
 Telephone No.: 704-590-5382

		
	 For wire payments:
	 	 HealthTrust Purchasing Group
 c/o Wachovia
Bank
 ABA #053000219
 Account #2079900143067
 Charlotte, NC 28275-1576

		
	 For all other mail deliveries:
	 	 HPG C/O Wachovia Bank
 Account Number: 2079900143067

 P.O. Box 751576
 Charlotte, NC 28275-1576

  

	 	3.7	Electronic Reports. In addition to the Product pricing listed in Exhibit A to this Agreement, on or prior to the Effective Date, Vendor agrees to provide HPG with an
electronic copy of Exhibit A that conforms to standards mutually acceptable by HPG and Vendor. 

  

	 	4.0	EDI and E-Commerce 

  

	 	4.1	Transmission of Orders. Order placement, order confirmation, change orders and invoices for Products and Services obtained pursuant to this Agreement shall be sent by use of
EDI or by internet based e-commerce system, except where Vendor or a Purchaser does not have the capability to use either method, or as otherwise authorized pursuant to Exhibit B. 

  

	 	4.2	 GHX. Vendor acknowledges that: (a) HPG has entered into an arrangement with Global Health Exchange, LLC (“GHX”) for GHX to provide to
HPG and Participants internet-based e-commerce services associated with the ordering of products and services; (b) many Participants will transition from EDI ordering systems to the GHX internet-based 

  

 Page 9 of 32 

	 	 
electronic marketplace system for order placement and confirmation; (c) Vendor will reasonably cooperate with HPG and GHX in facilitating efficient
transactions with Participants and Purchasers, and if applicable, any Distributor, through the GHX e-commerce system; and (d) if it has not already done so, Vendor will use commercially reasonable efforts to enter into an agreement with GHX on
mutually agreed terms, which will permit Products and Services to be obtained by Purchasers using the GHX internet-based e-commerce system. Vendor acknowledges that Vendor will not have access to the GHX internet-based e-commerce system unless it
negotiates a user agreement with GHX. 

  

	 	4.3	Transaction Data. Vendor and HPG acknowledge and agree that, as to any transactions for Product and/or Services through the GHX e-commerce system, Vendor and the applicable
Purchaser shall own all transaction data, but that HPG shall have the right to have access to such transaction data for performance of its group purchasing functions. 

  

	 	5.0	Price Warranty 

  

	 	5.1	Comparable Customers. Vendor represents and warrants that the prices charged for the Products and/or Services purchased hereunder, net of all discounts and rebates, do not
exceed Vendor’s net prices for the particular Products and/or Services charged to others who are the same class of customer as are Purchasers and who purchase under substantially similar contract terms and purchase volume commitments.

  

	 	5.2	Price Decreases. If Vendor offers any price decreases for Products and/or Services to a substantial number of its customers during the Term, Vendor agrees to notify HPG of
such price decreases and make such decreases available to similarly situated Purchasers immediately and in like amounts. 

  

	 	6.0	State Sales or Use Taxes 

  

	 	6.1	Tax Collection. Vendor shall be registered in all taxing jurisdictions where it is legally required to register. Any federal, state, or local sales, use, excise, or other
similar tax imposed on Vendor by virtue of this Agreement or the Products and/or Services provided by Vendor hereunder, or any such taxes imposed on Purchaser, shall be collected from Purchaser by Vendor, and paid to the appropriate taxing
jurisdiction by Vendor. Each invoice to Purchaser shall clearly and separately state the amount of such tax. Vendor shall promptly refund to Purchasers in cash, any over-charges of taxes collected by Vendor from Purchasers. 

 

	 	6.2	Tax Reconciliation. Upon request, Vendor shall provide reasonable assistance to HPG and each Purchaser to provide data and information in Vendor’s possession to assist
Purchaser’s reconciliation of its item files to Vendor’s files with regard to tax rates and taxability of Products and/or Services, including the provision of the following information to the extent Vendor tracks and has actual knowledge
of such information: 

  

	 	(1)	Is the product or package labeled in a manner that indicates it’s available only with a physician’s prescription (i.e., is it a federal legend item)?

  

 Page 10 of 32 

	 	(2)	Is the item a kit, pack, or tray? If yes, list all items contained in the kit, pack, or tray and each item’s approximate percentage of costs. 

  

	 	(3)	Is the product for single patient use? 

  

	 	(4)	Does the product carry a National Drug Code (“NDC”) label or serve as a generic equivalent for a product carrying an NDC label? 

  

	 	(5)	Is the product medicated? If yes, what is the primary active ingredient? 

  

	 	6.3	Tax Information. Vendor shall furnish to HPG and each Purchaser, upon request, a copy of Vendor’s registration certificate and number within each taxing jurisdiction
prior to collecting such sales or use taxes. If a purchase is tax-exempt, such Purchaser shall, prior to purchase, furnish Vendor with any documents necessary to demonstrate its tax-exempt status. Vendor shall also provide to each Purchaser, upon
request, Vendor’s Federal Tax Identification number. 

  

	 	7.0	Vendor Delivery Performance; Customer Service 

  

	 	7.1	Delivery Performance Warranty. Vendor represents and warrants to HPG and Purchasers that it shall make commercially reasonable efforts to maintain in inventory at appropriate
locations sufficient quantities of each Product and shall both choose a transportation mode and carrier and provide said carrier with appropriate instructions to ensure that any Purchaser ordering Products will receive delivery within seven
(7) business days after the date the order is received by Vendor (except for build-to-order products) unless a different delivery schedule is stated in Exhibit A or B, in which case the stated delivery schedule time period in
Exhibit A or B shall apply to this warranty. This delivery performance warranty shall become effective with respect to each such Product thirty (30) calendar days from the Effective Date of this Agreement, if such Product is
listed in Exhibit A, or from the date such Product is later added to Exhibit A of this Agreement. 

  

	 	7.2	Delivery Failures. If Vendor anticipates that it will not be able to deliver any particular Product ordered by any Purchaser within the later of (i) seven
(7) business days following either the date of receipt of the order (or within the delivery schedule of Exhibit A or B, if applicable); or (ii) the date of delivery stated in the order, Vendor shall immediately notify the
Purchaser and work with the Purchaser to resolve the supply issue to Purchaser’s satisfaction. This resolution may include assistance in the identification and location of an acceptable substitute at the same or lower pricing as the unavailable
Product. Vendor shall be responsible for paying additional costs for any expedited shipment of Products required to meet the delivery obligations stated in this Agreement. However, Purchaser shall be required to pay any additional freight charges
for any shipment where Purchaser requests a delivery period shorter than that stated in this Agreement. Payment of such additional shipping charges shall be in accordance with the freight payment terms of Exhibit B. 

 

 Page 11 of 32 

	 	7.3	Remedies for Delivery Failures. If Vendor is unable to ship Product or provide Services within the time periods specified in this Agreement or applicable order, Purchaser
shall have the right to either cancel the order, in whole or part, to accept alternative delivery dates, or to order a replacement from another source, in addition to any other rights of Purchaser arising under this Agreement or by law. If Vendor
backorders Products for any order or portion thereof which it is unable to ship for delivery within the required time period, Vendor shall notify the Purchaser and Purchaser the option of canceling the order with respect to the backordered Products.

  

	 	7.4	Intentionally Omitted. 

  

	 	7.5	No Breach of Award. Neither Purchaser nor HPG shall be deemed to be in breach of any Sole Source Award or Dual Source Award terms of this Agreement (if any) as a result of
the purchase of replacements for Product that Vendor is unable to provide as required by the terms of this Agreement. 

  

	 	7.6	Vendor Support. Vendor shall provide customer service support staff for receipt of telephone calls, e-mails and facsimiles from Purchasers and HPG for the purpose of
resolving issues related to transactions under this Agreement. Vendor’s service representatives shall be available between 6:00 A.M. and 5:00 P.M. Pacific time, Monday through Friday, except for holidays. 

  

	 	8.0	Shipment, Risk of Loss, Freight Charges 

  

	 	8.1	Shipment Terms. Freight/shipping charges, including insurance for the full value of Product shipped, are not included in the Product price and shall be “prepaid” by
Vendor and added to the invoice as a separate line item that is identified as either “freight” or “shipping” and “insurance” charges. Freight charges shall be for the net charge by the carrier and shall not include any
up-charges. 

  

	 	8.2	Packaging. Vendor assumes all responsibility for proper packaging of Products for safe shipment to Purchaser, in accordance with both the packing and shipping regulations of
the transportation service provider, and also, if applicable, the packaging, marking, labeling and shipping paper requirements of the United States Department of Transportation’s Hazardous Material Regulations. 

  

	 	8.3	Risk of Loss. Products shall be shipped on an F.O.B. origin basis, with title and risk of loss or damage passing to the ordering Purchaser upon Vendor’s delivery of the
Products to the carrier. In the event of a damaged, lost or missing shipment, Vendor shall, at Purchaser’s request and discretion, and at no cost to the Purchaser, submit a claim on behalf of the Purchaser with the carrier, and ensure the claim
is resolved to Purchaser’s reasonable satisfaction. 

  

	 	8.4	Shipping and Handling. Except as set forth in Exhibit B, no “Handling” or “Shipping and Handling” charges shall be added to any invoice, and
Purchasers shall have no obligation to pay “Handling” or “Shipping and Handling” charges for purchases under this Agreement. 

  

	 	8.5	Intentionally Omitted. 

  

 Page 12 of 32 

	 	9.0	Warranties and Disclaimer of Liability 

  

	 	9.1	Product Warranties. Vendor represents and warrants to HPG and Purchasers that the Products when delivered: 

  

	 	9.1.1	are new and not used, remanufactured or reconditioned (unless specified in the order); 

  

	 	9.1.2	intentionally omitted. 

  

	 	9.1.3	are warranted to perform as set forth in Exhibit B; 

  

	 	9.1.4	do not contain latex, mercury, polyvinyl chloride (PVC), 2 di-ethyl hexyl phthalate (DEHP) or any other chemical or component that has been determined to be a health and/or
environmental hazard; except as noted below: (1) certain Masimo monitors, including but not limited to the Radical and Radical 7 monitors, contain a sealed mercury switch, and (2) many Vendor Products have PVC components that may contain
DEHP as a plasticizer. 

  

	 	9.1.5	conform to or exceed applicable United States government approved grading applicable at time of shipment to Purchaser; 

  

	 	9.1.6	and any Services provided, conform to or exceed the requirements of all applicable industry standards and federal, state and local laws, regulations and ordinances, including
Federal Drug Administration (“FDA”) rules, regulations, guidelines and required approvals, requirements imposed by the Joint Commission (“JC”) and Medicare/Medicaid conditions of participation, and any amendments
thereto; and that Products will not display or print out any information that contains any abbreviations prohibited by JC standards; 

  

	 	9.1.7	if the Products are electrically powered, each Product is provided with a heavy-duty grade power cord that meets the requirements of UL-544, UL 60601-1, or NFPA 99 § 8-4.1 (and
subsets) or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices; the adapters and extension cords, if needed, for the use of this
Product, meet the requirements of NFPA 99 § 8-4.1.2.5 or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices; and to the extent
other requirements of NFPA apply to any Product, whether or not specifically referenced in this Agreement, Products will comply with such applicable NFPA standards; 

  

	 	9.1.8	carry a safety mark, if required by the Occupational Safety and Health Administration (“OSHA”), from a National Recognized Testing Laboratory
(“NRTL”) for use of electrical equipment in a public facility (as specified in the OSHA 29 CFR Standards, Part 1910, Subpart S-Electrical, Sec 1910.399.); 

  

 Page 13 of 32 

	 	9.1.9	are listed with Underwriters Laboratory (“UL”) or a nationally recognized testing laboratory as suitable for use in a healthcare facility, if such listing is
available for Products; if Products include medical electrical equipment, Products shall meet or exceed the requirements of either UL-544 or UL 60601-1Medical Electrical Equipment, Part 1: General Requirements for Safety, as amended or superseded,
or the then most current UL, National Fire Protection Association (“NFPA”) 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices;

  

	 	9.1.10	if the Products are electrically powered, each Product is provided with a heavy-duty grade power cord that meets the requirements of UL-544, UL 60601-1, or NFPA 99 § 8-4.1 (and
subsets) or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices; the adapters and extension cords, if needed, for the use of this
Product, meet the requirements of NFPA 99 § 8-4.1.2.5 or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices; and to the extent
other requirements of NFPA apply to any Product, whether or not specifically referenced in this Agreement, Products will comply with such applicable NFPA standards; 

  

	 	9.1.11	to the extent applicable, meet the requirements of NFPA 99 for Health Care Facilities, Chapter 8 or UL 544 or UL 2601-1 or the then most current UL, NFPA 99, NFPA 70, FDA, or other
applicable standard/code that addresses the safety and marking requirements of electrical medical devices, with maximum leakage current not to exceed the values set forth in NFPA 99 § 7-5.1.3 or 7-5.2 or the then most current UL, NFPA 99, NFPA
70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices, as applicable. (Actual leakage current test values for Products shall be furnished by Vendor at the request of HPG or any
Purchaser); 

  

	 	9.1.12	if the Products are equipment intended for use in an operating room environment or other location with anesthetizing equipment, each Product is labeled in accordance with NFPA 99
§ 9-2.1.8.3 or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical medical devices; each Product label shall indicate whether it is suitable for use
in anesthetizing locations under the requirements of NFPA 70 § 13-4.1 and 99 §7-5.1 or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable standard/code that addresses the safety and marking requirements of electrical
medical devices; if Product is intended to be used in locations where flammable anesthetics are used, the Product shall be marked in accordance with NFPA 70 § Article 505-9 or the then most current UL, NFPA 99, NFPA 70, FDA, or other applicable
standard/code that addresses the safety and marking requirements of electrical medical devices. References to UL or NFPA code sections in this Section 9.1 shall also be deemed to apply to any amendments or superseding sections thereto;

  

 Page 14 of 32 

	 	9.1.13	if the Products are equipment, each Product is shipped with an operator or user manual which includes: 

  

	 	9.1.13.1	Illustrations that show locations of controls. 

  

	 	9.1.13.2	Explanation of the function of each control. 

  

	 	9.1.13.3	Illustrations of proper connection to the patient and other equipment. 

  

	 	9.1.13.4	Step-by-step procedure for proper use of appliance. 

  

	 	9.1.13.5	Safety precautions (or considerations) in application and in servicing. 

  

	 	9.1.13.6	Effects of probable malfunctions on patient and employee safety. 

  

	 	9.1.13.7	Difficulties that might be encountered, and care to be taken if the Product is used on a patient at the same time as other electric devices. 

  

	 	9.1.13.8	Circuit diagrams for the particular Product shipped. 

  

	 	9.1.13.9	Functional description of the circuits in Product. 

  

	 	9.1.13.10	Power requirements, heat dissipation, weight, dimensions, output current, output voltage and other pertinent data for the Product. 

	 	

	 	9.1.13.11	All other warnings and instructions necessary to operate the equipment safely, effectively, and efficiently. 

  

	 	9.1.14	if the Products are equipment, each Product contains: 

  

	 	9.1.14.1	Certification that it meets medical device labeling requirements under the applicable FDA regulation. 

  

	 	9.1.14.2	Condensed operating instructions clearly and permanently displayed on the Product itself. 

  

	 	9.1.14.3	Nameplates, warning signs, condensed operating instructions, labels, etc. that are legible and will remain so for the expected life of the Product under the usual stringent hospital
service cleaning conditions. 

  

	 	9.1.14.4	Labeling in compliance with the medical device labeling requirements under the applicable FDA rules, regulations, and guidelines. 

  

	 	9.1.14.5	Labeling that provides all other warnings and instructions necessary to operate the equipment safely, effectively, and efficiently. 

  

	 	9.2	Product Failures. If any Product purchased hereunder fails to function in accordance with the express warranties stated herein within the warranty period stated in Exhibit
B, then Vendor shall promptly repair or replace, at Purchaser’s option, the Product at no additional cost to Purchaser. The terms and conditions of any warranty provided by Vendor hereunder, including the length of the warranty, shall not
reduce or eliminate any remedy available to Purchasers under Section 9.7 concerning any recall or provided by any federal, state, or local agency. 

  

	 	9.3	 Good Title. Vendor further represents and warrants to HPG and Purchasers that Vendor has good title to the Products supplied and that the Products are free
and clear from all 

  

 Page 15 of 32 

	 	 
liens and encumbrances, and Purchasers shall quietly and peacefully possess the Products without interruption or disturbance by a third party.

  

	 	9.4	Non-Infringement. Vendor has no knowledge that the Products and the possession and the use thereof by Purchaser in the manner intended by Vendor infringe or misappropriate
the patent, trade secret, trademark, copyrights or other intellectual property rights of any third party. To the extent Purchaser’s purchase, possession and/or use of any Products is covered by any intellectual property rights owned by Vendor
or any Affiliates of Vendor, provided Purchaser has paid the purchase price for Products, Vendor hereby expressly grants Purchaser a non-exclusive, perpetual, irrevocable license under such intellectual property rights to possess and use the
Products in the manner described in Vendor’s Product documentation. 

  

	 	9.5	Services. If Vendor is required to provide any Services under this Agreement, Vendor expressly represents and warrants to HPG and Purchasers that such Services shall be
performed timely, in a workman-like manner, consistent with industry standards; in compliance with all applicable federal, state and local laws and regulations; and otherwise in conformance with any standards provided in any exhibit to this
Agreement. Vendor shall obtain at its own cost any and all necessary consents, licenses, approvals, and permits required for the provision of Services. Vendor represents and warrants that any of its representatives routinely visiting the premises of
any Purchaser shall comply with such Purchaser’s credentialing and other policies, as applicable, provided that Purchaser shall obtain the consent of such representatives for any testing or background checks. 

  

	 	9.6	Beneficiaries; Survival. The express representations and warranties provided in this Agreement, together with any additional representations and/or warranties of Vendor,
shall run to HPG, Purchaser and their successors and permitted assigns and shall survive the termination or expiration of this Agreement. Vendor acknowledges and agrees that HPG would not execute this Agreement and Purchasers would not purchase
Products and/or Services but for the representations and warranties set forth in this Agreement. 

  

	 	9.7	Recalls. In the event any Product or any of its components will be or are subject to recall, as that term is defined under 21 C.F.R. Part 7 (“Recall”), or
subject to an FDA-initiated court action for removing or correcting violative, distributed products or components (“FDA-initiated court action”), Vendor shall promptly notify Purchasers and HPG. Notices to HPG shall be sent by e-mail to:

 vendorrecall@healthtrustpg.com, and the parties shall cooperate to the extent reasonably necessary to conduct such
recall in accordance with the policy and procedure established by the Vendor to address the recall. Vendor’s liability for a Product recall shall be limited to, at Vendor’s sole discretion and in full compliance with FDA requirements, the
repair or replacement of the part that causes the recall, or the return of the purchase price. Vendor shall be responsible for the cost it incurs for repairing and/or replacing the Product affected by the recall and for the payment of all freight or
shipping charges involved with such recall. This paragraph is not intended to further limit Masimo’s liability for product failures as set forth elsewhere in this Agreement, 

  

 Page 16 of 32 

 
including the warranty set forth in Exhibit B and the indemnification obligations set forth in Section 11. 
  

	 	9.8	To the extent such Recall precludes Vendor from supplying any Products or Services under this Agreement, any Purchaser compliance requirements or purchase requirements under this
Agreement or any facility agreement between any Purchaser and Vendor related to such Products shall not be effective for as long as Vendor is unable to supply such Products. In the event any Product pricing is dependent upon a Purchaser meeting
compliance or purchase requirements for designated Products, a Purchaser’s pricing will not change for failure to meet the compliance or purchase requirements during the time period when Vendor is unable to provide said designated Products.
Disaster Recovery Plan. Vendor represents and warrants to HPG and Purchasers that it has and shall maintain a disaster recovery plan to ensure delivery of Products upon the occurrence of any event or circumstance beyond Vendor’s
reasonable control, including without limitation acts of God, war or terrorist attack, riot, strike, labor disturbance, fire, explosion or flood at its primary manufacturing and distribution locations, and agrees to review such plan with HPG upon
request. 

  

	 	9.9	Documentation. Upon request, Vendor will supply HPG and Purchasers with written documentation, including certifications, operators manuals, safety marks, and the like for
Products, prior to a purchase or installation. 

  

	 	9.10	Safety Performance Testing Data. Upon request, Vendor will provide to HPG and Purchasers the safety performance testing data it submitted to the FDA before a Product is
purchased and documents demonstrating compliance with IEC 60601-1 + United States deviations (UL2601-1/UL6061-1) 

  

	 	9.11	Limitations; Mitigation. Except as is otherwise provided herein and except as may arise from a Party’s or any Purchaser’s GROSS NEGLIGENCE, WILLFUL MISCONDUCT,
BREACH OF SECTION 12 (“CONFIDENTIALITY”) OR OBLIGATIONS PURSUANT TO SECTION 11.1 (“INDEMNITY”), NEITHER PARTY NOR ANY PURCHASER SHALL BE LIABLE TO THE OTHER FOR THE OTHER’S SPECIAL, CONSEQUENTIAL, PUNITIVE,
INCIDENTAL OR INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY, AND WHETHER OR NOT THEY HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. ANY COSTS AND EXPENSES INCURRED BY HPG AND ANY PURCHASERS OR BY VENDOR TO MITIGATE OR LESSEN
ANY DAMAGES OR HARM CAUSED BY ANY FAILURE OF PRODUCTS OR SERVICES TO COMPLY WITH THE WARRANTIES REFERENCED IN THIS AGREEMENT SHALL BE CONSIDERED DIRECT DAMAGES. 

  

	 	10.0	Inspection 

 All Products shall be subject to
inspection and acceptance for up to ten (10) days after receipt by Purchaser, (the “Acceptance Period”) to confirm that such Product, as delivered, performs in material compliance with its published specifications. Any Products
which do not comply with Purchaser’s purchase order; in any way fail to comply with the warranties provided under this Agreement; or are defective in any way at any time prior to the end of the applicable 

  

 Page 17 of 32 

 
Acceptance Period, may be rejected by Purchaser on written notice to Vendor irrespective of date of payment therefor. If Vendor has not received such notice
within the Acceptance Period, the Equipment is deemed accepted upon expiration of the Acceptance Period. Purchaser may hold any Product rejected for reasons described herein pending Vendor’s instructions, or Purchaser, by mutual agreement with
Vendor, may return such Products to Vendor at Vendor’s expense, F.O.B. Origin, Freight Collect. 
  

	 	11.0	Indemnity 

  

	 	11.1	Bodily Injury. Vendor will defend, indemnify and hold HPG and Purchasers harmless against any and all liability, loss, damages, costs or expenses (including reasonable
attorney’s fees) that HPG and/or Purchaser may hereafter incur, as a result of any injury, illness or death of any person which is caused by any Products, to the extent that such injury, illness or death resulted from (i) Vendor’s
design or manufacture of Products or (ii) failure of any Product to materially comply with its published specification. “Product(s)” includes all those listed on Exhibit A, including any Sensors and Equipment provided to Purchaser
under this Agreement, including without limitation third party monitors that contain Vendor SET or Rainbow SET technology under license from Vendor (“OEM Monitors”). 

  

	 	11.2	Infringement. Vendor will defend, indemnify and hold HPG and Purchasers harmless against infringement or alleged infringement directly resulting from Products furnished under
this Agreement as well as the use thereof in the manner specified by Vendor, of any patent, copyright, trademark, trade secret, or any other proprietary right of any third party. In the event of such claim, Vendor shall, at its sole discretion,
either (i) modify the particular Product to make it non-infringing, (ii) obtain a license to allow the continued use of the Product, or (iii) terminate this Agreement, and take possession of and refund all fees paid for the infringing
Products. 

  

	 	11.3	 Exclusions. As conditions for indemnification, HPG and Purchasers shall (i) promptly notify Vendor of any claims for indemnity under this
Section 11, (ii) give Vendor an adequate opportunity to defend, including complete control of such defense, and (iii) provide reasonable assistance to Vendor, at Vendor’s expense and request, in connection with the defense and
settlement of any such claim. Vendor shall have no liability for settlements made without Vendor’s express written consent. Should HPG or Purchaser desire to have its own counsel participate in any such action, provided Vendor has undertaken
the defense of such action, the cost of such counsel shall be exclusively HPG’s or Purchaser’s. Notwithstanding the above, Vendor shall not be liable for any infringement of intellectual property rights of third parties or for any
liability, loss, damages, costs or expenses which Purchaser may incur as a result of any injury, illness or death resulting from (a) alterations or modifications to the Products made by Purchaser or third parties at Purchaser’s request and
without the written approval of a Vendor executive vice president or chief executive officer, (b) electrical/electronics, software/firmware, sensors, or product interface not furnished by Vendor, (c) combination of the Products with other
apparatus or technology not furnished by Vendor, (d) use of Products in combination with products or components not supplied by Vendor, (e) use of Products expressly prohibited under this Agreement (if any), or (f) 

  

 Page 18 of 32 

	 	 
for any claims not related directly to the Products. The preceding Vendor indemnification obligations apply to claims arising out of Vendor SET or Rainbow
SET technology contained in OEM Monitors or the combination of such technology with Vendor Sensors and Equipment. 

  

	 	11.4	If Vendor fails to assume its obligation to defend an HPG Indemnitee, then an HPG Indemnitee may do so to protect its interest and seek reimbursement from Vendor.

  

	 	11.5	Reimbursement of Costs for Third Party Litigation. With respect to any litigation when HPG is not a party thereto, in the event any subpoena or other legally binding request
on HPG is served by or on behalf of Vendor or any Affiliates of Vendor, requesting copies of documents maintained by HPG, Vendor agrees to reimburse HPG for its out-of-pocket costs associated with compliance with such requests. With respect to any
litigation when Vendor is not a party thereto, in the event any subpoena or other legally binding request on Vendor is served by or on behalf of HPG, a Purchaser or any Affiliates thereof requesting copies of documents maintained by Vendor, such
litigant agrees to reimburse Vendor for its out-of-pocket costs associated with compliance with such requests. 

  

	 	12.0	Confidentiality; Software License & Use Restrictions. 

  

	 	12.1	Confidentiality Obligations. During the Term and surviving its expiration or termination, the Party receiving confidential information (“Recipient”) will
regard and preserve as confidential and not disclose publicly or to any third party all information related to the business of the other Party (“Discloser”), Purchasers and their Affiliates, clients and patients that may be obtained
as the result of performance under this Agreement. Each Party agrees to hold the terms of this Agreement in confidence in accordance with the terms of this Agreement. Vendor agrees that the list of eligible Purchasers, the terms of this Agreement,
including the sales volumes of Products and Services, in the aggregate or by Purchaser, shall also be held in confidence and not disclosed publicly. HPG shall hold in confidence as Vendor’s confidential information all pricing for Products and
Services, except HPG may disclose pricing to its Participants in confidence on a need to know basis in connection with the performance of this Agreement. Subject to the requirements of Section 12.3 HIPAA Requirements below and any applicable
law or regulation, the confidentiality obligations of this Section 12.1 do not apply to: (a) information that is publicly known prior to the disclosure or becomes publicly known through no wrongful act of the Recipient;
(b) information that was in lawful possession of the Recipient prior to the disclosure and was not received as a result of any breach of confidentiality with respect to the Discloser, Purchaser or their Affiliates; (c) information that was
independently developed by Recipient outside the scope of this Agreement; (d) information which Recipient is required to disclose by law, court order or regulatory agency request; or (e) information that must be disclosed to third parties
in confidence for performance under this Agreement. In the event of a request for disclosure falling under part (d) above, immediate notice of such request shall be provided to the Discloser in order to provide an opportunity to oppose such
request for disclosure. 

  

 Page 19 of 32 

	 	12.2	Exclusions. HPG shall have the right to use Vendor pricing information on Products and Services for HPG’s internal analyses and for creating pricing evaluations for
disclosure to potential Participants pursuant to a confidentiality agreement. HPG shall also have the right to disclose such information to third parties for performance of such analysis pursuant to a confidentiality agreement. HPG shall have the
right to disclose the terms of this Agreement to Participants and to also provide copies of this Agreement to potential purchasers of any Purchaser or Participant, provided such disclosure is made pursuant to the terms of a confidentiality
agreement. HPG and Purchasers shall have the right to provide Product and Service pricing information in confidence to third party e-commerce companies which process orders between Purchasers and Vendor 

  

	 	12.3	HIPAA Requirements. Vendor acknowledges that many Purchasers are “covered entities” as that term is defined at 45 C.F.R. § 160.103. Vendor agrees to
comply with the Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996, as codified at 42 U.S.C. § 1320d et seq. (“HIPAA”) and any current and future regulations
promulgated thereunder including without limitation the federal privacy regulations contained in 45 C.F.R. Parts 160 and 164 (the “Federal Privacy Regulations”), the federal security standards contained in 45 C.F.R. Parts 160, 162
and 164 (the “Federal Security Regulations”), and the federal standards for electronic transactions contained in 45 C.F.R. Parts 160 and 162 (the “Federal Electronic Transaction Regulations”), all as amended from
time to time and collectively referred to herein as the “HIPAA Requirements”. Vendor agrees not to use or further disclose any Protected Health Information (as defined in the Federal Privacy Regulations) or EPHI (as defined in the
Federal Security Regulations) other than as permitted by the HIPAA Requirements and the terms of this Agreement. Vendor will make its internal practices, books, and records relating to the use and disclosure of Protected Health Information available
to the Secretary of Health and Human Services (“HHS”) to the extent required for determining Purchaser’s compliance with the HIPAA Requirements. 

  

	 	12.4	Software License Grant. The Products contain Vendor proprietary software (the “Software”), trade secrets and other proprietary information (collectively,
“Intellectual Property”). Vendor grants to Purchaser a non-exclusive, non-transferable, perpetual license to use the Software and Intellectual Property in connection with its use of the Products. This Agreement does not constitute a sale
of the Software or any Intellectual Property. The Purchaser may not reverse engineer, copy, modify, loan, rent, lease, assign, transfer, or sub-license the Software or Intellectual Property without Vendor’s prior written consent, which may be
withheld at Vendor’s sole discretion; any attempt to do so will render the license null and void and the right to use the Software and Intellectual Property invalid. 

  

	 	12.5	Limited Use of Equipment. [...***...]. HPG shall advise 

 *Confidential Treatment Requested 
  

 Page 20 of 32 

 Purchasers that the monitors are not intended to be used by anyone other than the Purchaser’s
qualified and trained personnel or third party maintenance personnel trained by Vendor (or trained in accordance with Vendor’s maintenance processes in the case where Vendor trains the trainer for the third party service provider). Except as is
described in the applicable user documentation or pursuant to Vendor’s maintenance training, the Purchaser may not modify or connect other monitors to the Vendor monitors, including software, hardware and related instruments without
Vendor’s prior written authorization, which authorization may be withheld at Vendor’s sole discretion. The Parties acknowledge that the monitors, Software, sensors and related disposable accessories are intended for use for processes,
procedures, experiments or any other uses for which are cleared for use by the Food and Drug Administration (FDA). 
  

	 	13.0	Publicity 

 Vendor shall have the right to
issue a press release within thirty (30) days after the Effective Date announcing the execution of this Agreement, subject to obtaining HPG’s prior written approval on the text of such release, which shall not be unreasonably withheld.
Except as stated above, no advertisement, solicitation, or public announcement of the existence of this Agreement or the relationship created hereby may be made by Vendor, unless Vendor is required by law to do so. In such event, the text of any
proposed announcements should be first submitted in writing to: Vice-President, National Agreements, HealthTrust Purchasing Group, 155 Franklin Road, Suite 400, Brentwood, TN 37027. Any violation of this provision shall be considered a material
breach of this Agreement, conferring on HPG the right to terminate this Agreement immediately without any right of Vendor to cure such breach. 
  

	 	14.0	Insurance 

 During the Term, Vendor shall
maintain at its own expense commercial general liability insurance for bodily injury, death and property loss and damage (including coverages for product liability, completed operations, contractual liability and personal injury liability) covering
Vendor for claims, lawsuits or damages arising out of its performance under this Agreement, and any negligent or otherwise wrongful acts or omissions by Vendor or any employee or agent of Vendor, with HPG and Purchasers listed as additional
insureds. All such policies of insurance may be provided on either an occurrence or claims-made basis, and shall provide limits of liability in the minimum amount of five million dollars ($5,000,000) per claimant (“claimant” is
defined as the injured person, his/her spouse, and children, if any) with an annual aggregate of ten million dollars ($10,000,000). If such coverage is provided on a claims-made basis, such insurance shall continue throughout the Term and for a
period of at least five (5) years thereafter, and upon the earlier expiration or cancellation of the insurance, Vendor shall purchase or arrange for the purchase of either an unlimited reporting endorsement (“Tail” Coverage) or
“Prior Acts” coverage from the subsequent insurer, with a retroactive date on or prior to the Effective Date of this Agreement and for a period of not less than five (5) years following the termination or expiration of this Agreement.
Vendor shall also maintain Automobile Liability insurance with limits of two million dollars ($2,000,000) per accident, Worker’s Compensation with statutory limits as applicable and Employer’s Liability insurance with limits of one million
dollars ($1,000,000). Upon HPG’s request, Vendor, or Vendor’s agent, shall provide HPG with a copy of all such policies and/or certificates of insurance 

  

 Page 21 of 32 

 
satisfactory to HPG, evidencing the existence of all coverage required hereunder. Vendor shall require its insurance carriers or agents to provide HPG, and
Vendor shall also provide HPG, with not less than thirty (30) days prior written notice in the event of a change in the liability policies of Vendor (ten (10) days if any such policy is cancelled for failure to pay renewal premiums).

  

	 	15.0	Order Cancellation 

 Purchaser may cancel any
order arising out of this Agreement in whole or in part, without liability, if (i) Products have not been shipped as of the date of Vendor’s receipt of notice of cancellation (and, in the case of build-to-order products, production has not
yet begun) ; (ii) Product deliveries are not made at the time and in the quantities specified; (iii) Products (or the possession and use thereof) infringe or misappropriate, or are alleged to infringe or misappropriate any patent,
trademark, copyright, trade secret or other intellectual property right; or (iv) the ordered Products (or the possession and use thereof) fail to comply with the terms of this Agreement or with any applicable law or regulation. Also, Purchaser
may immediately cancel any order where the Vendor is in breach of the Warranty of Non-exclusion, as set forth in Section 17.7. To cancel, Purchaser shall give notice to the Vendor in writing, and to the extent specified therein, Vendor shall
immediately terminate deliveries under the order. 
  

	 	16.0	Termination of Agreement 

  

	 	16.1	Termination with Cause. Vendor and HPG shall each have the right to terminate this Agreement in its entirety or with respect to certain Products or Services, in the event of
a material breach of the terms hereof by the other Party which is not cured within thirty (30) calendar days following receipt of written notice thereof specifying the breach. 

  

	 	16.2	Termination without Cause. HPG shall have the right to terminate this Agreement in its entirety or with respect to certain Products or Services without cause by providing at
least sixty (60) days written prior notice, without any liability to Vendor for such termination. 

  

	 	16.3	Termination for Tying Arrangements. Vendor may terminate this Agreement for convenience on sixty (60) days notice if HPG enters into an agreement with any other HPG
contracted supplier that amounts to being a Tying Arrangement. In such event, termination of this Agreement by Vendor shall be its sole remedy and HPG shall not be deemed to have breached this Agreement. As used in this paragraph, a “Tying
Arrangement” shall be defined as any discount program in which the Purchaser receives additional discounts or rebates in its purchase of unrelated products or services in return for its purchase of vital signs monitoring products from a
particular supplier. 

  

	 	16.4	Remedies. Subject to the provisions of Section 16.7, any termination by either Party, whether for default or otherwise, shall be without prejudice to any claims for
damages or other rights against the other Party, or between Vendor and any Purchasers, that preceded termination. No specific remedy set forth in this Agreement shall be in lieu of any other remedy to which a Party or any Purchaser may be entitled
pursuant to this Agreement or otherwise at law or equity. 

  

 Page 22 of 32 

	 	16.5	Change of Control. HPG shall also have the right to terminate this Agreement in its entirety or with respect to certain Products or Services, upon sixty (60) days prior
written notice upon the transfer, directly or indirectly, by sale, merger or otherwise, of substantially all of the assets of Vendor or its ultimate parent or any permitted assignee (upon assignment to such assignee) or in the event that more than
forty-nine percent (49%) of the ownership interest of Vendor, its ultimate parent or any such permitted assignee is transferred to an independent third party entity. 

  

	 	16.6	Inventory Upon Termination. With respect to any Products that are available through a Distributor, upon termination or expiration of this Agreement, Vendor agrees that it
will, within thirty (30) days following termination or expiration, purchase from the Distributor the Products remaining in Distributor’s inventory as of the effective date of termination or expiration, provided such inventory is new in its
original box and the date of shipment to Distributor is less than 90 days before the effective date of termination or expiration. Such remaining product shall be shipped back to Vendor at Distributor’s expense. 

  

	 	16.7	Termination of Sole / Dual Source Status. Upon fifteen (15) calendar days notice, HPG shall have the right to convert any Sole or Dual Source designation for any Product
in this Agreement to an “Optional/Preferred Source” designation, with no change in pricing from the Sole or Dual Source pricing, if Vendor fails to maintain at least a ninety-five percent (95%) fill rate for all purchases of such
Product by all of the Purchasers. “Fill rate” as used herein shall be described as the average of the individual fill rates for all orders of the Product by all Purchasers during any calendar month based upon the ratio of total
units ordered for such Product divided into the total units delivered within the delivery schedule requirements of Section 7 of this Agreement. 

  

	 	16.8	Survival of Terms. Sections 3.1 (GPO Fees) and 3.2 (Rebates) (to the extent any amounts are outstanding at the expiration or termination of this Agreement), 9 (Warranties),
11 (Indemnity), 12 (Confidentiality), 14 (Insurance), 16.8 (Survival), 17 (Books, Records and Compliance), 25 (Controlling Law), 26 (Legal Fees), and 29 (Notices), and any terms in this Agreement which by their nature must survive after the Term to
give their intended effect shall be deemed to survive termination or expiration of this Agreement. 

  

	 	17.0	Books, Records and Compliance Requirements 

  

	 	17.1	Access to Vendor Records. 

  

	 	17.1.1	To the extent the requirements of 42 CFR 420.300 et seq. are applicable to the transactions contemplated by this Agreement, Vendor agrees to make available to the Secretary
of HHS, the Comptroller General of the Government Accountability Office (“GAO”) and their authorized representatives, all contracts, books, documents and records relating to the nature and extent of charges hereunder until the
expiration of six (6) years after Products and Services are furnished under this Agreement if Products or Services are of the type reimbursable under Medicare or any other government healthcare program. 

  

 Page 23 of 32 

	 	17.1.2	If Vendor subcontracts with an organization “related” to Vendor to fulfill Vendor’s obligations under this Agreement and if said subcontract is worth Ten Thousand
Dollars ($10,000) or more over a consecutive twelve (12) month period, the subcontract will also contain clauses substantially identical to the paragraphs in this Section 17 which permit access by HPG, the HHS, GAO and their
representatives to the “related” organization’s books and records. 

  

	 	17.2	Discount Laws and Regulations. 

  

	 	17.2.1	Vendor agrees to comply at all times with the regulations issued by the Department of HHS published at 42 CFR 1001, and which relate to Vendor’s obligation to report and
disclose discounts, rebates and other price reductions to HPG and Purchasers for Products and/or Services purchased under this Agreement. Where a discount or other reduction in price of the Products is applicable, the Parties also intend to comply
with the requirements of 42 U.S.C. §1320a-7b(b)(3)(A) and the “safe harbor” regulations regarding discounts or other reductions in price set forth at 42 C.F.R. §1001.952(h). 

  

	 	17.2.2	The Parties acknowledge that Vendor will satisfy any and all requirements imposed on sellers by these laws and regulations and Purchasers will satisfy any and all applicable
requirements imposed on buyers by these regulations. 

  

	 	17.2.3	Intentionally Omitted. 

  

	 	17.2.4	Intentionally Omitted. 

  

	 	17.2.5	When Vendor sends Purchasers an invoice listing charges that include a capital cost component (e.g., equipment that must be either capitalized or reported as lease expense) and an
operating cost component (e.g., services and/or supplies), Vendor shall, as part of the Facility Agreement that includes a capital cost component and an operating cost component, separately list the prices, shipping fees and taxes applicable to
equipment, supplies and services. The price for all capital component items must be reported on the invoice at the net price, with no discount or rebate to be received separately or at a later point in time. 

  

 Page 24 of 32 

	 	17.3	Government Contractor Requirements. HPG is not a federal government contractor; however, some of the Purchasers that will purchase from Vendor under this Agreement may be
federal government contractors or subcontractors. Vendor acknowledges that purchase orders by any such entities incorporate the contract clauses regarding equal employment opportunity and affirmative action contained in 41 CFR 60-1.4 (Executive
Order 11246), 41 CFR 60-250.4 (Vietnam Era Veterans Readjustment and Assistance Act), and 41 CFR 60-741.5 (Rehabilitation Act). 

  

	 	17.4	 Audit Rights. HPG shall have the right, during normal business hours and with reasonable advance notice, to review Vendor’s books, documents and records
(whether in hard copy, electronic or other form) that reasonably pertain directly to the accounts of HPG, Participants, Purchasers, and their Affiliates, their compliance with the terms of this Agreement, the amounts payable to Vendor under this
Agreement, and the GPO Fees and rebates payable by Vendor for the Products and Services provided by Vendor hereunder. HPG may conduct no more than one such audit in any 12 month period. The audit shall be conducted by employees of HPG or its
Affiliates (including contract employees) or by an external auditing firm selected by HPG and approved by Vendor which approval shall not be unreasonably withheld. The auditors shall not use or disclose (either externally or within HPG), any audit
materials provided by Vendor hereunder except as needed for purposes of the audit. All such auditors shall sign Vendor’s confidentiality agreement before accessing confidential information, which agreement shall have terms comparable to those
in this paragraph and in Section 12 of this Agreement. The Parties agree that the methodology for such audit may include sampling and extrapolation in accordance with standard statistical estimations. In connection with any such audit, Vendor
shall provide an aging report, as well as a report containing the following data fields: GPOID, COID, Customer Number, Facility/Customer Name, Street Address, City, State, Invoice Date, Invoice Number, PO Number, HPG Contract Number, Internal Vendor
Contract ID Number, Contract Name and Description, Product/Item Number, Product/Item Description, Unit of Measure, Quantity Shipped, Unit Price, and Extended Price, solely to the extent that such information is maintained in Vendor’s order
entry system and, in the case of distributor transactions, to the extent such information is provided to Vendor by its distributors. At the request of HPG, the requested records shall be provided to HPG in electronic form at the offices of HPG or
HPG’s auditor. The cost of audit, including the cost of the auditors and reasonable cost of copies of books, documents, and records shall be paid by HPG. HPG shall have no obligation to pay any other costs incurred by Vendor, its employees or
agents in cooperating with HPG in such audit. Upon completion of the audit, Vendor will be notified in writing of the results (an “Audit Report”) within thirty (30) days. If an audit determines that Vendor has significantly
underpaid HPG or any Purchaser based on statistical methodology, or if Vendor desires to challenge the findings, Vendor’s sole option shall be to conduct its own audit of all applicable transactions and to share such findings and supporting
detail with HPG and its auditors. If no response to the Audit Report is received from Vendor within thirty (30) days 

  

 Page 25 of 32 

	 	 
following its issuance, the Audit Report shall be deemed accepted by Vendor. The Audit Report shall be distributed to HPG Participants, and HPG will issue
Vendor an invoice for any amounts due. Vendor shall pay to HPG for proper application and allocation, the amount of any overcharges and unapplied credits (as to Purchasers) and underpayments (as to HPG) determined by the audit within thirty
(30) days from receipt of invoice from HPG, and not use the overcharges or underpayments as a set-off in any fashion. If an audit reveals that Vendor has overpaid GPO Fees to HPG, Vendor may obtain refunds of such overpayments or apply the
balance of such overpayment to future GPO Fees payable to HPG on sales to all Purchasers. If an audit reveals that Vendor has undercharged any Purchaser (or overpaid any rebate), then Vendor reserves the right to supplementally invoice the Purchaser
for such amounts or set-off such amounts against any over charges or rebates for any Purchaser within thirty (30) days of the Purchaser transactions in question. Payment by Purchasers of mutually negotiated prices less than those listed for
Products in Exhibit A shall not be considered to be an undercharge and shall not be applied to reduce the amount of any overcharges by Vendor. The Parties agree to use good faith efforts to resolve any disputes arising from any Audit Report
issued pursuant to this Section 17.4. In the event that HPG and Vendor enter into any settlement with respect to an audit conducted hereunder, each Purchaser shall have the right to be excluded from such settlement, provided that the pro rata
portion of such settlement allocable to such Purchaser is refunded by HPG. 

  

	 	17.5	Warranty of Non-Exclusion. Vendor represents and warrants to HPG, Purchasers and their Affiliates that Vendor and its directors, officers, and employees (i) are not
currently excluded, debarred, or otherwise ineligible to participate in the Federal health care programs as defined in 42 USC § 1320a-7b(f) (the “Federal Healthcare Programs”); (ii) have not been convicted of a criminal
offense related to the provision of healthcare items or services but have not yet been excluded, debarred, or otherwise declared ineligible to participate in the Federal Healthcare Programs; and (iii) are not under investigation or otherwise
aware of any circumstances which may result in Vendor being excluded from participation in the Federal Healthcare Programs. These representations and warranties shall be ongoing during the Term and Vendor shall immediately notify HPG of any change
in the status of the representations and warranties set forth in this Section 17.5. Any breach of this Section 17.5 shall give HPG the right to terminate this Agreement immediately. 

  

	 	17.6	No Remuneration. Vendor represents and warrants to HPG and its Purchasers that it has not made, is not obligated to make, and will not make any payment or provide any
remuneration to any third party in return for HPG entering into this Agreement or for any business transacted under this Agreement. 

  

	 	17.7	 Background Checks. Vendor agrees to perform background checks on any Vendor employees hired on or after the Effective Date who have access to, or may have
access to, any Purchaser facility for the purpose of delivering, maintaining, servicing, or removing equipment and/or Products, to ensure such employees: (i) are not currently excluded, debarred or otherwise ineligible to participate in any
Federal Healthcare Program; (ii) have not been convicted of a criminal offense related to the provision of healthcare items or services but have not yet been excluded; (iii) have not been convicted of any felony; or (iv) as discovered
through any background check or based 

  

 Page 26 of 32 

	 	 
upon Vendor’s knowledge, have not been terminated from employment by any employer or contractor for theft, misappropriation of property, or any other
potentially illegal or unethical acts. Vendor agrees not to use any employee or potential employee failing to meet the criteria in items (i) through (iv) above to provide Services to any Purchaser under this Agreement. Any breach of this
Section 17.7 shall give HPG the right to terminate this Agreement immediately. 

  

	 	18.0	Reports 

 In addition to the reporting
obligations of Section 3.3, Vendor shall also be required to furnish to HPG the reports stated in Exhibit B. 
  

	 	19.0	Assignment 

 Neither Party shall assign this
Agreement in whole or in part, nor subcontract its obligations hereunder, without the prior written consent of the other Party, which consent shall not be unreasonably withheld. Any assignment or subcontract without such prior consent shall be void
and have no effect. Notwithstanding the foregoing, either Party may assign, without obtaining consent from Vendor, in whole or in part, the Party’s rights and obligations under this Agreement (i) to any entity which is an Affiliate of the
Party; and (ii) to a successor entity of the Party as part of an internal reorganization of the Party which results in the Party being organized in a different legal entity or corporate form, whether through conversion, merger, or otherwise.
Subject to the foregoing, all terms, conditions, covenants and Agreements contained herein shall inure to the benefit of, and be binding upon, any successor and any permitted assignees of the respective Parties hereto. It is further understood and
agreed that consent by either Party to such assignment in one instance shall not constitute consent by the Party to any other assignment. Notwithstanding anything else herein to the contrary, some or all of Vendor’s rights under any Purchaser
agreement may be assigned to an Affiliate or to a successor in interest resulting from a merger or acquisition, or transferred to a third party for purposes of financing, provided Vendor remains secondarily liable for its obligations under this
Agreement. 
  

	 	20.0	Merger of Terms and Amendments 

  

	 	20.1	Entire Agreement; Prior Agreement; Amendments. This Agreement constitutes the entire agreement between the Parties and as of the Effective Date, this Agreement terminates and
replaces any existing agreement between HPG and Vendor (the “Prior Agreement”) for purchases of products and services comparable to Products and Services by Purchaser. This Agreement shall exclusively govern the purchases of
Products and/or Services that occur following the Effective Date. The provisions of any Prior Agreement shall continue to apply to the products and services purchased thereunder prior to the Effective Date of this Agreement, and such Prior
Agreements shall continue in full force and effect in accordance with their terms with respect to purchases made thereunder. This Agreement, as executed and approved, shall not be modified except by written amendment, expressly stating an intent to
modify the terms of this Agreement, and signed by the Parties hereto. 

  

	 	20.2	 Conflicts. In the event of any conflict between the terms herein and the terms of any Exhibit hereto, the priority for control, from first to last priority,
shall be Exhibit B, 

  

 Page 27 of 32 

	 	 
Exhibit A, any other Exhibit, and then the terms herein. The terms of this Agreement shall take priority over any conflicting terms contained in any
Vendor Product warranty, whether referenced herein, attached to this Agreement, included with any Product sold by Vendor, or included as part of a facility agreement between Vendor and a Purchaser. 

  

	 	20.3	Exhibit A Revisions. Vendor reserves the right to delete Products shown on Exhibit A at any time, effective on sixty (60) days prior written notice, only if
Vendor is discontinuing its sales of such Product. Prices for Products are firm for the length of the Term. Any price increases shall be subject to prior written approval by HPG in its sole discretion. Vendor shall provide a Form 832 for all Exhibit
A revisions at the time of notice to HPG 

  

	 	20.4	Exhibit E. Exhibit E attached to this Agreement is a summary for use by HPG in communicating the business terms of this Agreement to Participants and Purchasers. The
Parties agree that the content of Exhibit E shall have no legal effect and is only for informational purposes. 

  

	 	21.0	Partial Invalidity 

 In the event that any
provision of this Agreement should for any reason be held invalid, unenforceable or contrary to public policy, the remainder of the Agreement shall remain in full force and effect notwithstanding. 
  

	 	22.0	Other Documents 

 The terms of any purchase
order issued by a Purchaser shall not apply to purchases of Products and Services hereunder, except as necessary to designate specific Products and Services, quantities, delivery dates, and other similar terms that may vary from order to order; and
the terms of this Agreement, to the extent applicable, shall be deemed incorporated in such purchase orders. The terms and conditions contained in any invoice, bill of lading, or other documents supplied by Vendor are expressly rejected and
superseded by this Agreement and shall not be included in any contract with a Purchaser. No letter of commitment, Standardization Incentive Program Acknowledgement, or any other document shall be required by Vendor to be signed by a Purchaser in
order to purchase Products and/or Services under this Agreement, unless expressly stated herein or later approved in writing by HPG. 
  

	 	23.0	Personal Inducements 

 No personal cash,
merchandise, equipment or other items of intrinsic value shall be offered by or on behalf of Vendor to HPG or Purchasers and/or their employees, officers, or directors as an inducement to purchase from Vendor. 
  

	 	24.0	Vendor Relations Policy 

 Vendor acknowledges
that HPG has a Vendor Relations Policy relating to ethics and compliance issues between suppliers and HPG, and that it has received a copy of this policy. The Vendor Relations Policy is also available through the internet at: 
  

 Page 28 of 32 

 http://www.healthtrustcorp.com/about-vendor-ethics.php 
 If Vendor becomes aware of any actions by any HPG employee or representative, which are not consistent with the provisions of Section 23 or of the
Vendor Relations Policy referenced above, Vendor shall so advise the Compliance Officer for HPG (either by phone to 615-344-3037, or in writing to HPG’s principal place of business) or by calling the Ethics Hotline at 1-800-345-7419. Vendor
agrees to notify any Purchasers or potential Purchasers of any possible conflict of interest between employees and representatives of Vendor selling Products and any Purchasers or their employees or representatives possibly involved in the
purchasing decision process. 
  

	 	25.0	Controlling Law 

 The performance of Vendor
and HPG under this Agreement shall be controlled and governed by the laws of the State of Tennessee, excluding conflicts of law provisions. 
  

	 	26.0	Legal Fees 

 In the event of any litigation
between Vendor, Purchaser or HPG, that relates to this Agreement, the prevailing party shall recover from the other party its own costs, expenses and legal fees (including but not limited to reasonable attorneys’ fees and expert witness’
fees). 
  

	 	27.0	Product Bar Coding 

 All Products when sold
shall be marked with an industry standard barcode for each unit of measure associated with each Product. 
  

	 	28.0	Minority and Women Owned Business Enterprises 

  

	 	28.1	Policies. HPG and Vendor hereby acknowledge their respective corporate policies and practices to not only encourage, but to expand the participation of Minority and Women
Owned Business Enterprises (“MWBEs”) in their procurement processes and their desire to work together to encourage their use of MWBEs in fulfillment of the obligations under this Agreement. As used in this Agreement, MWBEs shall be
defined to include any company certified as a minority or women owned business by the National Minority Supplier Development Council or any local affiliates thereof, or any Federal, National, State, Municipal, or Local agencies that certify minority
and/or women owned businesses in accordance with PL. 95-507. 

  

	 	28.2	Contracting with MWBEs. Vendor recognizes and acknowledges that in conjunction with HPG’s efforts to involve MWBEs in its contracting process that HPG may enter into
purchasing agreements with MWBEs which will enable Participants and their Affiliates to purchase supplies and/or equipment comparable to those listed as Products under this Agreement. In such event, notwithstanding any other terms of this Agreement
to the contrary, the Parties agree that, if HPG enters into any such agreement(s) with any MWBEs, such will not be deemed to be a breach of this Agreement by HPG, nor will any purchases by Participants or their Affiliates from MWBEs be deemed to be
a breach of this Agreement. 

  

 Page 29 of 32 

	 	28.3	Reporting of MWBE Activity. At HPG’s request, Vendor shall, on a quarterly basis, identify and report in writing to HPG all MWBE activities in which it participates,
specifically identifying such activities and purchases relating to Products and Services obtained under this Agreement. These reports shall be submitted using the format shown on Exhibit C of this Agreement. Quarterly reports shall be
submitted even if there have been no MWBE dollars expended during the applicable reporting period. Vendor shall only report those activities related to goods and services necessary for, and directly related to, the fulfillment of Vendor’s
obligations under this Agreement. Vendor shall identify in such reports any first and second tier MWBEs it or its subcontractors have used during the reporting period. The MWBE contact for Vendor shall be the person listed in Exhibit B. All
quarterly reports shall be sent to: 

 Director of Business Diversity 
 HealthTrust Purchasing Group 
 155 Franklin Road 
 Suite 300 
 Brentwood, TN 37027 
  

	 	29.0	Notices 

 Notices under this Agreement shall
all be in writing, effective upon receipt and shall be sent by any of the following methods (i) facsimile with return facsimile acknowledging receipt; (ii) United States Postal Service certified or registered mail with return receipt
showing receipt; (iii) courier delivery service with proof of delivery; or (iv) personal delivery. Either Party hereunder may change the names and addresses for receipt of notices by notice given as provided for herein. Notices to Vendor
shall be sent to the person and address listed in Exhibit B. Unless stated otherwise in this Agreement, notices to HPG shall be sent as follows: 
 Vice President, National Agreements 
 HealthTrust Purchasing Group, LP 
 155 Franklin Road, Suite 400 
 Brentwood,
Tennessee 37027 
  

	 	30.0	New Technology 

 The terms of this
Section 30.0, New Technology, shall be applicable only to those Products and/or Services that are included in any Dual Source or Sole Source Award designated in Exhibit B. If, during the Term, new technology (more than an improvement or
enhancement to an existing Product) for a Product covered by this Agreement becomes available from any source including Vendor, which (i) offers technological advancements; (ii) would improve clinical outcomes or patient care; or
(iii) would streamline work processes, as compared to existing Products (hereinafter, “New Technology Product”), HPG shall have the right to evaluate and ultimately contract with another supplier so that HPG can offer to
Participants New Technology Products. Vendor shall provide HPG with the first opportunity to purchase, at discounts comparable to those applicable to Products under this Agreement, New Technology Products offered by Vendor and not referenced in
Exhibit A of this Agreement and shall notify 

  

 Page 30 of 32 

 
HPG of such at least thirty (30) days prior to New Technology Products being made available for purchase. Vendor shall also meet with HPG to provide
required product information to HPG and its clinical committees prior to the New Technology Product being made available to Purchasers for purchase. HPG shall offer Vendor equal consideration and review for potential supply commitments for New
Technology Products on a Dual Source basis. In the event that HPG enters into any national or group agreement for Participants to purchase a New Technology Product on a Sole Source, Dual Source or Optional Source Award basis from a source other than
Vendor or any Dual Source supplier of Products (if applicable), neither such agreement nor the purchase of the New Technology Product (by itself) shall constitute a breach of this Agreement or failure by HPG or Purchasers to meet the purchasing
requirements under this Agreement. 
  

 Page 31 of 32 

 IN WITNESS WHEREOF, the Parties hereby indicate their acceptance of the terms of this Agreement by
the signatures of their authorized representatives. 
  

									
	 HealthTrust Purchasing Group, LP:
 a Delaware limited partnership
	 		 	Vendor: Masimo Americas, Inc.
	by CMS GP, LLC	 		 		 	
	a Delaware limited liability company	 		 		 	
	its general partner	 		 		 	
					
	By:	 	 /s/ Edward Jones
	 		 	By:	 	 /s/ Jim Beyer

	Name:	 	Edward Jones	 		 	Name:	 	Jim Beyer
	Title:	 	V.P., National Agrmts.	 		 	Title:	 	V.P. Sales, Strategic Accts.
	Date:	 	1/17/08	 		 	Date:	 	Jan. 8, 2008
				
		 		 		 	Vendor Federal Tax ID No.: 20-1901752

  

 Page 32 of 32 

 Exhibits 
  

			
	A.	  	Products & Services with Prices and Environmental Disclosures
		
	B.	  	Specific Purchasing Terms
		
	C.	  	Supplier Diversity Subcontracting Report
		
	D.	  	Contract Compliance Process
		
	E.	  	Communication for Contract Terms
		
	F.	  	Facility Agreement: Deferred Equipment Purchase Plan

 Exhibit A 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Products and Services with Prices and Environmental Disclosures 
  

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	1859	  	LNCS Adtx, Adult Adhesive Sensors, 18 in., 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1860	  	LNCS Pdtx, Pediatric Adhesive Sensors, 18 in., 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2328	  	LNCS Inf, Infant Adhesive Sensors, 18 in., 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2329	  	LNCS Neo, Neonatal/Adult Adhesive Sensors, 18 in., 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2330	  	LNCS NeoPT, Neonatal Preterm Adhesive, 18 in., 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2317	  	LNCS Adtx-3, Adult Adhesive Sensor, 3 ft.	  	BX	  	20	  	[...***...]	 	[...***...]
	2318	  	LNCS Pdtx-3, Pediatric Adhesive Sensor, 3 ft.	  	BX	  	20	  	[...***...]	 	[...***...]
	2319	  	LNCS Inf-3, Infant Adhesive Sensor, 3 ft.	  	BX	  	20	  	[...***...]	 	[...***...]
	2320	  	LNCS Neo-3, Neonatal/Adult Adhesive Sensor, 3 ft.	  	BX	  	20	  	[...***...]	 	[...***...]
	2321	  	LNCS NeoPt-3, Neonatal Preterm Adhesive Sensor, 3 ft.	  	BX	  	20	  	[...***...]	 	[...***...]
	1863	  	LNCS DC-I, Adult Reusable Sensor, 3 ft. 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1864	  	LNCS DC-IP, Pediatric Reusable Sensor, 3 ft. 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1895	  	LNCS TC-I, Tip-Clip EAR, Ear Reusable Sensor, 3 ft. 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1896	  	LNCS TF-I, Reusable Forehead Sensor, 3 ft. 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2258	  	LNCS YI, Multisite Reusable Sensor, 3 ft. 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1596	  	CleanShieldTM Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1597	  	Standard Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1598	  	Standard Petite Wrap, 100/box, Adult slender digit/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1396	  	LNOP DCSC, Adult Reusable Spotcheck Sensor, 3 ft cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1969	  	LNOP DC-I-dc12, Adult Reusable Direct Connect Sensor, 12 foot cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2017	  	LNC- 4 Cable, 4 ft. Patient Cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1814	  	LNC-10 Cable, 10 ft. Patient Cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2013	  	LNC-14 Cable, 14ft. Patient Cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1816	  	LNCS to PC Series; LNCS Series to LNOP PC Series Adapter Cable, 18 in.	  	EA	  	1	  	[...***...]	 	[...***...]
	2021	  	LNC-4-EXT; LNCS Extension Cable, 4ft	  	EA	  	1	  	[...***...]	 	[...***...]
	2016	  	LNC-10-GE; LNCS to GE Patient Cable, 10 ft., SET	  	EA	  	1	  	[...***...]	 	[...***...]
	2263	  	LNC 10’ Patient Cable; LNCS Sensor to Philips 12-pin CMS SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2264	  	LNC 10’ Patient Cable to GE conventional SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2266	  	LNC 10’ Patient Cable to SL conventional SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2268	  	LNC 10’ Patient Cable to Nellcor 180 Oximeter, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2269	  	LNC 10’ Patient Cable to Nellcor 395 Oximeter, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	1001	  	LNOP Adt, Adult Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1829	  	LNOP Adtx, Adult Adhesive Sensors, transparent tape, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1025	  	LNOP Pdt, Pediatric Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]

 *Confidential Treatment Requested 
  

 Page A-1 (1) 

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	1830	  	LNOP Pdtx, Pediatric Adhesive Sensors, transparent tape, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1002	  	LNOP Neo, Neonatal Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1003	  	LNOP NeoPt, Neonatal Sensitive Skin Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1611	  	LNOP Neo Bridge, Neonatal Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1612	  	LNOP NeoPt Bridge, Neonatal Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1798	  	LNOP Neo-L, Neonatal Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1651	  	LNOP NeoPt-L, Neonatal Sensitive Skin Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	1800	  	LNOP Inf-L, Infant Adhesive Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2203	  	LNOP Newborn Neonatal, Neonatal Sensors, 20/box	  	BX	  	20	  	[...***...]	 	[...***...]
	2204	  	LNOP Newborn Infant, Neonatal Sensors, 20/ox	  	BX	  	20	  	[...***...]	 	[...***...]
	1970	  	LNOP Blue, Neonatal/Infant/Pediatric Sensors, 10/box	  	BX	  	10	  	[...***...]	 	[...***...]
	1277	  	LNOPv Ad: Adult value line adhesive sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1832	  	LNOPv In: Infant value line adhesive sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1831	  	LNOPv Ne: Neonatal value line adhesive sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1269	  	LNOP DCI, Adult Reusable Sensor, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1396	  	LNOP DCSC, Adult Reusable Spotcheck Sensor, 3 ft cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1969	  	LNOP DC-I-dc12, Adult Reusable Direct Connect Sensor, 12 foot cable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1276	  	LNOP DCIP, Pediatric Reusable Sensor, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1794	  	LNOP TC-I Tip-Clip, Reusable Sensor, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1793	  	LNOP TF-I Transflectance Forehead Sensor, Reusable, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1560	  	LNOP DC-195 (LNOPv-150), 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1544	  	LNOP YI, Multisite Reusable Sensor, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1596	  	CleanShieldTM Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1597	  	Standard Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1598	  	Standard Petite Wrap, 100/box, Adult slender digit/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1173	  	PC04 Cable, 1/box, 4 ft. LNOP Patient Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1005	  	PC08 Cable, 1/box, 8 ft. LNOP Patient Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1006	  	PC12 Cable, 1/box, 12 ft. LNOP Patient Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1619	  	PC04-Ext Cable, 1/box, 4 ft. LNOP Extension Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1520	  	PXC16 LNOP Mountable Extension Cable, 1/box, 16 ft. Extension Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1555	  	PXC30 LNOP Mountable Extension Cable, 1/box, 30 ft. Extension Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	2263	  	LNC 10’ Patient Cable; LNCS Sensor to Philips 12-pin CMS SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2264	  	LNC 10’ Patient Cable to GE conventional SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2266	  	LNC 10’ Patient Cable to SL conventional SpO2, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2268	  	LNC 10’ Patient Cable to Nellcor 180 Oximeter, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2269	  	LNC 10’ Patient Cable to Nellcor 395 Oximeter, Adapter	  	EA	  	1	  	[...***...]	 	[...***...]
	2201	  	Rainbow DCI-dc3, Adult Reusable Direct Connect Sensor, 3 ft, 1/box (SpO2, SpCO and SpMet)	  	EA	  	1	  	[...***...]	 	[...***...]
	2202	  	Rainbow DCI-dc12, Adult Reusable Direct Connect Sensor, 12 ft, 1/box (SpO2, SpCO and SpMet)	  	EA	  	1	  	[...***...]	 	[...***...]
	2069	  	Rainbow DCIP-dc3, Pediatric/Adult Slender Reusable Direct Connect Sensor, 3ft., 1/box (SpO2, SpCO and SpMet)	  	EA	  	1	  	[...***...]	 	[...***...]
	2070	  	Rainbow DCIP-dc12, Pediatric/Adult Slender Reusable Direct Connect Sensor, 12ft., 1/box (SpO2, SpCO and SpMet)	  	EA	  	1	  	[...***...]	 	[...***...]
	2053	  	RED DCI-dc3, Adult Reusable Direct Connect Sensor, 3 ft, (No Cable Req’d; for Rad-57 & Radical-7), 1/box	  	EA	  	1	  	[...***...]	 	[...***...]

 *Confidential Treatment Requested 
  

 Page A-1 (2) 

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	2054	  	RED DCI-dc12, Adult Reusable Direct Connect Sensor, 12 ft, (No Cable Req’d; for Rad-57 & Radical-7), 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2055	  	Red LNC-04, LNCS 20-pin SpO2 Patient Cable, 4 ft , 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2056	  	Red LNC-10, LNCS 20-pin SpO2 Patient Cable, 10 ft , 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2057	  	Red LNC-14, LNCS 20-pin SpO2 Patient Cable, 14 ft , 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	2058	  	Red PC-04: LNOP 20-pin SpO2; LNOP Patient Cable for Rad-57 or Radical-7, 4 ft	  	EA	  	1	  	[...***...]	 	[...***...]
	2059	  	Red PC-08: LNOP 20-pin SpO2; LNOP Patient Cable for Rad-57 or Radical-7, 8 ft	  	EA	  	1	  	[...***...]	 	[...***...]
	2060	  	Red PC-12: LNOP 20-pin SpO2; LNOP Patient Cable for Rad-57 or Radical-7, 12 ft	  	EA	  	1	  	[...***...]	 	[...***...]
	9019	  	Configurable, Rad-8, Horizontal	  	EA	  	1	  	[...***...]	 	[...***...]
	9020	  	Configurable, Rad-8, Vertical	  	EA	  	1	  	[...***...]	 	[...***...]
	9028	  	Configurable Rad-9 Pulse Oximeter	  	EA	  	1	  	[...***...]	 	[...***...]
	9021	  	Configurable, Radical Docking Station RDS-1	  	EA	  	1	  	[...***...]	 	[...***...]
	9031	  	Radical-7 Handheld, Blue Screen	  	EA	  	1	  	[...***...]	 	[...***...]
	1311	  	Radical Docking Station RDS-1B (w/Ext Battery)	  	EA	  	1	  	[...***...]	 	[...***...]
	9023	  	Configurable, Radical Docking Station RDS-3	  	EA	  	1	  	[...***...]	 	[...***...]
	9031	  	Radical-7 Handheld, Blue Screen	  	EA	  	1	  	[...***...]	 	[...***...]
	9086	  	Radical-7 Handheld, TFT Color Display	  	EA	  	1	  	[...***...]	 	[...***...]
	2205	  	Rad-57m Handheld CO-Oximeter with SpMet includes Rainbow DCI-dc3 Reusable Sensor and Ops Manual	  	EA	  	1	  	[...***...]	 	[...***...]
	9025	  	Configurable, Rad-5 Handheld Pulse Oximeter, incl. LNOP DCSC Reusable sensor and Ops Manual, Premium, World Wide, DCSC (fka #1883 or #1802)	  	EA	  	1	  	[...***...]	 	[...***...]
	9026	  	Configurable, Rad-5v Handheld Pulse Oximeter, incl., LNOP DCSC Reusable sensor and Ops Manual, World Wide, DCSC (fka #1884 or #1705)	  	EA	  	1	  	[...***...]	 	[...***...]
	1892	  	Rad-5 Handheld Pulse Oximeter, Premium, PC-04 Patient Cable & LNOP Adhesive sensor kit and Ops Manual	  	EA	  	1	  	[...***...]	 	[...***...]
	1891	  	Rad-5v Handheld Pulse Oximeter, PC-04 Patient Cable & LNOP Adhesive sensor kit and Ops Manual	  	EA	  	1	  	[...***...]	 	[...***...]
	1957	  	Rad-5 Handheld Pulse Oximeter, Premium, DC-IP Pediatric Reusable Sensor & PC-04 Patient Cable and Ops Manual	  	EA	  	1	  	[...***...]	 	[...***...]
	1958	  	Rad-5v Handheld Pulse Oximeter, DC-IP Pediatric Reusable Sensor & PC-04 Patient Cable	  	EA	  	1	  	[...***...]	 	[...***...]
	2207	  	Water Resistant Handheld Carrying Case for Rad-57, Black	  	EA	  	1	  	[...***...]	 	[...***...]
	2208	  	Water Resistant Handheld Carrying Case for Rad-57, Red	  	EA	  	1	  	[...***...]	 	[...***...]
	13158	  	Rad-5/5v Handheld Soft Carrying Case	  	EA	  	1	  	[...***...]	 	[...***...]
	1908	  	TrendCom Trend Download Software	  	EA	  	1	  	[...***...]	 	[...***...]
	1909	  	Rad-5/5v PRONTO Trend download serial cable	  	EA	  	1	  	[...***...]	 	[...***...]
	2063	  	Rad-57 PRONTO Trend download serial cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1842	  	Handheld Protective Boot - Gray	  	EA	  	1	  	[...***...]	 	[...***...]
	1980	  	Handheld Protective Boot - Yellow	  	EA	  	1	  	[...***...]	 	[...***...]
	1981	  	Handheld Protective Boot - Red	  	EA	  	1	  	[...***...]	 	[...***...]
	1982	  	Handheld Protective Boot - Orange	  	EA	  	1	  	[...***...]	 	[...***...]
	2097	  	Handheld Protective Boot - Royal Blue	  	EA	  	1	  	[...***...]	 	[...***...]
	2098	  	Handheld Protective Boot - Light Blue; use w/Rad5, Rad-5v and Rad 57	  	EA	  	1	  	[...***...]	 	[...***...]
	2099	  	Handheld Protective Boot - Pink; use w/Rad5, Rad-5v and Rad 57	  	EA	  	1	  	[...***...]	 	[...***...]
	1816	  	Adapter Cable, LNCS to PC Series; LNCS Series to LNOP PC Series Adapter Cable, 18 in.	  	EA	  	1	  	[...***...]	 	[...***...]
	1645	  	MAC-1 Adapter Cable, LNOP Sensor to Nellcor device, Patient Cable, or LNCS Series Patient Cables, 18 in.	  	EA	  	1	  	[...***...]	 	[...***...]
	1927	  	MAC-1 Adapter Cable, LNOP Sensor to Nellcor device or LNCS Series Patient Cables, 12ft	  	EA	  	1	  	[...***...]	 	[...***...]

 *Confidential Treatment Requested 
  

 Page A-1 (3) 

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	1937	  	Sample Kit, MAC-1 Adapter Cable, LNOP DC-I	  	EA	  	1	  	[...***...]	 	[...***...]
	1805	  	MAC-1 & LNOP DC-195 Sample Kit	  	EA	  	1	  	[...***...]	 	[...***...]
	1806	  	Sample Kit, MAC-1 Adapter Cable, 2 LNOP Adt, 2 LNOP Pdt	  	EA	  	1	  	[...***...]	 	[...***...]
	1807	  	Sample Kit, MAC-1 Adapter Cable, 2 LNOP Neo-L, 2 LNOP Inf-L	  	EA	  	1	  	[...***...]	 	[...***...]
	1849	  	AC-1 LNOP Sensor to Philips CMS Instrument Adapter Cable, 12 pin, 12 ft.	  	EA	  	1	  	[...***...]	 	[...***...]
	2307	  	Replacement adhesive tapes for LNCS Inf and Inf-3 sensors, 100/box	  	BX	  	100	  	[...***...]	 	[...***...]
	2308	  	Replacement adhesive tapes for LNCS Neo and Neo-3 sensors, 100/box	  	BX	  	100	  	[...***...]	 	[...***...]
	2309	  	Replacement adhesive tapes for LNCS NeoPt and NeoPt-3 sensors, 10/pack	  	PK	  	10	  	[...***...]	 	[...***...]
	1053	  	Replacement Posey Wrap Bag for LNOP NeoPt and NeoPt-Bridge Sensors, 12/pack	  	PK	  	12	  	[...***...]	 	[...***...]
	1054	  	Replacement Tapes Bag for LNOP Neo and Neo-Bridge Sensors, 100/pack	  	PK	  	100	  	[...***...]	 	[...***...]
	1926	  	Replacement wrap for 1651 LNOP NeoPt-L sensor	  	PK	  	1	  	[...***...]	 	[...***...]
	1799	  	Replacement Tapes for 1798 LNOP Neo-L Sensors, 100/pack	  	PK	  	100	  	[...***...]	 	[...***...]
	1801	  	Replacement Tapes for 1800 LNOP Inf-L Sensors, 100/pack	  	PK	  	100	  	[...***...]	 	[...***...]
	1596	  	CleanShieldTM Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1597	  	Standard Multisite Wrap, 100/box, Adult/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1598	  	Standard Petite Wrap, 100/box, Adult slender digit/Pediatric/Neonatal adhesive attachment wraps for LNOP YI Multisite Reusable Sensor	  	BX	  	100	  	[...***...]	 	[...***...]
	1602	  	Foam Wraps for LNOP YI Sensors, 12/pack	  	PK	  	12	  	[...***...]	 	[...***...]
	1601	  	Accessory Clothing Clips, 5/pack	  	PK	  	5	  	[...***...]	 	[...***...]
	1600	  	Accessory Adhesive Squares, (144 squares per pack)	  	PK	  	144	  	[...***...]	 	[...***...]
	1608	  	Headband for LNOP/LNCS TF-I, 5/pack	  	PK	  	5	  	[...***...]	 	[...***...]
	1903	  	Adhesive Pad LNOP/LNCS TF-I, 20/pack	  	PK	  	20	  	[...***...]	 	[...***...]
	2215	  	Headband for LNOP/LNCS TF-I, 12/box	  	BX	  	12	  	[...***...]	 	[...***...]
	1282	  	LNOP Sensor Application Training Pack, 1-Adt, 1-Pdt, 1-Neo, 1-NeoPt, 2 cotton swabs, 2 alcohol swabs, 1-foot w/app. Card	  	EA	  	1	  	[...***...]	 	[...***...]
	1116	  	LNOP Sensor Sample Pack, 4-Adt, 2-Pdt, 2-Neo, 2-NeoPt Adhesive Sensors	  	EA	  	1	  	[...***...]	 	[...***...]
	2345	  	LNCS Sensor Training Kit, 1-Adtx, 1-Pdtx, 1-Inf, 1-Neo, 1-NeoPt Adhesive Sensors and 1-foot w/application Card	  	PK	  	1	  	[...***...]	 	[...***...]
	2346	  	LNCS Sensor Sample Pack, 3 ft. 1 Adtx-3, 1 Pdtx-3, 1 Inf-3 and 1 Neo-3 Adhesive Sensors	  	PK	  	1	  	[...***...]	 	[...***...]
	2347	  	LNCS Adult Sample Pack, 1-Adtx, 1-Pdtx, and 1-Neo Adhesive Sensors	  	PK	  	1	  	[...***...]	 	[...***...]
	2348	  	LNCS Neo Sample Pack, 1-Inf, 1-Neo and 1-NeoPt Adhesive Sensors	  	PK	  	1	  	[...***...]	 	[...***...]
	1229	  	LNOP Neo Sensor Sample Pack, 3-Neo, 1-NeoPt	  	EA	  	1	  	[...***...]	 	[...***...]
	1283	  	LNOP Sensor Sample Pack, 2-Adt, 1-Ped, 1-Neo	  	EA	  	1	  	[...***...]	 	[...***...]
	1228	  	LNOP Adult Sensor Sample Pack, 3-Adt / 1-Pdt Adhesive Sensors	  	EA	  	1	  	[...***...]	 	[...***...]
	1774	  	SPO2.COM A, Adult Adhesive Sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1775	  	SPO2.COM P, Pediatric Adhesive Sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1776	  	SPO2.COM N, Neonatal Adhesive Sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1777	  	SPO2.COM I, Infant Adhesive Sensors, 24/box	  	BX	  	24	  	[...***...]	 	[...***...]
	1778	  	SPO2.COM RS-I Reusable Finger Clip	  	EA	  	1	  	[...***...]	 	[...***...]
	1851	  	SPO2.COM Sensor Sample Pack (1 ea. Ad, Pd, Ne and In)	  	EA	  	1	  	[...***...]	 	[...***...]
	1810	  	NRC-180 Patient Cable, Nellcor 180 to SPO2.COM, 10 ft, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1811	  	NRC-395 Patient Cable, Nellcor 395 to SPO2.COM, 10 ft, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1854	  	NRC-GE Patient Cable, GE to SPO2.COM, 10 ft, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1853	  	NRC-P12 Patient Cable, Philips 12-pin to SPO2.COM, 10 ft, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1852	  	NRC-P8 Patient Cable, Philips 8-pin to SPO2.COM, 3.3ft	  	EA	  	1	  	[...***...]	 	[...***...]

 *Confidential Treatment Requested 
  

 Page A-1 (4) 

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	1886	  	NRC-P8 EXT Extension Cable, 2m, 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1900	  	NRC-SL Patient Cable, SpaceLabs to SPO2.COM, 10ft	  	EA	  	1	  	[...***...]	 	[...***...]
	1595	  	SatShare Cable, AT01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1324	  	SatShare Cable, DO01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1326	  	SatShare Cable, DO02, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1528	  	SatShare Cable, DO03, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1533	  	SatShare Cable, DO04, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	2023	  	SatShare Cable, DO05, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	2223	  	SatShare Cable, DO06, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1325	  	SatShare Cable, DS01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1539	  	SatShare Cable, DS02, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1365	  	SatShare Cable, DS03, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1357	  	SatShare Cable, HP03, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1321	  	SatShare Cable, MQ01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1789	  	SatShare Cable, MS01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1367	  	SatShare Cable, NK01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1368	  	SatShare Cable, NK02, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1366	  	SatShare Cable, OH01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1646	  	SatShare Cable, OH02, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1323	  	SatShare Cable, SL01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1362	  	SatShare Cable, SL02, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1322	  	SatShare Cable, SM01, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1605	  	SatShare Extension Cable, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	1846	  	Masimo SET IntelliVue Module (Module and MP12 Patient Cable)	  	EA	  	1	  	[...***...]	 	[...***...]
	2281	  	LNC MP10 (LNCS to IntelliVue Module and MMS) (New prod; replaces PN#1902 and PN#1949)	  	EA	  	1	  	[...***...]	 	[...***...]
	2282	  	LNOP MP12 (LNOP to IntelliVue Module and MMS) (New prod; replaces pn#1847 and #1848)	  	EA	  	1	  	[...***...]	 	[...***...]
	1881	  	Masimo SET VueLink Module w/cable (Module and VueLink cable)	  	EA	  	1	  	[...***...]	 	[...***...]
	1841	  	VueLink cable; for use with Masimo SET, 3 ft.	  	EA	  	1	  	[...***...]	 	[...***...]
	12949	  	GE Tram upgrade (see note: Minimum 10 units required)	  	EA	  	1	  	[...***...]	 	[...***...]
	13108	  	GE Dash upgrade (see note: Minimum 10 units required)	  	EA	  	1	  	[...***...]	 	[...***...]
	2016	  	LNC-10-GE, LNCS to GE Patient Cable, 10 ft., 1/box	  	EA	  	1	  	[...***...]	 	[...***...]
	1592	  	ProCal cable; Masimo 1.5m, Drager/Siemens	  	EA	  	1	  	[...***...]	 	[...***...]
	12994	  	RadLink serial cable - RadLink to Radical, 12”	  	EA	  	1	  	[...***...]	 	[...***...]
	30859	  	RadLink serial cable - RadLink to Radical, 18”	  	EA	  	1	  	[...***...]	 	[...***...]
	1593	  	Masimo Tester - for Oximeter SPO02 & PR Testing	  	EA	  	1	  	[...***...]	 	[...***...]
	1795	  	Masimo Tester with cable	  	EA	  	1	  	[...***...]	 	[...***...]
	1315	  	Replacement Battery, Radical Handheld	  	EA	  	1	  	[...***...]	 	[...***...]
	1317	  	Radical Pole Clamp	  	EA	  	1	  	[...***...]	 	[...***...]
	1395	  	Radical Handheld Lock	  	EA	  	1	  	[...***...]	 	[...***...]
	1584	  	Radical Power Cord Lock, 5/pack	  	PK	  	5	  	[...***...]	 	[...***...]
	1904	  	Rad-9 Power Cord Lock, 5/pack	  	PK	  	5	  	[...***...]	 	[...***...]
	11601	  	Radical User Manual – English, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	30502	  	Eagle Bracket (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	30503	  	Right Angle Bracket (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	30512	  	Box Bracket (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	30579	  	V-Block (Radical and Rad-8 in conjunction w/ Baseplate or L-Bracket)	  	EA	  	1	  	[...***...]	 	[...***...]
	30580	  	Baseplate (Radical and Rad-8)	  	EA	  	1	  	[...***...]	 	[...***...]

 *Confidential Treatment Requested 
  

 Page A-1 (5) 

											
	 MFG.
CATALOG
NUMBER
	  	 SHORT DESCRIPTION
 (Maximum of 35 Characters)
	  	Unit of
Measure	  	UOM
Factor
(QTY)	  	HPG Tier 2
Base Unit
Price	 	HPG Tier 1
IDN Unit
Price
	30581	  	L Bracket (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	30583	  	Radical Slide Plate (Radical and Rad-8)	  	EA	  	1	  	[...***...]	 	[...***...]
	30750	  	J Bracket (Radical and Rad-8)	  	EA	  	1	  	[...***...]	 	[...***...]
	30751	  	Left Angle Bracket (Radical and Rad-8)	  	EA	  	1	  	[...***...]	 	[...***...]
	30801	  	C-Clamp (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	30807	  	Merlin Yolk (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	2097	  	Handheld Protective Boot - Royal Blue	  	EA	  	1	  	[...***...]	 	[...***...]
	2227	  	Rad-8 Mounting Bracket	  	EA	  	1	  	[...***...]	 	[...***...]
	2228	  	Rad-8 Power Cord Lock	  	EA	  	1	  	[...***...]	 	[...***...]
	11773	  	Wall Mount Extension Arm (Radical)	  	EA	  	1	  	[...***...]	 	[...***...]
	13833	  	Medium Duty Roll Stand with Handle & Basket	  	EA	  	1	  	[...***...]	 	[...***...]
	12114	  	Radical Service Manual, Masimo	  	EA	  	1	  	[...***...]	 	[...***...]
	12262	  	Operator’s Manual, Rad-9	  	EA	  	1	  	[...***...]	 	[...***...]
	13017	  	Operator’s Manual, Rad-5/5v	  	EA	  	1	  	[...***...]	 	[...***...]
	13116	  	Operator’s Manual, IntelliVue - English	  	EA	  	1	  	[...***...]	 	[...***...]
	13279	  	Operator’s Manual, Rad-57	  	EA	  	1	  	[...***...]	 	[...***...]
	31068	  	Operator’s Manual, Rad-57cm	  	EA	  	1	  	[...***...]	 	[...***...]
	30475	  	Radical Series Handheld Case	  	EA	  	1	  	[...***...]	 	[...***...]
	30534	  	Radical Series Handheld Lock Key	  	EA	  	1	  	[...***...]	 	[...***...]

 Initial 
 HPG                 
 Vendor                 
 *Confidential
Treatment Requested 
  

 Page A-1 (6) 

 Exhibit B 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Specific Purchasing Terms 
 Product Sub-Category: Pulse Oximetry (monitors and sensors)

 Award Basis: Dual Source 
 Compliance: 
 If any Products are being made available under this Agreement on a Sole Source, Dual Source, or Multi-Source Award
basis, then HPG and Vendor agree to use the process outlined in Exhibit D to address any Participants who do not substantially meet any applicable compliance level. 
  

			
	Effective Date:	  	
		
	 The Effective Date is:
	  	February 1, 2008
		
	Expiration Date:	  	
		
	 The Expiration Date is:
	  	January 31, 2011

 Prior Agreement: Not applicable 
 GPO Fees: [...***...] percent ([...***...]%) 
 Product Warranty and Duration: 
 Warranty; Limitation of Liability. Vendor warrants to Purchaser that the Vendor monitors, sensors and other accessories provided will
conform to the published product specifications of Vendor in all material respects and be free from material defects in materials and workmanship; [...***...]. Provided that payments are current and Purchaser is not otherwise in breach of this
Agreement, Vendor’s obligation if any Vendor monitors, sensors or other accessories found upon examination by Vendor, to be defective during the warranty period shall be limited to repair or replacement. This warranty is subject to the
following exclusions, exceptions and limitations: a) repair and maintenance necessitated by neglect, misuse or 

  

 *Confidential Treatment Requested 
  

 Page B-1 

 
improper operation of the monitors, Software, or device; b) modification of monitors, sensors and Software without the express written authorization of
Vendor or as otherwise provided in the Product documentation; c) supplies, devices or electrical work external to the Vendor monitors or not manufactured by or for Vendor; d) use of sensors or other accessories other than those manufactured by or
for Vendor and distributed by Vendor; and e) use of the monitors and sensors for uses and/or in environments for which they are not intended. For monitors manufactured by third-parties and not sold under Vendor’s name or trademark, Vendor will
pass on to Purchaser all terms and rights provided by the manufacturer. Vendor is not responsible and will charge the Purchaser for repair, replacement, or maintenance necessitated by neglect, misuse, improper operation, accident, fire, water
immersion, vandalism, weather, war, or any Act of God, and unauthorized non-Vendor monitors attached to Vendor monitors, or unauthorized modification of Vendor monitors or software. Warranty does not extend to any equipment, or software not
manufactured by or for Vendor and that does not have Vendor’s name or Trademark. EXCEPT AS OTHERWISE PROVIDED IN THE HPG AGREEMENT WITH MASIMO, THE FOREGOING WARRANTY, IS IN LIEU OF AND EXCLUDES ALL OTHER EXPRESS OR IMPLIED PRODUCT WARRANTIES,
ARISING BY OPERATION OF LAW OR OTHERWISE, AND NO OTHER WARRANTIES EXIST, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE. VENDOR WILL NOT BE LIABLE FOR ANY INCIDENTAL OR CONSEQUENTIAL
DAMAGES, EXPENSES, LOST PROFITS, OR OTHER DAMAGES ARISING OUT OF THE USE OR INABILITY TO USE THE EQUIPMENT AND SOFTWARE, EVEN IF VENDOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. Some jurisdictions may not permit the limitation of liability
under certain circumstances; the foregoing limitations and exclusions are not applicable to the extent not permitted under the laws of the relevant jurisdiction. 
 Product Information Requests 
 At the request of HPG or a Purchaser, Vendor shall provide information on Products related to the
following subjects: 
  

	 	•	 	 Latex free 

  

	 	•	 	 Mercury free 

  

	 	•	 	 Polyvinyl Chloride (PVC) free 

  

	 	•	 	 Di-ethylhexyl phthalate (DEHP) free 

  

	 	•	 	 Certified by Green Seal or Environmental Choice Program 

  

	 	•	 	 Compliance with U.S. Government’s Comprehensive Procurement Guidelines for recycled content (Product) 

  

	 	•	 	 Compliance with U.S. Government’s Comprehensive Procurement Guidelines for recycled content (Packaging) 

  

	 	•	 	 Energy Star Qualified 

  

	 	•	 	 Halogenated organics free 

  

	 	•	 	 Persistent Bioaccumulative Toxin (PBTs) free 

  

	 	•	 	 Carcinogens and reproductive toxin free (CA Prop 65) 

  

	 	•	 	 Full disclosure on product insert of all Product ingredients 

  

 Page B-2 

 Ordering Process: 
 EDI 
 Purchase Order 
 Verbal 
 Facsimile 
 Payment Terms: 
 Net due thirty (30) days from the receipt of invoice, Vendor shall have the right to charge, and Purchaser agrees to pay, a late fee equal to one percent
(1%) per month (or the maximum allowed by law, whichever is less) of the amount of any fees not paid by Purchaser within thirty (30) days from receipt of an invoice therefor. 
 Delivery Time: 
 Seven (7) business days from receipt of order except for build-to-order products

 Ordering Point: 
  ̈
  Either Vendor Direct or Distributor 
 Distributors: 
 Includes any HPG-designated distributor that has entered into a written distribution agreement with Vendor. If a Participant requests the use of an
HPG-designated distributor with which Vendor does not already have a distribution agreement, then Vendor will negotiate contract terms in good faith with the distributor. 
 F.O.B. Designation: 
 Shipments shall be: 
 F.O.B. Origin 
 Freight / Shipping and Insurance
Charges: 
 Freight/shipping and insurance charges are not included in the Product price and shall be “prepaid” by Vendor and added to the
invoice as a separate line item that is identified as either “freight” or “shipping” charge and insurance charge. 
 Training,
Repair, Safety: 
 (Indicate for each item whether Vendor is to provide or enter Not Applicable (“NA”).) 
  

 Page B-3 

 Operator Training provided to each Purchaser by Vendor: n/a 
 Preventative maintenance and repair instruction to be supplied to each Purchaser by Vendor: n/a 
 Repair and replacement parts lists, ordering instructions, and alternative sources of parts to be supplied to each Purchaser by Vendor: n/a 
 Vendor shall provide each Purchaser Material Safety Data Sheets (MSDS) for all material/chemical Product purchases in compliance with OSHA standards and those of any
other applicable federal, state or local law or regulation. 
 Vendor Contacts for Notices: 
 Vendor’s MWBE Contact: 
 Enter contact
information here 
 Jim Beyer 
 VP of Sales, Strategic Accounts 
 Masimo Americas, Inc. 
 40 Parker 
 Irvine, CA 92618

 Vendor’s contact for notices under the Agreement: 
 Enter contact information here 
 (same) 
 Initial: 
 HPG                 
 Vendor                 
  

 Page B-4 

 Exhibit C 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Supplier Diversity Subcontracting Report 
 HPG Vendor Name: 
 Reporting Period: (Qtr/Yr) 
 List each MWBE Subcontractor
(Name/Address/Phone) and provide the following for each: 
  

	 	•	 	 Minority/Woman Owned Business (use Diversity Codes listed below) 

  

	 	•	 	 Applicable HPG Agreement No. 

  

	 	•	 	 Products/Services Provided 

  

	 	•	 	 Spend (state applicable period) 

 Total Spend for all
MWBE’s 
 Diversity Codes: 
  

	 	•	 	 MBE (Minority Business Enterprise) 

  

	 	•	 	 African 

  

	 	•	 	 Hispanic 

  

	 	•	 	 Native 

  

	 	•	 	 Asian-Pacific & Hasidic Jewish Americans 

  

	 	•	 	 WBE (Women Business Enterprise)(Non-minority Woman-Owned Business) 

  

	 	•	 	 DIS (Disabled) 

  

					
	NOTE:	 	Submit form to:	 	For questions contact:
	 1.   Do not include contractors with less than $1,000 in spend
 2.   An electronic copy of a Supplier Diversity Subcontracting Report is available upon request
	 	 Director of Business Diversity
 HealthTrust Purchasing
Group
 155 Franklin Road
 Suite 300
 Brentwood, TN 37027
	 	 Director of Business Diversity
 HealthTrust Purchasing
Group
 155 Franklin Road
 Suite 300
 Brentwood, TN 37027

  

 Page C-1 

 Exhibit D 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Contract Compliance Process 
 In the event Vendor identifies a Participant that is not meeting its designated
commitment requirement for specific Product(s) as stated in a writing between Participant and a Vendor (“Commitment Level”), the following steps are to be followed for addressing the compliance issues: 
  

	1.	Vendor shall notify HPG of the non-compliance via the compliance form attached as Exhibit D-1. (The issue should not be sent directly to HPG by the Vendor representative in any
other format). Vendor must verify that their local representative has met with the Materials Manager or the applicable Department Director for the Participant to discuss the issue of non-compliance prior to submission to HPG.

  

	2.	Upon receipt of the compliance form at HPG, the compliance team will contact the Participant to verify the Vendor representative has recently met with the Materials Manager or the
applicable Department Director to discuss the issue. Vendor will be notified if HPG finds the Vendor representative has not discussed the issue directly with the Participant and place the process on hold until such discussion has occurred.

  

	3.	HPG will then ask the Participant if it agrees that it is not meeting the Compliance Level required. If the Participant is in agreement, HPG will move the Participant to a lower
Commitment Level with corresponding higher prices based on Vendor’s suggestion, if such pricing is available under this Agreement. This move will not occur until thirty (30) days from the date of the original receipt of the compliance form
by HPG. 

  

	4.	If the Participant does not agree with Vendor’s assessment, Participant will provide to HPG usage numbers for that Product area for the previous six (6) months. HPG will
calculate the overall percentage based on contract guidelines. If the Participant is meeting its commitment over the six (6) month period, Vendor will be notified that no pricing change should occur. 

  

	5.	If HPG determines the Participant is not meeting its Commitment Level, the HPG compliance team will coordinate with Vendor and Participant in an effort to determine the applicable
new pricing tier. Participant shall be moved to the new pricing tier on a date mutually agreed to by Vendor, HPG and the Participant, or as specified in any SIP Acknowledgement or Letter of Commitment between Vendor and the Participant.

  

	6.	In any event, all compliance resolution issues will be addressed by HPG within sixty (60) days, with HPG using commercially reasonable efforts to resolve such issues within
such time period. 

  

 Page D-1 

 Exhibit D-1 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Compliance Form 
 Vendor Name: 
 Contact Name: 
 Phone Number: 
 Date: 
 Enter information here 
 Division/Product Area: 
 Enter information here 
 Facility Name: 
 Address: 
 City: 
 State: 
 Group or Parent: 
 Enter information here 

SIP Acknowledgement or LOC? 
 If yes, attach copy.

 Compliance Problem/Product Area: 
 (current
compliance level vs. contract compliance requirement—state the dollar impact and projected lost savings opportunity) 
 Primary Facility Contact(s):

 Name: 
 Title: 
 Phone Number: 
 Email Address (if available):

 What has been done to resolve the issue locally? 
  

 Page D-2 

 (Include details such as: (i) meeting dates and with whom; (ii) evaluation results if any;
(iii)expected decision date for product area; and (iv) last interface date with the facility.) 
 What are your recommended next steps for this
account? 
 Enter information here 
 Internal Use
Only: 
 COID: 
 Assigned to:

 Contract Number: 
 Issue
Status: 
 Record Activity: 
  

 Page D-3 

 Exhibit E 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 Communication for Contract Terms 
 This Contract Summary Sheet has been created for communicating information
on this referenced agreement to HPG members. It is not to be considered as part of the agreement or to have any legal effect relative to the agreement. 
  

	1.	Types or Categories of Products on Contract 

 Please list
specific examples of the types of products on this agreement. 
 This should not be a repeat of the contract description. 
 -Pulse Oximetry technology and related accessories 
  

	2.	Customer Service Hours 

 What are the hours of operation of
the vendor’s customer service contact? 
 1-800-326-4890 #1 – Customer Service: 6am – 5pm PST 
 1-800-326-4890 #2 – Technical Support: 24 hours/day, 7 days/week 
  

	3.	Pricing Through Term of Agreement 

 Describe if the pricing
is firm through the term of the agreement 
 Yes, pricing is firm through the Agreement term 
  

	4.	Freight Charges, Shipping and Delivery Time Period 

 Describe how freight charges are billed (e.g., included in price; paid by Vendor and added to invoice; etc.). 
 Freight/shipping
charges, including insurance for the full value of Product shipped, are not included in the Product price and shall be “prepaid” by Vendor and added to the invoice as a separate line item that is identified as either “freight” or
“shipping” and “insurance” charges. 
 Vendor represents and warrants to HPG and Purchasers that it shall make
commercially reasonable efforts to maintain in inventory at appropriate locations sufficient quantities of each Product and shall both choose a transportation mode and carrier and provide said carrier with appropriate instructions to ensure that any
Purchaser ordering Products will receive delivery within seven (7) business days after the date the order is received by Vendor 
  

 Page E-1 

 Indicate if delivery is FOB Destination or FOB Origin. 
 FOB Origin: In the event of a damaged, lost or missing shipment, Vendor shall, at Purchaser’s request and discretion, and at no cost to the
Purchaser, submit a claim on behalf of the Purchaser with the carrier, and ensure the claim is resolved to Purchaser’s reasonable satisfaction. 
 What is delivery time period from receipt of order? 
 Seven (7) business days after the date the
order is received by Vendor except for Build-to-Order products 
  

	5.	Rebates 

 Describe the rebate structure for this agreement.
Do not include actual rebate percentages. 
 NA 
  

	6.	Other Fees 

 Describe any other fees (besides rebates and
admin fees) for this agreement. 
 NA 
  

	7.	Warranty Policy 

 Describe the warranty for this agreement.
Please include the warranty period. 
  

	 	•	 	 Portable Tabletop and Handheld Pulse Oximeters: 1 Year from date of first use, not to exceed 14 months from shipment

  

	 	•	 	 Batteries, reusable cables, sensors and accessories: 6 months from first use, not to exceed 8 months from shipment

  

	 	•	 	 Disposable Single Patient Use Adhesive Sensors: Single patient use within 120
days after shipment 

 The following is the specific warranty and limitation of liability language provided by the
Vendor: 
 Warranty; Limitation of Liability. Vendor warrants to Purchaser that the Vendor monitors, sensors and other
accessories provided will conform to the published product specifications of Vendor in all material respects and be free from material defects in materials and workmanship; [...***...] 
 *Confidential Treatment Requested 
  

 Page E-2 

 [...***...]. Provided that payments are current and Purchaser is not otherwise in breach of this
Agreement, Vendor’s obligation if any Vendor monitors, sensors or other accessories found upon examination by Vendor, to be defective during the warranty period shall be limited to repair or replacement. This warranty is subject to the
following exclusions, exceptions and limitations: a) repair and maintenance necessitated by neglect, misuse or improper operation of the monitors, Software, or device; b) modification of monitors, sensors and Software without the express written
authorization of Vendor or as otherwise provided in the Product documentation; c) supplies, devices or electrical work external to the Vendor monitors or not manufactured by or for Vendor; d) use of sensors or other accessories other than those
manufactured by or for Vendor and distributed by Vendor; and e) use of the monitors and sensors for uses and/or in environments for which they are not intended. For monitors manufactured by third-parties and not sold under Vendor’s name or
trademark, Vendor will pass on to Purchaser all terms and rights provided by the manufacturer. Vendor is not responsible and will charge the Purchaser for repair, replacement, or maintenance necessitated by neglect, misuse, improper operation,
accident, fire, water immersion, vandalism, weather, war, or any Act of God, and unauthorized non-Vendor monitors attached to Vendor monitors, or unauthorized modification of Vendor monitors or software. Warranty does not extend to any equipment, or
software not manufactured by or for Vendor and that does not have Vendor’s name or Trademark. EXCEPT AS OTHERWISE PROVIDED IN THE HPG AGREEMENT WITH MASIMO, THE FOREGOING WARRANTY, IS IN LIEU OF AND EXCLUDES ALL OTHER EXPRESS OR IMPLIED PRODUCT
WARRANTIES, ARISING BY OPERATION OF LAW OR OTHERWISE, AND NO OTHER WARRANTIES EXIST, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE. VENDOR WILL NOT BE LIABLE FOR ANY INCIDENTAL OR
CONSEQUENTIAL DAMAGES, EXPENSES, LOST PROFITS, OR OTHER DAMAGES ARISING OUT OF THE USE OR INABILITY TO USE THE EQUIPMENT AND SOFTWARE, EVEN IF VENDOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. Some jurisdictions may not permit the
limitation of liability under certain circumstances; the foregoing limitations and exclusions are not applicable to the extent not permitted under the laws of the relevant jurisdiction. 
  

	8.	Order Cancellation / Return Goods Policy 

 Describe the
order cancellation or return goods policy for this agreement. 
 Return Policy (non-warranty) 
 *Confidential Treatment Requested 
  

 Page E-3 

 Call Masimo Corporation at 1-800-362-4890 and select option #2 to request an RMA number to return your product.
Products must be unopened and in original packaging. A restocking fee of 25% will be charged, subject to change by Masimo. 
 Return Policy (warranty
returns) 
 Call Masimo Corporation at 1-800-362-4890 and select option #2 to request an RMA number to return your product. Please clean contaminated/dirty
product before returning and make sure it is fully dry before packaging the product. Package the product securely and enclose the following information and items: 
  

	 	•	 	 A letter describing in detail any difficulties experienced with the product. Please include the RMA number in the letter. 

  

	 	•	 	 Reference a contact person’s name, telephone, and or fax for any questions about the product. 

  

	 	•	 	 A certificate stating the oximeter or other product has been decontaminated for bloodborne pathogens. 

  

	 	•	 	 Non-warranty equipment repairs require a purchase order. 

 All Products shall be subject to inspection and acceptance for up to ten (10) days after receipt by Purchaser, (the “Acceptance Period”) to confirm that such Product, as delivered, performs in material
compliance with its published specifications. Any Products which do not comply with Purchaser’s purchase order; in any way fail to comply with the warranties provided under this Agreement; or are defective in any way at any time prior to the
end of the applicable Acceptance Period, may be rejected by Purchaser on written notice to Vendor irrespective of date of payment therefor. If Vendor has not received such notice within the Acceptance Period, the Equipment is deemed accepted upon
expiration of the Acceptance Period. Purchaser may hold any Product rejected for reasons described herein pending Vendor’s instructions, or Purchaser, by mutual agreement with Vendor, may return such Products to Vendor at Vendor’s expense,
F.O.B. Origin, Freight Collect. 
  

	9.	Backorder/Fill Rates 

 What are the back order / fill rates
for this agreement? 
 At least 95% fill rates 
  

	10.	Value Added Services 

 Describe any value-added services
for the members on this agreement. 
 NA 
  

 Page E-4 

	11.	Bulk-Buy 

 Describe the bulk-buy program for this
agreement. 
 NA 
  

	12.	Price Tiers 

 Tier 2 = All HPG members 

Tier 1 = IDN Tier identified as [...***...] hospitals committing to purchase a minimum of [...***...] of Masimo Pulse Oximetry products
(Direct or through Distribution) 
 What tier will new members be loaded to? 
 Tier 2, with the exception of members that previously executed Deferred Equipment Purchase Agreements whereby the terms of these Agreements will
remain in affect unless the parties agree to amend the Deferred Equipment Purchase Agreement. 
 How will vendor decide whether facility
is in compliance with tier requirements? 
 Tier 2 requires no minimum compliance levels 
 Tier 1 is IDN committing a minimum of [...***...] of their pulse oximetry purchases to Masimo. Any IDN not in compliance [...***...] after
agreement will be reverted to Tier 1 pricing. 
 How often does vendor review compliance? 
 Quarterly 
 Describe grace period for
compliance, if applicable. 
 [...***...] after IDN agreement executed 
 What notification will vendors provide before changing a member’s tier designation? 
 30 days following written notice per the Contract Compliance process listed in Exhibit D of this Agreement 
 Define each tier on this agreement, including what compliance level a member must achieve to qualify. Please list the tiers in order from best to worst.

 Tier 1 = IDN Tier identified as [...***...] hospitals committing to purchase a minimum of [...***...] of Masimo Pulse
Oximetry products (Direct or through Distribution) 
 Tier 2 = All HPG members 
  

	13.	Letters Of Commitment (LOCs) 

 If this agreement requires
an LOC please complete this section. 
 *Confidential Treatment Requested 
  

 Page E-5 

 What are the benefits of signing the LOC? Please provide detail. 
 An LOC only applies to member Health Systems that include [...***...] hospitals who indicate that Masimo is their preferred oximetry supplier and commit that a
minimum of [...***...] of their oximetry purchases will be from Masimo. 
 What is the deadline for existing members to sign the
LOC? 
 Anytime during the term of this Agreement 
 What is the deadline for new members to sign the LOC? 
 No deadline, anytime during the term of this
Agreement 
 If this is a tiered agreement, what tier will a member be loaded to if they do not submit an LOC? 
 Tier 2 
 How often can a member submit
a new LOC form with a new tier designation? 
 Anytime during the term of this Agreement 
 How long after the vendor receives an LOC will the distributor have pricing loaded? 
 30 Days 
 What’s the cutoff
period for the LOC after which a member cannot submit an LOC or receive best tier pricing? 
 NA 
 Should the LOC for this agreement be returned to HPG or the vendor? 
 LOC should be submitted to Vendor 
 Does the LOC require the signature of the vendor’s local rep?

 It requires signature from the applicable Masimo Regional Vice President 
  

	14.	Group Letters of Commitment 

 If this agreement has an
option for Groups to sign an LOC complete this section. If there is a Group LOC option on this agreement, does it have a separate LOC form? 
 An LOC only applies to member Health Systems that include [...***...] hospitals who indicate that Masimo is their preferred oximetry supplier and commit that a minimum of [...***...] of their oximetry purchases will be from
Masimo. 
 *Confidential Treatment Requested 
  

 Page E-6 

 How is a group defined for commitment to this agreement? 
 Identified as [...***...] hospitals indicating Masimo as their preferred pulse oximetry manufacturer of choice by committing to a minimum of
[...***...] of their pulse oximetry purchases from Masimo 
 What are the benefits of a group commitment for this agreement?

 Enhanced Pricing 
 Should the form be returned to HPG or the vendor? 
 Vendor 
  

	15.	Standardization Incentive Program (SIP) 

 If this agreement
has an SIP complete this section. 
 What are the benefits of participating for this agreement? 
 NA 
 Should the form be returned to
HPG or the vendor? 
 NA 
  

	16.	Group Standardization Incentive Program 

 If this agreement
has a Group SIP complete this section. 
 What are the benefits for a group participating for this agreement? 
 NA 
 Should the form be returned to
HPG or the vendor? 
 NA 
  

	17.	Other Forms 

 If this agreement has any other form complete
this section. 
 If there are any other types of forms that a facility might need to sign, for example a CPRR or lease document, what are the
benefits for an HPG member of signing any other forms (aside from the LOC and/or SIP) on this agreement? 
 A Facility Agreement is
available to assist in financing the Equipment. 
 If there are any other types of forms that a facility might need to sign, for example a
CPRR or lease document, should other forms (aside from the 
 *Confidential Treatment Requested 
  

 Page E-7 

 LOC and/or SIP) related to this agreement be submitted to HPG or the vendor? 
 NA 
  

	18.	Other Group Forms 

 If this agreement has any other group
form complete this section. 
 What are the benefits for an HPG member group of signing any other group forms (aside from the LOC and/or SIP)
on this agreement? 
 NA 
 Should other group forms (aside from the LOC and/or SIP) related to this agreement be submitted to HPG or the vendor? 
 NA

  

	19.	Strategic Sourcing Opportunities 

 For specific HPG members

 Please summarize the Strategic Sourcing opportunities for this agreement? 
 NA 
  

	20.	Pricing Supplement 

 If there is capitated pricing, please
provide pricing details and options. 
 NA 
 If there are upcharges, please provide details and options. 
 NA 
 If there are other discounts, please provide details and options. 
 NA 
 If there are other loaner or instrument fees, please provide details and options. 
 NA 
 If there are any other fees,
please provide details and options. 
 NA 
  

	21.	Consignment 

 Describe the consignment policy and process
for this agreement. 
 NA 
  

	22.	Formulary Program 

 Describe the formulary program for this
agreement. 
 NA 
  

 Page E-8 

	23.	Trade-In Policy 

 Describe the trade-in policy for this
agreement. 
 NA 
  

	24.	Indigent Care program 

 Summarize the indigent care program
for this agreement. 
 NA 
  

	25.	Additional Contract Information 

 Please provide any
additional contract information you believe would be of value to HPG membership that was not captured by any of the specific questions. 
 Note the following provisions: 
 — Vendor shall not be liable for any infringement of intellectual
property rights of third parties or for any liability, loss, damages, costs or expenses which Purchaser may incur as a result of any injury, illness or death resulting from (a) alterations or modifications to the Products made by Purchaser or
third parties at Purchaser’s request and without the written approval of a Vendor executive vice president or chief executive officer, (b) electrical/electronics, software/firmware, sensors, or product interface not furnished by Vendor,
(c) combination of the Products with other apparatus or technology not furnished by Vendor, (d) use of Products in combination with products or components not supplied by Vendor, (e) use of Products expressly prohibited under this
Agreement (if any), or (f) for any claims not related directly to the Products. The preceding Vendor indemnification obligations apply to claims arising out of Vendor SET or Rainbow SET technology contained in OEM Monitors or the combination of
such technology with Vendor Sensors and Equipment. 
 Software License Grant. The Products contain Vendor proprietary software (the
“Software”), trade secrets and other proprietary information (collectively, “Intellectual Property”). Vendor grants to Purchaser a non-exclusive, non-transferable, perpetual license to use the Software and Intellectual Property
in connection with its use of the Products. This Agreement does not constitute a sale of the Software or any Intellectual Property. The Purchaser may not reverse engineer, copy, modify, loan, rent, lease, assign, transfer, or sub-license the
Software or Intellectual Property without Vendor’s prior written consent, which may be withheld at Vendor’s sole discretion; any attempt to do so will render the license null and void and the right to use the Software and Intellectual
Property invalid. 
 Limited Use of Equipment. [...***...] 
 *Confidential Treatement Requested 
  

 Page E-9 

 [...***...]. HPG shall advise Purchasers that the monitors are not intended to be used by anyone other than the
Purchaser’s qualified and trained personnel or third party maintenance personnel trained by Vendor (or trained in accordance with Vendor’s maintenance processes in the case where Vendor trains the trainer for the third party service
provider). Except as is described in the applicable user documentation or pursuant to Vendor’s maintenance training, the Purchaser may not modify or connect other monitors to the Vendor monitors, including software, hardware and related
instruments without Vendor’s prior written authorization, which authorization may be withheld at Vendor’s sole discretion. The Parties acknowledge that the monitors, Software, sensors and related disposable accessories are intended for use
for processes, procedures, experiments or any other uses for which are cleared for use by the Food and Drug Administration (FDA). 
 *Confidential Treatment Requested 
  

 Page E-10 

 Exhibit F 
 HealthTrust Purchasing Group 
 Purchasing Agreement 
 No. HPG-1331 
 Vendor: Masimo
Americas, Inc. 
 February 1, 2008 
 DEFERRED EQUIPMENT PURCHASE PLAN 
  

 Page F-1 

 MASIMO PULSE OXIMETRY SUPPLY AGREEMENT 
 [...***...] DEFERRED EQUIPMENT PURCHASE PLAN 
 [...***...] 
 HealthTrust Purchasing Group Members 
 This Agreement is dated as of the             day of
                    , 200    , (the “Effective Date”), by and between: 
 Masimo Americas, Inc. (“Masimo”) 
 40 Parker 
 Irvine, CA 92618 
 and 
  

			
	  
	 	(“Purchaser”)
	  
	 	
	  
	 	

 [...***...] Whereas, the Purchaser and Masimo desire to enter into an agreement pursuant to which Masimo
will provide certain equipment to Purchaser (the “Equipment”) in exchange for a sensor purchase commitment over the Term, as defined herein; 
 [...***...] 
 Now, therefore, for good and valuable consideration, the receipt of which is acknowledged, the
parties agree as follows: 
  

	1.	Purchase and Sale of Sensors. 

 Masimo shall
sell to Purchaser and Purchaser shall buy from Masimo, under the terms and conditions of this Agreement, [...***...] of pulse oximetry sensors (hereinafter referred to as the “Sensor(s)”) during the Term, as defined
herein. 
  

	2.	Sensor Commitment; Additional Products. 

 [...***...] The attached Schedule A lists the price of the Sensors and Equipment (if applicable) sold and purchased hereunder and defines the Annual Minimum Sensor Purchase Commitment from Purchaser for Purchaser’s
facilities as listed in Schedule A, and is incorporated herein by reference. 
 [...***...] 
 Purchaser may make additional purchases by mutual agreement with Masimo upon execution of additional Schedules that reference this Agreement. Masimo may
inform Purchaser of new Sensors and products (“Additional Products”) that it wishes to make available to Purchaser after the Effective Date of this Agreement by providing a written notice of the availability of the Additional
Products, the part number and the price for such Additional Products. Masimo acknowledges that Purchaser is not obligated to purchase such Additional Products, but if Purchaser chooses to do so, the terms of sale for such Additional Products shall
be the terms set forth in this Agreement or per the terms of an amendment to this Agreement. No change to the Annual Minimum Purchase Commitment, as defined on Schedule A, is made as a result of the addition of Additional Products unless
agreed to in writing by the parties through an amendment to this Agreement. If any of the Additional Products are at a considerably higher price point, the parties agree to renegotiate pricing and Masimo will submit these renegotiated priced
products to Purchaser for written approval. 
  

	3.	Terms of Sale. 

 [...***...] The
attached Schedule B, describes the terms of sale of the Sensors and Equipment, and is incorporated herein by reference. 
 *Confidential Treatment Requested 
  

 Page F-2 

 [...***...] 
 This Agreement also incorporates all applicable provisions of the agreement entitled Purchasing Agreement, by and between Masimo and HealthTrust Purchasing Group (the “GPO Agreement”) as set forth in
Schedule C. No other terms will apply to this Agreement and any additional or varying terms supplied by Purchaser with any order or otherwise shall be disregarded and ineffective. In the event of any conflict between the terms of the GPO
Agreement and those in this Agreement, the terms of this Agreement shall control. 
  

	4.	Invoice Payment. 

 Masimo shall invoice
Purchaser for Sensors as shipments of Sensors are made. 
  

	5.	Purchase Orders. 

 All Sensors purchased
pursuant to this Agreement shall be implemented by Purchaser’s issuance of purchase orders to Masimo. No terms in such purchase order shall amend or supplement the terms of this Agreement. This paragraph does not limit Purchaser’s
obligation under the Annual Minimum Purchase Commitment. 
  

	6.	Term. 

 This Agreement is binding and
effective as of the Effective Date set forth above. Purchaser’s obligation to buy Sensors and the start date for its initial Annual Minimum Purchase Commitment (the “Start Date”) shall be the earlier of (i) 60 days after
the Effective Date or (ii) the first deployment of Equipment. This Agreement shall continue in effect until the ______ anniversary of the Start Date (the “Term”). The parties shall each make commercially reasonable efforts to
deploy the Equipment within 45 days after the Effective Date. 
  

	7.	Acceptance. 

 The parties agree that
Masimo’s record of shipment/delivery and Purchaser’s acceptance of such number of Equipment shall be presumptive evidence of such delivery and acceptance by Purchaser. 
  

	8.	Press Release. 

 Either party may issue a
press release announcing the existence and general content of this Agreement and the reasons the Purchaser has chosen Masimo, provided that the issuing party receives written approval from the other party in advance of its publication. Except for
the press release or as required by law, neither Party shall, without the other Party’s prior written approval, disclose any terms of this Agreement. 
  

	9.	Agreement Validity Period. 

 The terms of
this Agreement are subject to Masimo’s receipt of this Agreement executed by Purchaser on or before the ___ day of                     ,
2007. 
 This Agreement is dated as of the Effective Date above. 
  

							
	 Purchaser
	 	Masimo Americas, Inc.
				
	 By:
	 	  
	 	By:	 	  

	 Print:
	 	  
	 	Print:	 	  

	 Title:
	 	  
	 	Title:	 	  

	 Date:
	 	  
	 	Date:	 	  

 *Confidential Treatment Requested 
  

 Page F-3 

 SCHEDULE A 
 [...***...] DEFERRED EQUIPMENT PURCHASE PLAN 
 [...***...] 

 This Schedule applies to the following facilities (the “Facilities”, collectively, “Purchaser”): List the name of each
Hospital Facility. 
 Masimo agrees to provide the use of the following Equipment and accessories to Purchaser at [...***...] cost during the
Term of this Agreement (acquisition prices shown for information purposes only and are the price under the GPO Agreement). 
  

									
	 MFR/
 Part #
	 	 Item Description
	  	Qty	  	Unit Price	  	Extended
Price
	 Masimo 9031
	 	 Radical-7 Oximeter with LCD Display, Masimo SET Sp02 and Rainbow
 SET Pulse CO-Oximetry technology platform
	  	1	  		  	
	 Masimo 9086
	 	Radical-7 Oximeter with TFT Color Display, Masimo SET Sp02 and Rainbow SET Pulse CO-Oximetry technology platform	  	1	  		  	
	 Masimo 9030
	 	Radical Handheld Oximeter with Masimo SET Sp02	  	1	  		  	
	 Maxima 9021
	 	RDS1 Oximeter Docking Station with SatShare Capability	  	1	  		  	
	 Masimo 9023
	 	RDS3 Oximeter Docking Station	  	1	  		  	
	 Masimo 9019
	 	Rad-8 Oximeter w/ Masimo SET and Horizontal LED Display	  		  		  	
	 Masimo 9028
	 	Rad-9 Oximeter w/ Masimo SET and LCD Display	  	1	  		  	
	 GE -12949
	 	GE Solar/Tram Internal Upgrade to Masimo. SET Sp02	  	1	  		  	
	 GE -13108
	 	GE Dash Internal Upgrade to Masimo SET Sp02	  	1	  		  	
	 GE
	 	GE Dinamap Internal Upgrade to Masimo SET Sp02	  	1	  		  	
	 Welch Allyn
	 	Welch Allyn Propaq Internal Upgrade to Masimo SET Sp02	  	1	  		  	
	 Philips -1846
	 	Philips IntelliVue Masimo SET Sp02 single parameter module	  	1	  		  	
	 SUBTOTAL: Capital Equipment
	  		  		  	SUBTOTAL
	 Masimo
	 	SatShare Cables	  	1	  		  	
	 Masimo
	 	Mounting Brackets - SatShared Radical Oximeters	  	1	  		  	
	 Masimo 2281
	 	LNC 10’ Dual-Key Patient Cable for Philips IntelliVue Series	  	1	  		  	
	 Masimo 2263
	 	LNC 10’ Adapter Cable to Philips 12-pin “CMS” Sp02 Socket	  	I	  		  	
	 Masimo 2264
	 	LNC 10’ Adapter Cable to GE Conventional Sp02 Socket	  	I	  		  	
	 Masimo 12525
	 	ProFox Software	  	I	  		  	
	 Masimo 1795
	 	Tester for Masimo SET Sp02 and Pulse Rate	  	1	  		  	
	 Masimo 1395
	 	Radical Series Handheld Locks	  	1	  		  	
	 Masimo 1863
	 	LNCS DC-1 Adult Reusable Finger Sensor	  	1	  		  	
	 Masimo 1864
	 	LNCS DC-IP Pediatric Reusable Finger Sensor	  	1	  		  	
	 Masimo 1896
	 	LNCS TF-I Reusable Forehead Sensor	  	1	  		  	
	 Masimo 1895
	 	LNCS TC-I Tip Clip Reusable Ear Sensor	  	1	  		  	
	 SUBTOTAL: Accessories
	  		  		  	SUBTOTAL
	 Masimo
	 	Installation and Training Services	  	1	  		  	
	 Masimo
	 	Extended Warranty for Masimo Tabletop Oximeters	  	1	  		  	
	 SUBTOTAL: Installation and Warranty Services
	  		  		  	SUBTOTAL
				
	 TOTAL: Equipment, Accessories and Services
	  		  		  	TOTAL

 Sensor Purchase Commitment: [...***...] 
 *Confidential Treatment Requested 
  

 Page F-4 

 Purchaser agrees to purchase Sensors in the minimum quantities set forth below each year beginning on the Start Date or
any anniversary thereof (the “Annual Minimum Purchase Commitment”) during the Term of the Agreement. 
  

													
	 	  	 	  	Annual Minimum Sensor Purchase Commitment
	 Part
Number
	  	 Description
	  	Baseline
Quantity	  	Guaranteed
Quantity	  	Unit Price	  	Extended Price
	 1859
	  	LNCS ADT Adult Adhesive Sensor	  		  	0	  	$	 [,,,***,,,]	  	$	—  
	 1860
	  	LNCS PDT Pediatric Adhesive Sensor	  		  	0	  	$	 [...***...]	  	$	 —  
	 1861
	  	LNCS INF-L Infant Adhesive Sensor	  		  	0	  	$	 [...***...]	  	$	 —  
	 1862
	  	LNCS NEO-L Neonatal Adhesive Sensor	  		  	0	  	$	 [...***...]	  	$	 —  
	 1901
	  	LNCS NEO-PT Neonatal SofTouch Adhesive Sensor	  		  	0	  	$	 [...***...]	  	$	 —  
		  	TOTALS:	  	0	  	0	  			  	$	 —  

 [...***...] 
 Sites: This Agreement is based on Purchaser’s agreement to convert ____ pulse oximetry sites at the Facilities to utilize Masimo Sensors. Purchaser agrees to use best efforts to make all its
clinicians who will be using the Equipment available for on-site training or to complete Masimo’s online e-Learning tutorial in the use of Masimo SET oximetry and Sensors. 
 Annual Minimum Purchase Commitment. Purchaser may adjust the mix of adhesive sensors purchased from the quantities listed in the above table provided the Annual Minimum Purchase Commitment in
“dollars” is achieved. [...***...] 
 The value of any Equipment provided by Masimo to Purchasers may be considered to be a discount, rebate
or other reduction in price to the Sensors obtained under the Agreement. Purchasers may have an obligation to disclose and/or appropriately reflect any such discounts, rebates or price reductions in any costs claimed or charges made to Medicare,
Medicaid, or health insurers requiring disclosure by separately stating Purchaser’s costs for Equipment and Sensors. A worksheet for Purchaser to calculate its equipment and supply costs under this Agreement is available through the HealthTrust
Purchasing Group SCRUBS website or by calling Customer Service for HealthTrust Purchasing Group (888-222-1172). 
 *Confidential Treatment
Requested 
  

 Page F-5 

 SCHEDULE B 
 TERMS AND CONDITIONS 
 1. [...***...] Equipment Ownership. Purchaser
acknowledges that Masimo has and retains title to the Equipment until Purchaser has met all its obligations under the contract, including the aggregated Annual Minimum Purchase Commitment. Title to the Equipment automatically transfers to Purchaser
on completion of all such obligations. 
 [...***...]  
 [...***...] Purchaser will not sell, assign, sublet, transfer, abandon, part with contract, create, incur, assume or suffer to exist any claim mortgage, pledge, lien, security interest or other charge or
encumbrance of any kind upon or with respect to the Equipment or any part thereof or any of Purchaser’s rights under this Agreement, without Masimo’s written consent. Masimo shall have the option to make, and require Purchaser to execute,
any and all information and/or lien filings Masimo deems appropriate under the Uniform Commercial Code to perfect a security interest in the Equipment. During the term of this Agreement, Purchaser shall bear the entire risk of loss and damage to the
Equipment from any and every cause whatsoever, except for acts by Masimo. Except for loss of use caused by a Masimo material breach of contract that is not timely cured, no loss or damage to the Equipment (or any part thereof), or any failure of
operation, shall impair any obligations of Purchaser (including, without limitation, payment obligations) under this Agreement, which shall continue in full force and effect. 
 2. Software License Grant. The Sensors and Equipment contain Masimo proprietary software (the “Software”), trade secrets and other proprietary information (collectively,
“Intellectual Property”). Masimo grants to Purchaser a non-exclusive, non-transferable, perpetual license to use the Software and Intellectual Property in connection with its authorized use of the Equipment and Sensors. This
Agreement does not constitute a sale of the Software or any Intellectual Property. The Purchaser may not reverse engineer, copy, modify, loan, rent, lease, assign, transfer, or sub-license the Software or Intellectual Property without Masimo’s
prior written consent, which may be withheld at Masimo’s sole discretion; any attempt to do so will render the license null and void and use of the Software and Intellectual Property invalid. 
 3. Confidentiality. Neither party shall disclose to any unrelated third party or to any related party that is not bound by the obligations of
confidentiality set forth herein or in its applicable participation agreement with HealthTrust Purchasing Group, or use for any purpose other than performance of this Agreement any information and proprietary material disclosed to it without the
prior written consent of the disclosing party. The obligations of confidentiality shall not apply to information that at the time of disclosure or subsequently (i) is a matter of general public knowledge other than by a breach of this
Agreement, (ii) is rightfully communicated to the recipient free of any obligation of confidence, or (iii) is made public by the disclosing party; or to information that is required to be disclosed by applicable law, provided however, that
the recipient shall promptly notify the disclosing party of such requirement. 
 4. Limited Use of Equipment. [...***...] The monitors
are not intended to be used by anyone other than the Purchaser’s qualified and trained personnel or third party maintenance personnel trained by Masimo (or trained in accordance with Masimo’s maintenance processes in the case where Masimo
trains the trainer for the third party service provider). Except as is described in the applicable user documentation or pursuant to Masimo’s maintenance training, the Purchaser may not modify or connect other monitors to the Masimo monitors,
including software, hardware and related instruments without Masimo’s prior written authorization, which authorization may be withheld at Masimo’s sole discretion. The Parties acknowledge that the monitors, Software, sensors and related
disposable accessories are intended for use for processes, procedures, experiments or any other uses for which are cleared for use by the Food and Drug Administration (FDA). 
 5. Delivery; Payment. Prices are shown on Schedule A and are FOB shipment origin, with freight and packaging added to invoice. Risk of loss shall pass to the Purchaser FOB shipment origin.
Purchaser shall pay all sales, use, property, excise, import or export, value added or similar taxes (except Masimo’s income or franchise taxes) levied upon the delivery, transport, use or possession of the products. Payment terms are net 30
days from shipment date. Service charges of 1 1/2 % per month or the maximum rate permitted by law, if lower, may be charged on past due amounts. Masimo reserves the right to make partial deliveries. The carrier shall not be construed to be an
agent of Masimo. Masimo shall not be held responsible for delays by carrier to make deliveries for any cause. 
 6. Service, Installation and
Training. Installation and training are scheduled by mutual consent between Masimo and the Purchaser. Telephone support is provided to the Purchaser twenty-four (24) hours per day, seven (7) days per week. If the Purchaser
experiences difficulty using the Equipment or sensors the Purchaser should call Masimo’s telephone support number. 
 7. Warranty; Limitation of
Liability. Masimo warrants that the Masimo Equipment, Sensors and other accessories provided will materially conform to the published product specifications of Masimo and be free from material defects in materials and workmanship;
[...***...]. Provided that payments are current and Purchaser is not otherwise in breach of this Agreement, Masimo’s obligation if any Masimo Equipment, 
 *Confidential Treatment Requested 
  

 Page F-6 

 Sensors or other accessories found upon examination by Masimo, to be defective during the warranty period shall be
limited to repair or replacement. This warranty is subject to the following exclusions, exceptions and limitations: a) repair and maintenance necessitated by damage, neglect, misuse or improper operation of the Equipment, Software, or device; b)
modification of Equipment, Sensors and Software without the express written authorization of Masimo; c) supplies, devices or electrical work external to the Masimo Equipment or not manufactured by Masimo; d) use of sensors or other accessories other
than those manufactured and distributed by Masimo; and e) use of the Equipment and Sensors for uses and/or in environments for which they are not intended. For Equipment manufactured by third-parties, Masimo will pass on to Purchaser all terms and
rights provided by the manufacturer. Masimo is not responsible and will charge the Purchaser for repair, replacement, or maintenance caused by damage, neglect, misuse, improper operation, accident, fire, water, vandalism, weather, war, or any Act of
God, and unauthorized Equipment attached to Masimo Equipment, or unauthorized modification of Masimo Equipment or software. Warranty does not extend to any equipment, or software not manufactured by Masimo. THE FOREGOING WARRANTY IS IN LIEU OF AND
EXCLUDES ALL OTHER EXPRESS OR IMPLIED WARRANTIES, ARISING BY OPERATION OF LAW OR OTHERWISE, AND NO OTHER WARRANTIES EXIST, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE. MASIMO WILL NOT BE
LIABLE FOR ANY INCIDENTAL OR CONSEQUENTIAL DAMAGES, EXPENSES, LOST PROFITS, OR OTHER DAMAGES ARISING OUT OF THE USE OR INABILITY TO USE THE EQUIPMENT AND SOFTWARE, EVEN IF MASIMO HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. 
 8. Indemnification. 
 8.1 Bodily Injury. Masimo
will defend, indemnify and hold Purchaser harmless against any and all liability, loss, damages, costs or expenses that Purchaser may hereafter incur, as a result of any injury, illness or death of any person which is caused by any Products, to the
extent that such injury, illness or death resulted from (i) Masimo’s design or manufacture of the standard Products or (ii) failure of any Product at the time of shipment to Purchaser to materially comply with its published
specification. “Product(s)” means any Sensors, accessories and Equipment provided to Purchaser under this Agreement, including without limitation third party monitors that contain Masimo SET or Rainbow SET technology under license from
Masimo (“OEM Monitors”). 
 8.2 Infringement. Masimo will defend, indemnify and hold Purchaser harmless against infringement or
alleged infringement directly resulting from standard Products furnished under this Agreement, of any patent, copyright, trademark, trade secret, or any other proprietary right of any third party. In the event of such claim, Masimo may, at its sole
discretion, (i) modify the particular Product to make it non-infringing, (ii) obtain a license to allow the continued use of the Product, or (iii) terminate this Agreement, and take possession of and refund all fees paid for the
infringing Products. 
 8.3 Exclusions. Masimo shall have no liability or responsibility of any kind to Purchaser under this Section
(“Indemnification”) unless Purchaser (i) promptly notifies Masimo of such claims, (ii) gives Masimo an adequate opportunity to defend, including complete control of such defense, and (iii) provides reasonable assistance to
Masimo, at Masimo’s expense and request, in connection with the defense and settlement of any such claim. Masimo shall have no liability for settlements made without Masimo’s express written consent. Should Purchaser desire to have its own
counsel participate in any such action, the cost of such counsel shall be exclusively Purchaser’s. Notwithstanding the above, Masimo shall not be liable for any infringement of intellectual property rights of third parties or for any
liability, loss, damages, costs or expenses which Purchaser may incur as a result of any injury, illness or death resulting from (a) alterations or modifications to the Products made by Purchaser or others (or by Masimo, in the case of an
infringement claim) at Purchaser’s request, (b) electrical/electronics, software/firmware, sensors, or product interface not furnished by Masimo, (c) combination of the Products with other apparatus or technology not furnished or, in
the case of infringement claims, specified in writing by Masimo, (d) use of products or components not supplied by Masimo, (e) use of Products not permitted under this Agreement, or (f) for any claims not related directly to the
Products. The preceding sentence does not exclude Masimo’s indemnification obligations for claims arising out of Masimo SET or Rainbow SET technology contained in OEM Monitors or the combination of such technology with Masimo Sensors and
Equipment. If Masimo fails to assume its obligation to defend Purchaser, then Purchaser may do so to protect its interest and seek reimbursement from Masimo. 
 9. Termination. In the event of a breach of a material obligation of this Agreement by either party, the other party will provide written notice including all supporting documentation of the breach. If the breach is not cured
within thirty (30) days of receipt of such notice (ten (10) days in the event of breach of payment obligations), the notifying party shall be entitled, in addition to all other remedies available to such party, to terminate this Agreement
for cause and without penalty by providing written notice in accordance with the Agreement. Termination of this Agreement for material breach shall be without prejudice to all accrued rights and remedies the parties may have, and shall not affect
any continuing rights and obligations the parties may have under this Agreement. All payments made before the date of termination are non-refundable. Purchaser shall pay any outstanding balances due Masimo for services performed or products
delivered prior to termination, except for those, if any, that are related to Masimo’s breach. [...***...]. 
 10. Power and Authority;
Amendments. Masimo and Purchaser each represent to the other that each has full and complete power and authority to execute this Agreement and that this Agreement constitutes a valid and binding obligation of Masimo and Purchaser,
respectively, enforceable in accordance with its terms. Amendments to this Agreement (other than the addition of Additional Products), which includes without limitation any additional terms not set forth herein, may only be made via a written
amendment signed by Masimo and by Purchaser. Only an executive vice-president or the president of Masimo has the authority to sign this Agreement or any amendment or schedule hereto. 
 11. General. This Agreement contains the entire understanding between Masimo and the Purchaser and supersedes all prior understandings, written or oral, regarding the subject of this Agreement.
Notwithstanding anything else herein to the contrary, some or all of Masimo’s rights under this agreement may be assigned to a third party for purposes of financing, an affiliate, or a successor in interest resulting from a merger or
acquisition. If any provision of these Terms and Conditions is found to be unenforceable, it will not affect the validity of the remainder of these Terms and Conditions, which shall remain valid and enforceable according to the terms hereof. This
Agreement shall not be binding until approved by Masimo at its home office. The courts and substantive laws of the states of both parties’ home offices shall have non-exclusive jurisdiction to resolve any disputes between the parties. The
prevailing party in any litigation between the parties shall receive from the other party all reasonable costs incurred by the prevailing party, including attorneys’ fees. This Agreement may be signed by facsimile copies and in counterparts.

 *Confidential Treatment Requested 
  

 Page F-7 

 SCHEDULE C 
 ADDITIONAL TERMS APPLICABLE TO HPG PURCHASERS 
 This Agreement incorporates by reference all applicable terms and
conditions from the sections of the GPO Agreement identified below: 
  

	 	7.0	Vendor Delivery Performance; Customer Service 

  

	 	8.0	Shipment, Risk of Loss, Freight Charges 

  

	 	9.0	Warranties and Disclaimer of Liability 

  

	 	10.0	Inspection. 

  

	 	11.0	Indemnity 

  

	 	12.0	Confidentiality; Software License & Use Restrictions. 

  

	 	14.0	Insurance 

  

	 	15.0	Order Cancellation (as to specific orders and not as to this Agreement in its entirety) 

  

	 	17.0	Books, Records and Compliance Requirements 

 (excluding Sections 17.2.5, and 17.3 – 17.7) 
 By mutual agreement with Purchaser, Masimo may include the actual terms listed above in lieu of
incorporating them by reference. If Masimo needs to disclose the terms of this Agreement in the course of its business, such terms shall not be deemed confidential to HPG for purposes of such disclosure. 
 Implementation. Masimo will use commercially reasonable efforts to deliver and distribute all equipment listed in Schedule “A” including pulse
oximeters and internal upgrades or replacements in accordance with a mutually agreed upon implementation schedule. The parties agree to use commercially best efforts to jointly develop and complete an implementation plan that is comprehensive, but
also includes the efficient use of Purchaser’s resources to complete the process in an agreed upon, expeditious timeframe. Masimo will provide a comprehensive training program for designated staff for all products provided. Purchaser will
designate a Project Manager with responsibility for high level planning and coordination of the Implementation with the Masimo Project Manager. 
  

 Page F-8Amended and Restated Cross-Licensing Agreement

 Exhibit 10.34 
 ***Text Omitted and Filed Separately 
 Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 230.406 
 AMENDED AND RESTATED 
 CROSS-LICENSING AGREEMENT 
 BETWEEN 
 MASIMO LABORATORIES 
 AND 
 MASIMO CORPORATION 
 EFFECTIVE
JANUARY 1, 2007 

 EXHIBITS 
  

			
	Exhibit A	  	MASIMO SET® Definition
	Exhibit B	  	Trademarks, Legend, Logos
	Exhibit C	  	Price for Products
	Exhibit D	  	End-User License Agreement

 AMENDED AND RESTATED CROSS-LICENSING AGREEMENT 
 THIS AMENDED AND RESTATED CROSS-LICENSING AGREEMENT (the “Agreement”), effective as of January 1, 2007 (the “Effective Date”),
is an amendment and restatement of the CROSS-LICENSING AGREEMENT originally made and entered into as of the 2nd day of May, 1998 (as subsequently amended, the “Original Agreement”), by and between MASIMO LABORATORIES, a Delaware
corporation (“LABS”), and MASIMO CORPORATION, a Delaware corporation (“MASIMO”), with reference to the following: 
 R
E C I T A L S 
 A. MASIMO has developed a technology (“MASIMO Technology” as defined herein). MASIMO Technology incorporates
circuitry and software which, among other things, acquires and detects signals generated by red and infrared LEDs, and which is designed to extract arterial oxygen saturation and pulse rate values from such signals. 
 B. Pursuant to the Original Agreement, as previously amended, LABS has an exclusive license to MASIMO Technology for certain applications. 
 C. Pursuant to the Original Agreement, as previously amended, LABS has a license to make, use and sell devices which incorporate MASIMO Technology
subject to certain restrictions for distribution throughout the world. 
 D. Pursuant to the Original Agreement, as previously amended,
MASIMO has an option to license to certain technology developed by LABS for use in blood glucose monitoring and total hemoglobin/hematocrit applications, and MASIMO desires to have an option to license certain technology developed by LABS for use in
certain other Non-Vital Signs Monitoring in the professional caregiver market. 
 E. MASIMO has acquired substantial Know-How (as defined
below) in extracting signals from signals contaminated by noise. 
 F. MASIMO has acquired and expects to continue to acquire a reputation
for excellence, and its trademark has and will continue to acquire valuable goodwill. 
 G. Labs has acquired substantial Know-How (as
defined below) in extracting signals from interfering signals. 
 H. Labs has acquired and expects to acquire a reputation for excellence.

 I. MASIMO and LABS entered into three amendments of the Original Agreement relating to increasing funding to LABS and extending the period
for execution of the option to license certain technology developed by LABS. 
 J. MASIMO and LABS entered into a Fourth Amendment to the
Original Agreement to enable MASIMO to have its option to blood glucose monitoring and total hemoglobin/hematocrit applications be separately exercisable and to obtain a license to carboxyhemoglobin and methemoglobin, which Fourth Amendment
superseded all earlier amendments to the Agreement. 
  

 3 

 K. The Parties desire to enter into this Agreement to amend and restate the Original Agreement and the
terms of the Fourth Amendment, to include additional terms, and to have this Agreement supersede the Original Agreement and the Fourth Amendment. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth in the Original Agreement and hereinafter set forth, LABS and MASIMO hereby agree as follows: 
 1. DEFINITIONS. As used in this Agreement, the following terms, whether used in the singular or the plural shall have the following meaning:

 1.1. Accessory means cables or any other accessories manufactured by a Party for use with any of the Products.

 1.2. Affiliate means, with respect to each Party, any legal entity that is, directly or indirectly, controlling,
controlled by or under common control with the Party. For purposes of this definition, a Party shall be deemed to control another entity if it owns or controls, directly or indirectly, more than fifty percent (50%) of the voting equity of the
other entity (or other comparable ownership interest for an entity other than a corporation). 
 1.3. Average Selling
Price means the total amount, in dollars (based upon the first sale to arms-length customers), for a device, sensor, accessory or other product divided by the number of devices, sensors, accessories or other products sold during the relevant
period, or quarterly if not otherwise stated, on a product-by-product basis. 
 1.4. Change in Control means, with
respect to a Party, the occurrence of any of the following: (i) the direct or indirect sale, transfer, conveyance or other disposition (including by merger, consolidation, operation of law or otherwise), in one or a series of related
transactions, of all or substantially all of the properties or assets of such Party to a non-Affiliate third party; (ii) any non-Affiliate third party becomes the ultimate beneficial owner, directly or indirectly, of 50% or more of the voting
power of the voting stock of such Party; (iii) Joe E. Kiani is not the CEO of either company; or (iv) such Party consolidates with, or merges with or into, any third party, or any third party consolidates with, or merges with or into such
entity. 
 1.5. Distributor means, as applicable, (i) a party that markets LABS Licensed Devices or Stand Alone
Licensed Devices to End-Users on behalf of LABS, (ii) a customer of LABS that buys LABS Licensed Devices or Stand Alone Licensed Devices from LABS, private labels such devices, and markets such LABS Licensed Devices or Stand Alone Licensed
Devices to End-Users, (iii) a party that markets MASIMO Licensed Devices to End-Users on behalf of MASIMO, or (iv) a customer of MASIMO that buys MASIMO Licensed Devices from MASIMO, private labels such devices, and markets such MASIMO
Licensed Devices to End-Users. 
 1.6. Enabled means that a parameter is actually activated such that it measures the
parameter when an appropriate sensor is attached. 
 1.7. End User is, as applicable, a direct user of LABS Licensed
Devices, Stand Alone Licensed Devices or MASIMO Licensed Devices. 
  

 4 

 1.8. Improvement means any invention, adaptation, modification or change, except
for those that are purely aesthetic as trade dress. 
 1.9. LABS Combo Device means a LABS’ device that
incorporates Masimo Technology for monitoring Non-Vital Signs Parameters and Vital Signs Parameters. 
 1.10. LABS
Confidential Information means confidential information and proprietary material of LABS, including, but not limited to, (i) the LABS Technology, (ii) any Improvements, patents, copyrights, trade secrets, and any other intellectual
property and proprietary rights owned by LABS in accordance with Article 11, and (iii) the following types of information and other information of a similar nature: ideas, concepts, materials, techniques, models, data, designs, documentation,
flow charts, budgets, projections, forecasts, marketing and development plans, communication protocols and testing procedures. 
 1.11. LABS Licensed Device means a LABS’ device (finished product, chipset or board containing circuitry or software, software, or any combination) that incorporates Masimo Technology for monitoring Non-Vital Signs Parameters or
a LABS Combo Device. 
 1.12. LABS Market means any product market in which the product is intended to be used by a
patient or pharmacist rather than by a professional medical caregiver, regardless of the particular location of the sale. For example, the LABS Market includes sales to doctors, hospitals, EMS professionals or otherwise, provided the product is
intended to be recommended, or resold, for use by the patient or pharmacist. 
 1.13. LABS Technology means any of the
following Rainbow Technology rights (i) owned by LABS as of the Effective Date, or (ii) developed or conceived by LABS during the Term and owned by LABS in accordance with Article 11: Technical information, inventions, concepts, products,
components, trade secrets, know-how, techniques, designs, processes, communications protocols, software, Improvements, whether patentable or not, patents, patent applications, including any patents issuing thereon and any and all divisions,
continuations and continuations-in-part thereof, and any and all reissues and reexaminations of any such patents, copyrights, copyright registrations and applications, and all other intellectual property rights. LABS Technology excludes (i) any
technology owned by a third party and licensed to LABS, and (ii) the MASIMO Technology. Notwithstanding Section 11.3, Labs Technology also includes the glucose measurement technology acquired from Argose. 
 1.14. Current Licensed Device means a device that incorporates Rainbow Technology for measurement of carbon monoxide (HbCO),
methemoglobin (HbMet), total hemoglobin and/or fractional arterial oxygen saturation (whether Enabled or not). A Current Licensed Device includes boards or software for integration into devices of third parties, such as original equipment
manufacturers. 
 1.15. MASIMO Board means a circuit board or chip set manufactured or distributed by or for MASIMO,
that incorporates MASIMO Technology, and/or Rainbow Technology and/or Optioned Technology. 
 1.16. MASIMO Confidential
Information means confidential information and proprietary material of MASIMO, including, but not limited to, (i) the MASIMO Technology, 

  

 5 

 
(ii) any Improvements, patents, copyrights, trade secrets, and any other intellectual property and proprietary rights owned by MASIMO in accordance with
Article 11, (iii) the MASIMO Software, and (iv) the following types of information and other information of a similar nature: ideas, concepts, materials, techniques, models, data, designs, documentation, flow charts, budgets, projections,
forecasts, marketing and development plans, communication protocols, and testing procedures. 
 1.17. MASIMO Licensed
Device means a Current Licensed Device or an Optioned Technology Device. 
 1.18. MASIMO Licensed Trademarks means
the MASIMO SET, Rainbow, and other Rainbow related product designation and word mark(s) set forth on Exhibit B.1. 
 1.19.
MASIMO Market means any product market where the product is intended to be used by a professional caregiver, including but not limited to hospital caregivers, surgicenter caregivers, paramedic vehicles caregivers, doctor’s offices
caregivers, EMS facilities caregivers and vehicles where emergency medical services are provided. 
 1.20. MASIMO Sensor means a sensor manufactured or distributed by or for MASIMO for use in SpO2 Measurement
and/or Non-Vital Signs Monitoring. 
 1.21. MASIMO Product Design means all product design rights other than those that
are purely aesthetic, including industrial designs, tooling, process and manufacturing designs, all for products that include Masimo SET. 
 1.22. MASIMO SET has the meaning set forth in Exhibit A. 
 1.23. MASIMO
Software means any and all computer/instrument software and/or firmware owned by MASIMO that is used or useful in connection with MASIMO Technology for use in Vital Signs Monitoring or Non-Vital Signs Monitoring, including any and all
Improvements thereto, all in source code and object code format, and all written documentation relating to such software. 
 1.24. MASIMO Technology means any of the following MASIMO SET, Masimo Product Design rights, or Masimo Sensor rights, as initially licensed to LABS on May 2, 1998, as the same has been Improved by MASIMO since that time,
(i) owned by MASIMO as of the Effective Date, or (ii) developed or , conceived by MASIMO during the Term and owned by MASIMO in accordance with Article 11: technical information, inventions, concepts, products, components, trade secrets,
know-how, techniques, designs, processes, communications protocols, whether patentable or not, patent applications, copyright applications, patents, copyrights and all other intellectual property. MASIMO Technology excludes (i) any technology
owned by a third party and licensed to MASIMO, and (ii) the Rainbow Technology. 
 1.25. Net Selling Price of a
Product means the total sales revenue for such Product (including any amounts for rental or leasing of such product), excluding charges for returns, rebates, credits, post-sale adjustments, including adjustments for doubtful accounts, outbound
prepaid or allowed transportation charges, sales taxes, tariffs or duties directly imposed with reference to particular sales or similar items. 
 1.26. Non-Vital Signs Monitoring means non-invasive measurement Non-Vital-Signs Parameters using Masimo Technology. 
  

 6 

 1.27. Non-Vital-Signs Parameter means any noninvasive or minimally invasive
measurement of body fluid constituents other than Vital Signs, including, but not limited to, blood glucose, fractional arterial oxygen saturation (defined as the correction to SpO2 by eliminating one or more dysfunctional hemoglobins (i.e., CO,
methemoglobin and/or [...***...]), total hemoglobin, hematocrit, carbon monoxide (HbCO), methemoglobin (HbMet), [...***...], bilirubin, [...***...]. 
 1.28. Optioned Technology means LABS Technology developed using MASIMO Technology and Improvements owned by Labs for use in
Non-Vital Signs Monitoring other than monitoring of carbon monoxide (HbCO), methemoglobin (HbMet), total hemoglobin and/or fractional arterial oxygen saturation. 
 1.29. Optioned Technology Device means a device that incorporates Rainbow Technology for measurement of any Non-Vital Signs
Parameter (whether Enabled or not) for which MASIMO has exercised one or more of the options under Section 4.1. An Optioned Technology Device includes boards or software for integration into devices of third parties, such as original equipment
manufacturers (OEM). 
 1.30. Parameter means a Vital Signs Parameter or a Non-Vital-Signs Parameter, as applicable.

 1.31. Party means LABS or MASIMO; Parties means LABS and MASIMO. 
 1.32. Products means (i) in the case of MASIMO, MASIMO Boards, MASIMO Sensors and Accessories, and (ii) in the case of
LABS, LABS Licensed Devices and Stand Alone Licensed Devices. 
 1.33. Rainbow Sensor means a sensor incorporating
Rainbow Technology for measuring Non-Vital-Signs Parameters and possibly one or more Vital Signs using Masimo Technology. 
 1.34. Rainbow Technology means LABS technology for Non-Vital Signs Monitoring using Masimo Technology and at least 6 wavelengths. 
 1.35. SpO2 Measurement means noninvasive measurement of arterial oxygen saturation (accounting for at least Hb and HbO2
), fractional saturation, plethysmographic waveforms, and/or pulse rate from neonate, pediatric and adult subjects. 
 1.36. Stand Alone Licensed Devices means LABS’ completed patient monitor devices that are not capable of Non-Vital Signs
Monitoring but that incorporate a MASIMO Board as the exclusive method to obtain SpO2 Measurement. 
 1.37. Standard Cost,
or Cost, means the cost for direct materials and labor, overhead and administration, in accordance with generally accepted accounting principles. 
 1.38. Vital Signs Monitoring means measurement and/or monitoring of Vital Signs Parameters. 
 *Confidential Treatment Requested 
  

 7 

 1.39. Vital Signs
Parameters means SpO2, peripheral venous oxygen saturation, mixed venous oxygen saturation, fetal oximetry, Sudden Infant Death Syndrome
(“SIDS”), ECG, blood pressure (non-invasive blood pressure, invasive blood pressure and continuous non-invasive blood pressure), temperature, respiration rate, CO2, SvO2, pulse rate, respiration rate, cardiac output, EEG, perfusion index (“PI”), depth of anesthesia,
cerebral oximetry, tissue oximetry and/or EMG, and associated features derived from these parameters, such as 3-D Alarms, Pleth Variability Index (“PVI”), and other features. 
 2. LICENSE GRANTS 
 2.1. Licenses Granted to LABS. 
 2.1.1. MASIMO grants to LABS an exclusive (including of MASIMO, subject to
Section 2.2.1), royalty-bearing, perpetual, worldwide license (i) to use the MASIMO Technology to develop Non-Vital Signs Monitoring and to develop LABS Licensed Devices, (ii) to make, have made, use, offer to sell and sell LABS
Licensed Devices , including on an OEM basis, (iii) to sublicense MASIMO Technology for the development of or for use in Non-Vital Signs Monitoring and LABS Licensed Devices, and (iv) to sublicense the use, manufacture and sale of LABS
Licensed Devices. 
 2.1.2. MASIMO further grants to LABS an exclusive, perpetual, worldwide license (i) to copy, modify,
and make derivative works of the MASIMO Software for incorporation into LABS Licensed Devices, (ii) to distribute the MASIMO Software in conjunction with a transfer of a LABS Licensed Device to End-Users and Distributors, and (iii) to
sublicense the right to copy and modify the MASIMO Software for incorporation into LABS Licensed Devices. 
 2.1.3. MASIMO
further grants to LABS the non-exclusive right to incorporate MASIMO Boards into LABS Licensed Devices and Stand Alone Licensed Devices and to make, have made, use and sell the same (including, but not limited to, in a private label contract which
does not include LABS name, but which includes MASIMO’s name as provided herein), in the case of Stand Alone Licensed Devices, outside the MASIMO Market. LABS shall also have the right to sublicense to one Affiliate only its rights under this
Section, provided that, (i) LABS shall procure that such Affiliate complies with the terms and conditions of this Agreement, and (ii) LABS and such Affiliate shall be jointly and severally liable for any non-performance or breach by such
Affiliate. 
 2.1.4. Masimo further grants the option, for distribution inside the Labs Market, to Labs to license or obtain
any and all additional Vital Signs parameters that MASIMO develops during the course of this Agreement on terms no less favorable than any other third party non-exclusive licensee. In the event that Masimo does not have a license with any other
third party, then Masimo agrees to negotiate for a license for such parameters with LABS in good faith. This option does not apply if Masimo licenses the additional Vital Sign Parameter on an exclusive basis to a third party prior to Labs exercising
this option. 
 2.1.5. LABS agrees to distribute and to have its sublicensees distribute (i) Stand Alone Licensed Devices
and (ii) LABS Licensed Devices in conjunction with and by providing the end-user with an end-user agreement materially equivalent to the “License Agreement” that is attached hereto as Exhibit D. 
  

 8 

 2.1.6. LABS’ license under this Agreement does not include the right to sell MASIMO
Boards or MASIMO Sensors on an OEM basis except in connection with an OEM sale for integration in LABS Licensed Devices, or in connection with a sublicense of Stand Alone Licensed Devices. 
 2.2. Licenses to MASIMO. 
 2.2.1. License Back to Masimo. LABS grants back to MASIMO a non-exclusive royalty-bearing, worldwide license (i) to use the MASIMO Technology to develop, Non-Vital Signs Monitoring, (ii) to make, have
made, use, offer to sell and sell products incorporating any such developed Non Vital Signs Monitoring for distribution solely outside the LABS Market. Labs consents to any agreement entered by Masimo prior to the date of this Agreement, relating to
Non-Vital Signs products. 
 2.2.2. License to HbCO, HbMet, total hemoglobin and fractional arterial oxygen saturation.
LABS grants to MASIMO a license to make, have made, use, offer to sell and sell Current Licensed Devices only (i) for distribution outside the LABS Market, and (ii) to LABS. Such license is exclusive (on a parameter-by-parameter basis) in
the MASIMO Market until the later of (A) 20 years from the Effective Date or (B) expiration of the last to expire of any LABS patents covering the applicable parameter. Such license shall include the right to sell Current Licensed Devices
on an OEM basis. 
 2.2.3. License to Rainbow Sensors. LABS further grants to MASIMO a license to make, have made, use,
offer to sell and sell Rainbow Sensors only (i) for distribution outside the LABS Market, and (ii) for sale to LABS. Such license is exclusive in the MASIMO Market until the later of (A) 20 years from the Effective Date, or
(B) expiration of the last to expire of any LABS patents covering the Rainbow Sensors. 
 2.3. Trademarks, Legends
and Logos. 
 2.3.1. No Implied License. Each of LABS and MASIMO agrees to include the following legend on the
exterior of or in manuals or other documentation provided with products that contain technology licensed from the other Party which it sells directly. 
 NO IMPLIED LICENSE 
 Possession or purchase of this device does not convey any express or implied license to
use the device with replacement parts which would, alone, or in combination with this device, fall within the scope of one or more of the patents relating to this device. 
 A sample label is shown in Exhibit B. LABS agrees to use reasonable commercial efforts to cause all sublicensees to include this or a similar legend on devices containing MASIMO Technology or in the use manuals or
other documentation shipped with such instruments. 
 2.3.2. Trademark License Grant by MASIMO. MASIMO hereby grants to
LABS a nonexclusive license, including the right to grant sublicenses, to use the MASIMO Licensed Trademarks in connection with the Labs Licensed Devices and Stand Alone Licensed Devices, and in connection with the design, manufacture, distribution,
advertisement, promotion, sale and offering for sale of such devices; provided, 

  

 9 

 
however, that such trademarks are used to indicate the source of incorporated technology and do not indicate that MASIMO is the manufacturer of any such
devices. 
 2.3.3. Quality Control—Devices. LABS agrees that any products bearing any Masimo Licensed Trademark
shall be of a high standard of quality, so as to protect and enhance the goodwill pertaining to the Licensed Trademarks. Masimo has the right to inspect the manufacturing and distribution points of LABS for products bearing Masimo Licensed
Trademarks, at any reasonable time, to ensure the ongoing quality of any product bearing that Party’s Licensed Trademarks. Should Masimo at any time determine that the quality of any product bearing a Masimo Licensed Trademark does not adhere
to these quality standards, Masimo will provide written detailed notice to LABS. LABS shall have three months from such notice to bring the quality of such product up to standard or to cease any further use of the Masimo Licensed Trademark in
connection with the promotion or sale of such device or product until MASIMO has indicated that it is satisfied that the deficiencies in quality of the particular product has been corrected. For any sublicenses granted under the Masimo Licensed
Trademarks, LABS agrees to use reasonable commercial efforts to coordinate quality control consistent with this Section over the manufacture, advertisement, promotion and sale of any products offered by the sublicensee using the MASIMO Licensed
Trademarks. 
 2.3.4. LABS Trademark Marking. LABS agrees that it shall use the MASIMO SET product designation set
forth in Exhibit B (i) on all LABS Combo Devices that are marketed directly by LABS, and (ii) all Stand Alone Licensed Devices that are marketed directly by LABS, in each case, on a front panel site associated with the Vital Signs
Monitoring. Prior to any such use, LABS shall obtain consent from MASIMO as to the use and location of the Licensed Trademark, which consent shall not be unreasonably withheld. LABS shall use reasonable efforts to cause all sublicensees and
Distributors to include such MASIMO Product Designation in accordance with this provision. Labs may, but is not required, to mark products that include Non-Vital Signs Monitoring with any of the Rainbow associated logos (Rainbow, Rainbow SET, SpCO,
...), at LABS discretion. 
 2.3.5. Labs Name. LABS agrees to change its name to eliminate the term
“Masimo” at such time that LABS begins selling any product. 
 2.3.6. Advertising. All advertising directly
by LABS for LABS Combo Devices or Stand Alone Licensed Devices shall include one or more of the MASIMO SET Licensed Trademarks. LABS agrees to use reasonable efforts to have sublicensees and Distributors comply with the provisions of this section.

 2.3.7. No Other Use. Neither Party shall use the trademarks of the other Party in direct combination with other
trade names, trademarks or symbols of such Party or its sublicensees or Distributors. 
 2.3.8. No Damaging Use. Each
Party agrees not to use the trademarks of the other Party in any way which might endanger the owners’ rights in or ownership of the trademarks. 
 2.3.9. Trademark Expenses. The expense of obtaining and maintaining Masimo Licensed Trademarks registrations shall be borne by MASIMO. 
  

 10 

 2.3.10. Trademark Rights on Change in Control. In the event of a Change in Control
of MASIMO, if the acquiring or resulting entity or party permanently ceases to use MASIMO as a company name and as trademark, all rights to the MASIMO trademark shall be and are hereby assigned to LABS including all goodwill associated with the
trademark. For the avoidance of doubt, the purpose of this paragraph is to assign the MASIMO mark if MASIMO is no longer using it, therefore so long as the acquiring or resulting entity or party is using MASIMO as either a company name or as a
trademark, no assignment under this Section shall apply. 
 2.3.11. Patent Marking. Each Party agrees to mark products
sold under license from the other Party in accordance with the Statutes of the United States relating to marking of patented articles. Each Party agrees to use reasonable efforts to cause its sublicensees and Distributors to comply with this
provision. 
 2.3.12. Maintenance of Licensed Patents. Each Party is responsible for determining whether, where, and on
what to pursue patent protection for its technology. Either Party (the “Licensor Party”) may discontinue prosecution or maintenance, abandon, or dedicate to the public any of patents and patent applications included in the MASIMO
Technology or LABS Technology, as applicable, owned by such Party and in its sole discretion, provided, however, that the Licensor Party shall take reasonable efforts to provide the other Party (the “Licensee Party”) with at least 15 days
notice prior to abandonment or other dedication to the public of any patent or patent application in the United States or Western Europe. Upon such notice, the Licensee Party shall have 7 days to notify the Licensor Party, in its sole discretion,
that such licensed patent should not be abandoned or otherwise dedicated to the public. In such event, the Licensee Party shall be responsible for payment of any costs of maintaining such licensed patents or controlling prosecution at its expense of
any licensed patent applications. While there is a single CEO, no written notice to the other company is required. In addition, failure to provide the notice in this paragraph is not a material breach of this Agreement. 
 3. RESEARCH AND DEVELOPMENT/LICENSE FEES 
 3.1. Previous Research & Development. The Parties acknowledge that MASIMO has funded research and development conducted by LABS related to, among other things, methemoglobin, fractional arterial oxygen
saturation, blood glucose, and/or total hemoglobin measurement in a cumulative amount of seven -million -five -hundred -thousand dollars ($7,500,000), and that in consideration of such payment, MASIMO has been granted the options in this Agreement.

 3.2. License Fees for Rainbow Technology. MASIMO agrees to pay a license fee of five million dollars ($5,000,000)
for the license to carbon monoxide (HbCO), methemoglobin (HbMet), and fractional arterial oxygen saturation granted and two million five hundred thousand dollars ($2,500,000) for the license to total hemoglobin, under Section 2.2.2. MASIMO
acknowledges that it has exercised its option to license total hemoglobin and has licensed fractional arterial oxygen saturation. LABS agrees to use such license fee primarily for the development of Non-Vital Signs Monitoring applications. Such
license fee shall be payable in monthly payments, as requested by LABS in accordance with the following sentence. LABS will request payment of the license fee in an amount corresponding to such development costs no more often than monthly, and
MASIMO shall pay LABS the license fee in an amount corresponding to such 

  

 11 

 
development costs within 30 days following receipt of such request for reimbursement. At LABS’ option, some or all of the license fee can be paid in the
form of contracted development work done by MASIMO on LABS’ behalf pursuant to written request by LABS. MASIMO understands that LABS has no proof of concept for any Non-Vital-Signs Parameters other than those delivered as of this date and makes
no representation that proof of concept will ever be achieved for any other Parameter. Except as provided in Section 4.3, upon payment of the license fee described above, no further monthly payment shall be due under this Section.
Notwithstanding the above or anything else contained herein to the contrary, LABS may request that any licensing, royalty, option or other fees due to LABS be paid on a quarterly basis. As of December 31, 2006, MASIMO has paid approximately
$3,600,000 of the $7,500,000 described above. 
 4. MASIMO OPTION 
 4.1. Option Grant. LABS grants to Masimo an option to license Optioned Technology as further set forth in this Article 4 (the
“Option”). 
 4.2. Optioned Technology. The “Option” shall be exercisable separately for each
parameter included in the Optioned Technology within 180 days of delivery of written notice by LABS to MASIMO stating that proof of feasibility has been achieved separately for such parameter, which notice will include written and reasonably support
of such feasibility. The option period shall be extended if MASIMO provides written notice disputing proof of feasibility and during the time period thereafter, during which the parties will work in good faith to agree on whether or not proof of
feasibility has been achieved. If the parties can not agree within 90 days, the matter will be submitted to an independent three-member panel (the “Panel”). Each Party shall select one member of the Panel, and the two members shall select
a third member. No Panel member may be an employee, officer, director, or owner of any shares of either Party, or related to any employee, officer, director or owner of any shares of either Party, or otherwise affiliated with either Party such that
such affiliation would tend to influence such person’s ability to independently evaluate this issue. The determination of the Panel shall be binding upon the Parties. 
 4.3. License Terms. Upon exercise of the Option, LABS hereby grants to MASIMO a license to make, have made, use, offer to sell and
sell applicable Optioned Technology Devices for distribution only (i) outside the Labs Market and (ii) to Labs. The foregoing license shall be sublicensable to any MASIMO Affiliate. Such license shall be exclusive in the Masimo Market
until the later of (i) 20 years from the exercise date, or (ii) expiration of the last to expire of any LABS patents covering the Optioned Technology at issue. Such license shall include the right to sell applicable Optioned Technology
Devices on an OEM basis. However, Masimo does not have the right to provide Licensed Devices or Optioned Technology to any OEM for sale into Labs Market without Labs’ approval, which will be in Labs sole discretion. 
 4.4. Exercise of Option. In order to exercise the Option for each Optioned Technology, MASIMO agrees to pay LABS for each
application for which the option is exercised as follows (it being understood that the option rights to total hemoglobin have previously been exercised): 
 (a) $2,500,000 for Glucose 
  

 12 

 (b) $500,000 for any other Non-Vital Sign Parameter. However, if a Non-Vital Sign Parameter is merely a
combination of already licensed Non-Vital-Sign Parameters, such will not require this additional exercise fee. 
 Such payments will be made
in monthly installments in accordance with and subject to Section 3.2. 
 4.5. Certain Exceptions. The Parties
understand that the exclusivity in the licenses to MASIMO under this Article will in no way preclude LABS from conducting testing and studies in the MASIMO or LABS Market relating to the Optioned Technology and making inadvertent sales to the MASIMO
market. Notwithstanding the foregoing, except as expressly provided herein, neither LABS nor MASIMO shall knowingly sell any Products in the other Party’s Market. 
 4.6. Payment on Change in Control. Upon any Change in Control of MASIMO, the option for glucose shall be automatically exercised.
Upon such Change in Control, MASIMO agrees to pay LABS the license fee for glucose immediately. 
 4.7. Termination of
Exclusivity. 
 4.7.1. Reasonable Efforts. Subject to Section 4.7.2, the exclusivity of Section 2.2 and
4.2 and 4.3 shall terminate, as applicable, if MASIMO is not exercising commercially reasonable efforts to develop or marketing a device incorporating the applicable Optioned Technology or Rainbow Technology on a parameter-by-parameter basis within
one (1) year of the grant of any such license. 
 4.7.2. Notification and Cure. LABS must first notify MASIMO of
its intent to cancel the exclusivity under Section 4.7.1. MASIMO shall have ninety (90) days to cure its failure to take commercially reasonable efforts to develop or market such devices. If MASIMO has not cured its failure within such
period, LABS may terminate the exclusivity on written notice to MASIMO of such termination. In the event that LABS and MASIMO disagree as to whether MASIMO is reasonably marketing such devices, the Party shall submit the disagreement to an
independent three-member panel (the “Panel”). Each Party shall select one member of the Panel, and the two members shall select a third member. No Panel member may be an employee, officer, director, or owner of any shares of either Party,
or related to any employee, officer, director or owner of any shares of either Party, or otherwise affiliated with either Party such that such affiliation would tend to influence such person’s ability to independently evaluate this issue. The
determination of the Panel shall be binding upon the Parties, and the cost of the proceedings are born by the losing party. 
 4.8. Delivery of MASIMO Systems to LABS. MASIMO agrees to make available to LABS upon request, one (1) sample of each MASIMO Licensed Device. LABS will have the right to test this device and to approve the functionality of LABS
Technology in such device. Such approval will not be unreasonably withheld. After such testing, the device may remain with LABS, at LABS’ option, for further technical assistance and as a demonstration unit as long as this Agreement is in
effect. 
  

 13 

 5. ROYALTIES 
 5.1. Royalties to MASIMO For Licensed Devices. Without limiting Section 5.2, the Parties acknowledge that no royalties shall
be payable to MASIMO for the distribution or sale of LABS Licensed Devices or Stand Alone Licensed Devices. 
 5.2.
Royalties to MASIMO for Integrated Consumable. LABS shall pay to MASIMO royalties in the amount of ten percent (10%) of SpO2 sensor or accessory value of LABS’ Average Selling Price of sensors or accessories that measure Vital Signs
Parameters for use in LABS Licensed Devices or Stand Alone Devices. The SpO2 sensor value of sensors that are capable of Non-Vital Signs Monitoring, shall be LABS average selling price for its sales of comparable sensors that only measure SpO2. At
the later of (A) 20 years from the Effective Date or (B) expiration of the last to expire of any Masimo patents covering Masimo Technology, the royalty shall be reduced by 2%. 
 5.3. [Intentionally Omitted.] 
 5.4. Royalty on Rainbow Technology. MASIMO will pay to LABS royalties in the amount of ten percent (10%) of the Rainbow Royalty Base (as defined below) for MASIMO Licensed Devices, and sensors and
accessories for measuring Non-Vital-Signs Parameters in MASIMO Licensed Devices in accordance with the following. 
 (a) Except for the
handheld products, the “Rainbow Royalty Base” will include that portion of (i) a MASIMO Licensed Device Enabled to measure a Non-Vital-Signs Parameter, and (ii) sensors and accessories for measuring Non-Vital-Signs Parameters in
MASIMO Licensed Devices. In other words, if a Masimo Licensed Device, sensor or accessory is Enabled to measure more than Vital Signs Parameters, then the difference between that standard product (the one that measures only Vital Signs Parameters)
and the price charged for a similar type product that can also measure the Non-Vital Signs Parameter/s is the amount that will be multiplied by the 10% royalty. The differential is calculated base on the ASP on a region by region and product by
product basis. 
 (b) For handheld products, such as Rad-57, the entire price of the product is multiplied by the 10% royalty. 
 (c) For multiparameter devices (i.e., a device that uses more than one sensor at a time), the Royalty Base will be (i) the Net Selling Price of the
device, times (ii) the number of Non-Vital-Signs Parameter that the device is Enabled to measure, divided by (iii) the total number of Parameters that the device is Enabled to measure (excluding insignificant parameters such as
temperature, PI, PVI, and Pulse Rate). 
 (d) Hospital Contracts. MASIMO will pay a 10% royalty on the fraction of all revenue from the
contract signed after January 1, 2009 for the placement of Masimo Licensed Devices (for a committed sensor contract) in relation to the fraction of Enabled rainbow devices compared Masimo Licensed Devices with only Vital Signs Parameters
Enabled as follows: 
 (10%)(Total revenue invoiced under contract on running basis)(# Masimo Licensed Devices on average with Non-Vital Signs
Parameters Enabled. 
  

 14 

  
 (# Masimo Licensed Devices on average with Non-Vital Signs Parameters enabled + # Masimo Licensed Devices on average with only Vital Signs Parameters enabled). 
 (e) Non-Vital Signs Parameter upgrades and sensors sold separately or in addition by Masimo shall be considered a separate revenue source for which a 10%
royalty shall apply. Royalties shall not be paid up front but shall be due after payments are made under the contract, on a quarterly basis, 30 days after each quarter end. 
 (f) At the later of (A) 20 years from the Effective Date or (B) expiration of the last to expire of any LABS patents covering the applicable
parameter, the royalty rate shall reduce by 2%. 
 (g) Notwithstanding the foregoing, beginning on a Change in Control, the royalty due to
LABS from MASIMO on a particular product will not be less than the following minimum amount: 
 $0 per completed MASIMO Licensed Device

 $0 on OEM Boards 
 $2 per
disposable sensor capable of CO and/or MET 
 $3 per disposable sensor that includes hemoglobin capability 
 $25 per reusable sensor capable of CO and/or MET 
 $50 per reusable sensor that includes hemoglobin capability 
 $10 per cable if it permits a Non-Vital Sign Parameter 
 $50 per Non-Vital Signs Parameter to OEM for each Enabled parameter, $100 to end users for each parameter when Enabled 
 Royalties are payable within 30 days of the close of each quarter. 
 5.5. Minimum Royalties. MASIMO agrees to the aggregated minimum yearly royalties specified below (whether based on actual sales or
in make-up payments by MASIMO) for the license to Rainbow Technology and/or the license back for Masimo Technology for use in Non-Vital Signs Monitoring developed by LABS or by MASIMO. Such royalties shall begin upon the first commercial sale of any
MASIMO Licensed Device. Subsequent year payments are due within thirty (30) days after the end of each year. Failure to pay the minimum royalties by January 1, 2015 shall be a breach of this Agreement, subject to the notice and cure
provisions herein, and if such cure is not provided, shall thereafter automatically convert MASIMO’s license to a non-exclusive license as the exclusive remedy. After January 1, 2015, failure by MASIMO to pay minimum royalties shall be
considered a material breach of this Agreement. The minimum royalties shall be an advance on that year’s running royalty obligations, but 

  

 15 

 
shall not carry forward from year to year. While the CEO of Labs and Masimo are the same, the Minimum Royalties are payable to Labs as needed by Labs, with
any amounts not paid in a given year carried forward. Minimum royalties are eliminated after the license becomes non-exclusive by the terms of this Agreement. 
  

							
	 2007
	  	2008	  	2009	  	2010 and beyond
	$3.15 M	  	$3.5 M	  	$4 M	  	$5M

 5.6. Notwithstanding Section 5.5, on a Change in Control of MASIMO, the
acquiring entity shall pay the minimum royalties in accordance with the tables below instead of the table in Section 5.5 (with no maximum ceiling for aggregated Non-Vital-Signs Parameters). Minimum royalties are eliminated after the license
becomes non-exclusive by the terms of this Agreement. 
 Aggregated Minimum Royalty for CO, Met, Fractional O2, Hb and/or Glucose

  

							
	 2007
	  	2008	  	2009	  	2010 and beyond
	$5 M	  	$7 M	  	$10 M	  	$15M

 Additional Minimum Royalty Per Rainbow Parameter beyond CO, Met, Fractional O2,
Hb and Glucose 
  

									
	 Year 1*
	  	Year 2	  	Year 3	  	Year 4	  	Year 5 & Beyond
	$75,000	  	$250,000	  	$500,000	  	$1 M	  	$2M

  

	*	Year 1 refers to the first year of commercial release of such parameter. 

 5.7. Royalties on Other Markets. LABS will pay to MASIMO a royalty of 10% on each product that includes Vital Signs Monitoring that is sold outside of both the LABS Market and the MASIMO Market, unless MASIMO
licenses a third party the right to market outside of both the MASIMO Market and LABS Market, at which time the royalty is reduced to 3%. Similarly, MASIMO will pay LABS a royalty of 10% on each product that includes Non-Vital Signs Monitoring that
is sold outside of both the LABS Market and the 

  

 16 

 
MASIMO Market, unless LABS licenses a third party the right to market outside of both the MASIMO Market and LABS Market, at which time the royalty is reduced
to 3%. 
 5.8. Quarterly Accounting. Each Party shall provide the other Party with a quarterly accounting of total
Product shipments upon which a royalty is payable to the other Party, along with an accounting of the Net Selling Price for such products, if applicable. 
 5.9. Audit Rights. Each Party shall have the right to verify, at the requesting Party’s expense, and not more frequently than once per year and upon not less than ten (10) business days prior written
notice to the other Party, the accuracy of the accounting reports provided by the other Party hereunder, through inspection of the other Party’s pertinent records and books of accounts maintained in the ordinary course of business. Such audit
shall be conducted by a certified public accountant (the “CPA”) chosen by the requesting Party in its reasonable discretion, and which CPA is reasonably acceptable to the Party being audited. The requesting Party shall pay all costs,
expenses and fees of the CPA unless the audited Party has understated royalties or other payments owing to the requesting Party by more than five percent (5%) during the period audited, in which event the CPA’s costs, fees and expenses
shall be paid by the audited Party. 
 6. LICENSE FOR OTHER USES 
 6.1. MASIMO Technology. In the event LABS desires to use MASIMO Technology to develop any application not included within Vital
Signs Monitoring and Non-Vital Signs Monitoring, LABS is non-exclusively licensed to use MASIMO Technology to develop such application. All Improvements in connection with the foregoing made during the period that the CEOs of LABS and MASIMO are the
same, shall be owned by MASIMO. All Improvements in connection with the foregoing made during the period that the CEOs of LABS and MASIMO are different, shall be owned by the Party that made such Improvements. 
 6.2. LABS Technology. In the event MASIMO desires to use LABS Technology to develop any application not included within Vital Signs
Monitoring and Non-Vital Signs Monitoring, MASIMO is non-exclusively licensed to use LABS Technology to develop such application. All Improvements in connection with the foregoing made during the period that the CEOs of LABS and MASIMO are the same,
shall be owned by LABS. All Improvements in connection with the foregoing made during the period that the CEOs of LABS and MASIMO are different, shall be owned by the Party that made such Improvements. 
 7. PURCHASE AND SALE OF PRODUCTS 
 7.1. Products Available for Purchase. The provisions of this Article 7 shall apply to each Party to the extent such Party (the “Supplying Party”) is supplying Products to the other Party (the
“Ordering Party”). Each Supplying Party will sell the Products listed in Exhibit C to the Ordering Party in accordance with this Article 7. Upon mutual agreement of the Parties, the Parties shall amend Exhibit C to include any additional
Products available for supply by either Party to the other Party under this Agreement, including applicable pricing, minimum order quantities, and any other provisions applicable to the supply of such Product. 
  

 17 

 7.2. Purchase of Products. The purchase and sale of Products between the parties
shall be made by means of purchase orders placed by one Party or its designee to the other Party. Purchase orders issued before termination of this Agreement calling for delivery in ninety (90) days or less are non-cancelable. Purchase orders
calling for delivery in more than ninety (90) days shall be alterable and cancelable by the Ordering Party until ninety (90) days prior to the shipment date, after which such purchase orders become binding. 
 7.3. Minimum Order Quantities. The minimum quantity of Products that may be purchased on a purchase order for the Products listed
on Exhibit C as of the Effective Date is 50 units of a cable-part number, reusable sensor or MASIMO Board, and 500 units of disposable sensors. 
 7.4. Price. The Supplying Party’s transfer price for the Products
delivered to the Ordering Party in accordance with the terms of this Agreement shall be as set forth on Exhibit C. All prices are F.O.B. the Supplying Party’s manufacturing facility or distribution point in the United States. The transfer price
for SpO2 Sensors and Accessories includes packaging and labeling complying with MASIMO standard packaging guidelines provided to LABS from
time-to-time. The transfer price does not include custom packaging or labeling. If custom labeling is desired and feasible as determined by the Supplying Party, all costs associated with such labeling will be paid by the Ordering Party. Payment by
the Ordering Party to the Supplying Party shall be made thirty (30) days following receipt of an invoice by Ordering Party. 
 7.5. Currency Basis. Prices for the sale of Products hereunder shall be in United States dollars. 
 7.6.
Taxes and Levies. All payments for Products under this Article 7 are exclusive of taxes and each Party shall be responsible for paying all taxes relating to products marketed by that Party (except taxes based upon the other Party’s
income), including but not limited to all sales, use, personal property, customs, duties, assessments, levies, and other government impositions of any nature. 
 7.7. Transportation. The method of transportation and carrier selected for Products purchased by a Party shall be as specified by
such Party in its purchase orders. Unless otherwise agreed, all transportation charges for Products, including insurance, levies, and taxes, shall be paid by the Ordering Party. 
 7.8. Packaging. The Supplying Party shall package the Products for shipment. Each shipment shall include a packing list containing:
(i) purchase order number; (ii) model number of the Products; (iii) quantity; (iv) serial number or lot code of shipped Products; and (v) certificates of compliance for the applicable quality assurance test performed for the
Products being shipped. 
 7.9. Delivery. The Supplying Party shall use reasonable commercial efforts to fill all
purchase orders for Products by delivery dates and in the quantity specified by the other Party in its purchase orders. Notwithstanding the above, the Supplying Party shall have no obligation to deliver Products in less than ninety (90) days
from confirmation. If a purchase order calls for more than a 25% increase as compared to the previous three (3) month average of Products ordered, on a Product-by-Product basis, the Supplying Party shall use reasonable commercial efforts to
deliver an amount at least equal to the 

  

 18 

 
previous three (3) month average within ninety (90) days, and shall use reasonable commercial efforts to ship the remainder within one hundred
twenty (120) days of receipt of the purchase order. 
 7.10. Emergency Orders. Nothing herein shall prevent a
Party from placing emergency orders for Products for delivery in less than ninety (90) days. The Supplying Party agrees to use reasonable efforts to deliver such Products on the requested schedule. 
 8. COMPATIBILITY 
 8.1. MASIMO Probes. LABS agrees that it will not modify Masimo’s SpO
2 Sensors to be used with other than the MASIMO Boards, other boards designed by MASIMO for Vital Signs Monitoring or boards made by Labs under the
licenses herein. LABS will purchase Sensors for Vital Signs Monitoring applications exclusively from MASIMO unless the measurements for Vital Signs Monitoring applications and Non-Vital Signs Monitoring are best integrated in one sensor, as
determined by LABS in its sole discretion. In such case, LABS may design, develop and manufacture (including manufacturing according to any MASIMO design) integrated sensors and pay MASIMO a royalty of ten percent (10%) of LABS’ Vital
Signs Monitoring Portion of the Net Selling Price of integrated sensors; provided, however, that LABS undertakes all regulatory, service and warranty obligations with respect to such sensors and that such sensors pass MASIMO’s validation and
verification process such that the full capability of MASIMO SET is obtained. LABS will pay for such validation and verification services at MASIMO’s standard rates then in effect for third party OEM products. MASIMO SET will be enabled for
these SpO2 Sensors or other sensors which include MASIMO Technology for Vital Signs Monitoring. The Vital Signs Monitoring Portion is the average
selling price for the similar product that measures only Vital Signs Parameters. The differential is calculated base on the ASP on a region by region and product by product basis. 
 8.2. Engineering Support. During the period that MASIMO is funding LABS’ research and development, or there has been no Change
of Control, MASIMO shall provide reasonable engineering support to LABS for the integration of MASIMO SET into LABS Licensed Devices and Stand Alone Licensed Devices and for the manufacturing of any Masimo Products as permitted under this Agreement,
by assisting Labs with engineering and technical resources, sharing lab equipment, providing prototyping parts and components, legal and financial services, delivering a copy of all MASIMO Software for MASIMO Technology and sufficient information
and documentation (such as circuit diagrams, source code and specifications) to permit LABS to reasonably make, use and modify such MASIMO Software and to reasonably make, use and modify the MASIMO Technology. After a Change in Control, MASIMO shall
continue to deliver, as reasonably requested by LABS, sufficient information and documentation to permit LABS to reasonably use MASIMO Technology in accordance with the terms of this Agreement. After a Change of Control, if Labs asks MASIMO for more
than what MASIMO believes in its sole discretion is reasonable engineering assistance, MASIMO may charge LABS for those services at its actual costs for such support. To the extent necessary, engineering support will apply in reverse with respect to
any LABS Technology licensed to MASIMO on a pari passu basis. 
  

 19 

 9. INSPECTION AND ACCEPTANCE 
 9.1. Inspection/QA. Each Supplying Party shall provide and maintain an inspection procedure and quality assurance program for its
Products and its production processes. Complete records of all inspection and quality assurance work done by a Supplying Party shall be made available to the Ordering Party upon its request at reasonable times during the term of this Agreement.

 9.2. Product Defects and Returns. 
 9.2.1. Return Authorization. Any of the Products or lots of Products
(“Lot”) which materially fail to meet the specifications set forth in Exhibit C or otherwise applicable to such Products may be rejected by the Ordering Party and returned to the Supplying Party for replacement. Prior to returning any
Products to the Supplying Party, the Ordering Party shall notify the Supplying Party by facsimile that the Ordering Party has rejected the Products, inclusive of the reason or basis of such rejection. Within five (5) working days of the receipt
of the notification, the Supplying Party will issue a “Return to Vendor” (“RTV”) number to the Ordering Party by facsimile,
which RTV number will be the Ordering Party’s authorization to return the Products. 
 9.2.2. Product Replacement.
Subject to Section 9.2.1, Products which do not conform to the applicable specifications shall be returned by the Ordering Party to the Supplying Party freight collect and insured for full replacement value. Within twenty (20) days after
the date of receipt of the nonconforming Products, replacement Product will be shipped to the Supplying Party at the Supplying Party’s expense. Should the Supplying Party fail to replace rejected Products by shipping conforming Products within
thirty (30) days of its receipt of the nonconforming Products, the Ordering Party shall have the option to cancel the purchase of such Products without cost or liability and receive, at the Ordering Party’s option, a credit or rebate if
payment has been made. The Ordering Party shall pay freight charges, insurance and other customary charges for transportation for improperly rejected Products. 
 9.2.3. Costs. All costs to replace including transportation with respect to the defective Products shall be the sole responsibility
of the Supplying Party. 
 9.2.4. Unauthorized Correction. If the Ordering Party attempts to correct deficiencies to
the Products purchased under this Agreement without prior written authorization from the Supplying Party, then the Supplying Party shall have no further obligations with respect to such Products. 
 9.3. Nonconforming Acceptance. The Ordering Party may choose to accept Products which fail to conform in a minor aspect to the
specifications established by this Agreement without prejudice to its right to reject nonconforming items in the future. If the Ordering Party so chooses, the Ordering Party will notify the Supplying Party of its intent to accept nonconforming
items. However, the Supplying Party accepts no responsibility for nonconforming items accepted by the Ordering Party. 
 10.
CONFIDENTIALITY 
 10.1. Confidentiality. Each Party shall maintain in confidence all Confidential Information of
the other Party received in the course of performance under this 

  

 20 

 
Agreement, and shall not disclose such Confidential Information to any third party. In maintaining the confidentiality of Confidential Information of the
other Party, each Party shall exercise the same degree of care that it exercises with its own confidential information, and in no event less than a reasonable degree of care. Each Party shall ensure that each of its officers, directors, employees,
subcontractors, consultants, representatives and agents holds in confidence and makes no use of the Confidential Information of the other Party for any purpose other than those permitted under this Agreement or required by law. 
 10.2. Exceptions. Neither Party’s obligations under this confidentiality provision shall apply to information that:

  

	 	a.	prior to the transmittal was of general public knowledge; 

  

	 	b.	becomes a matter of general public knowledge otherwise than as a consequence of a breach under this Agreement; 

  

	 	c.	is made public by the Party claiming confidentiality; 

  

	 	d.	is required to be disclosed by applicable law; provided however, that the Party who may be required to disclose such information shall notify the other Party in sufficient time for
the owner of such Confidential Information to file the appropriate documents with the court to obtain a protective order to enforce the confidentiality requirements of this Agreement; 

  

	 	e.	information which the receiving Party can establish by competent proof was in its possession at the time of disclosure by the disclosing Party and was not acquired, directly or
indirectly, from the disclosing Party; or 

  

	 	f.	information which is received from a third party; provided, however, that the receiving Party has no reason to know such information was obtained by said third party, directly or
indirectly, from the other Party under a nondisclosure agreement. 

 11. PROPRIETARY RIGHTS 
 11.1. MASIMO Technology. MASIMO retains all right, title, and interest in the MASIMO Technology, including, without limitation, all
patents, copyrights, trade secrets, and any other intellectual property and proprietary rights. Nothing in this Agreement should be construed as a sale of the MASIMO Technology or any copy of the MASIMO Software to LABS. 
 11.2. LABS Technology. LABS retains all right, title, and interest in the LABS Technology, including, without limitation, all
patents, copyrights, trade secrets, and any other intellectual property and proprietary rights. Nothing in this Agreement should be considered as a sale of the Labs Technology or any copy of the LABS Software to MASIMO. 
  

 21 

 11.3. Development for Non-Vital Signs Monitoring. Any development using or
Improvement to proprietary MASIMO Technology or LABS Technology made by LABS or by MASIMO that relates to Non-Vital Signs Monitoring, and any new technology acquired by LABS during the term of this Agreement shall be the sole property of LABS, and
LABS has the right to apply for copyrights, patents (including utility and design patents), or other protection for intellectual property rights anywhere in the world under its own name and at its own expense. Without limiting Section 11.1,
MASIMO hereby assigns to LABS all right, title, and interest in the foregoing. Any acquisition of products or technology by MASIMO for Non-Vital Signs Monitoring or Vital-Signs Monitoring or Improvements thereto by MASIMO, before or after the date
hereof, is not assigned to LABS and is exclusively retained by MASIMO, except for the assets of Argose, which are to be assigned to Labs. 
 11.4. Improvements for Vital Signs Monitoring. Any development using or Improvement to proprietary MASIMO Technology or Labs Technology made by MASIMO or LABS that relates to Vital Signs Monitoring, and any new
technology acquired by MASIMO during the term of this Agreement, shall be the sole property of MASIMO, and MASIMO has the right to apply for copyrights, patents (Including utility and design patents), or other protection for intellectual property
rights anywhere in the world under its own name and its own expense. Without limiting Section 11.2, LABS hereby assigns to MASIMO all right, title, and interest in the foregoing. Any acquisition of products or technology by LABS for Non-Vital
Signs Monitoring or Vital-Signs Monitoring or Improvements thereto by LABS, before or after the date hereof, is not assigned to MASIMO and is exclusively retained by LABS, unless LABS uses Masimo Technology to improve such acquired products or
technology to provide a Non-Vital Signs Parameter, in which case such Non-Vital Signs Parameter shall be included within the license or option and other terms provided to MASIMO herein. 
 11.5. Further Action. LABS and MASIMO agree to take such further action and execute such further documents as reasonably necessary
to establish ownership as set forth in Section 6.2, and Sections 11.1 through 11.6. 
 12. INDEMNIFICATION 
 12.1. MASIMO indemnification. MASIMO will defend, indemnify and hold LABS harmless against any and all liability, loss, damages,
costs or expenses which LABS may hereafter incur, as a result of any injury, illness or death of any person which is caused by any Product or device manufactured by MASIMO and purchased by LABS from MASIMO, to the extent that such injury, illness or
death results directly from such products manufactured or technology provided by MASIMO. 
 12.2. LABS indemnification.
LABS will defend, indemnify and hold MASIMO harmless against any and all liability, loss, damages, costs or expenses which MASIMO may hereafter incur, as a result of any injury, illness or death of any person which is caused by any Product or device
manufactured by LABS and purchased by MASIMO from LABS, to the extent that such injury, illness or death results directly from such products manufactured by LABS. For purposes of clarity, Labs shall have no liability of any kind for technology it
has only licensed to Masimo as compared to provided in a product sold to Masimo. 
  

 22 

 12.3. Infringement for Vital Signs Monitoring. MASIMO shall settle or defend, at
MASIMO’s own expense, and pay any direct damage, costs or fines resulting from all proceedings, threats of proceedings or claims against LABS or its customers for infringement or alleged infringement by the Vital Signs Monitoring application(s)
in LABS Licensed Devices or Stand Alone Licensed Devices, to the extent relating to the Masimo Technology licensed to LABS in this Agreement, of intellectual property rights of third parties. LABS agrees to notify MASIMO promptly in writing of any
such proceeding, and to give MASIMO necessary assistance where practical, to modify the applicable Product to make it noninfringing or, where practical, to obtain licenses under such intellectual property rights. MASIMO makes no representation that
Masimo Technology is not limited by any patent for Non-Vital Sign Measurements. 
 12.4. Tender of Defense The
indemnifying party shall have no liability or responsibility of any kind to the indemnified party under this Section unless the Party seeking indemnity shall have notified the other Party within a reasonable time of such claims, and the indemnifying
Party shall have been given an adequate opportunity to defend, including complete control of the defense and any settlement. Should the Party seeking indemnity desire to have its own counsel participate in any such action, the cost of such counsel
shall be exclusively Party seeking indemnity. 
 12.5. Notwithstanding the foregoing, the Party that owns intellectual
property licensed to the other Party under this Agreement shall have the first right to enforce such intellectual property, even in the market of the other Party, including the right to prosecute and settle all intellectual property claims. If the
licensor is unable to or unwilling to enforce intellectual property that relates to the other Parties market, as defined in this Agreement, the licensee will then have the right to enforce any intellectual property licensed exclusively in the
licensee’s market. The non-enforcing party will have no right to any recoveries from such enforcement. Notwithstanding the above, LABS shall not have the right to enforce U.S. Patent No. 6,263,222. 
 12.6. Patent Validity. During and after the term of this Agreement, each Party agrees not to challenge the validity of any of the
patents of the other Party to which this Agreement relates. 
 12.7. LIMITATION OF LIABILITY. EXCEPT FOR THE EXPRESS
WARRANTIES SET FORTH ABOVE, MASIMO AND LABS GRANT NO WARRANTIES, EITHER EXPRESS OR IMPLIED, ON THE PRODUCTS OR TECHNOLOGY PROVIDED TO EACH OTHER, AND EACH SPECIFICALLY DISCLAIMS ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
PURPOSE. THE STATED EXPRESS WARRANTY IS IN LIEU OF ALL LIABILITIES OR OBLIGATIONS OF MASIMO OR LABS FOR DAMAGES, INCLUDING, BUT NOT LIMITED TO, CONSEQUENTIAL DAMAGES OCCURRING OUT OF OR IN CONJUNCTION WITH THE USE OR PERFORMANCE OF THE PRODUCTS OR
TECHNOLOGY. IN NO EVENT SHALL MASIMO OR LABS BE RESPONSIBLE FOR CONSEQUENTIAL, INCIDENTAL, SPECIAL DAMAGES OR LOSS OF PROFIT SUFFERED BY THE OTHER PARTY IN CONNECTION WITH THIS AGREEMENT. 
 13. REGULATORY COMPLIANCE 
 13.1. LABS U.S. Regulatory Approvals. LABS shall be solely responsible for identifying and obtaining, at its sole cost and expense, all FDA and United States safety agency approvals and any other agency or regulatory approvals which
are required for the development, manufacture or sale of LABS Licensed Devices and Stand Alone 

  

 23 

 
Licensed Devices. MASIMO will reasonably cooperate with LABS by providing at no charge to LABS any MASIMO data in its possession that is reasonably required
to obtain the regulatory approvals, including but not limited to 510(k) application materials submitted by MASIMO for its own products that incorporate MASIMO Technology. Disclosure to LABS of any such data shall be subject to the confidentiality
provisions of Section 10 (“CONFIDENTIALITY”). 
 13.2. Other LABS Regulatory Approvals. LABS shall be
solely responsible, at its sole cost and expense, (i) for identifying and obtaining any necessary approvals or certifications by any non-U.S. governmental, safety or regulatory entity, including testing or other procedures, for the sale by LABS
of LABS Licensed Devices and Stand Alone Licensed Devices, (ii) for identifying and complying with any safety precautions, safety markings, labels or consumer notices required for LABS Licensed Devices in any country other then the United
States, and (iii) for assessing the appropriateness of the LABS Licensed Devices for any particular Customer application. MASIMO will cooperate with LABS by providing any data in its possession that is reasonably required to obtain such
approvals or certifications. Disclosure to LABS of any such data to any third party shall be subject to the confidentiality provisions of Section 10. 
 13.3. MASIMO U.S. Regulatory Approvals. MASIMO shall be solely responsible for identifying and obtaining, at its sole cost and expense, all FDA and United States safety agency approvals and any other agency or
regulatory approvals which are required for the development, manufacture or sale of Products by MASIMO in the MASIMO Market. LABS will reasonably cooperate with MASIMO by providing at no charge to MASIMO any LABS data in its possession that is
reasonably required to obtain the regulatory approvals, including but not limited to 510(k) application materials submitted by LABS for its own products that incorporate LABS Technology for Products in the MASIMO Market. Disclosure to MASIMO of any
such data shall be subject to the confidentiality provisions of Section 10. 
 13.4. Other MASIMO Regulatory
Approvals. MASIMO shall be solely responsible, at its sole cost and expense, (i) for identifying and obtaining any necessary approvals or certifications by any non-U.S. governmental, safety or regulatory entity, including testing or other
procedures, for the sale by MASIMO of MASIMO Licensed Devices, (ii) for identifying and complying with any safety precautions, safety markings, labels or consumer notices required for MASIMO Licensed Devices in any country other then the United
States, and (iii) for assessing the appropriateness of the MASIMO Licensed Devices for any particular Customer application. LABS will cooperate with MASIMO by providing any data in its possession that is reasonably required to obtain such
approvals or certifications. Disclosure to MASIMO of any such data to any third party shall be subject to the confidentiality provisions of Section 10. 
 13.5. Export Controls. Regardless of any disclosure to one Party by the other Party of an ultimate destination of the product
obtained from the one Party, the other Party shall not transfer or re-export, whether directly or indirectly, any software or hardware containing the technology of the other Party, the related documentation, or other related proprietary information
to anyone outside the U.S. as to which export may be in violation of the United States export laws or regulations without first obtaining the appropriate license from the U.S. Department of Commerce and/or any agency or department of the U.S.
government, as required. 
  

 24 

 14. INCIDENT REPORTING 
 14.1. By LABS. LABS represents that in addition to being responsible for all regulatory approvals for its Products, that should any
material incidents of failure of any LABS Licensed Devices which include Vital Signs Monitoring or Stand Alone Licensed Devices or injury related to such Products be reported to LABS, that it will take good faith efforts to promptly (i.e., within
two (2) business days) notify MASIMO of any such performance problems or deficiencies relating to Vital Signs Monitoring licensed from Masimo. 
 14.2. By MASIMO. MASIMO represents that in addition to being responsible for all regulatory approvals for its Products, that should any material incidents of failure of any MASIMO Licensed Device which includes
Non-vital Signs Monitoring or injury related to such Products be reported to MASIMO, that it will take good faith efforts to promptly (i.e., within two (2) business days) notify LABS of any such performance problems or deficiencies relating to
Non-Vital Signs Monitoring licensed from LABS. 
 15. TERM AND TERMINATION 
 15.1. Term. The term of this Agreement shall commence on the Effective Date and shall continue in effect until terminated in
accordance with this Article 15. 
 15.2. Termination for Breach. The default by one Party of a material obligation of
such Party under this Agreement shall entitle the other Party to give the Party in default written notice describing such default in detail (including all supporting documentation) and requiring it to remedy such default. If such default is not
fully remedied within ninety (90) days after the date of such notice, the notifying Party shall be entitled to, in addition to all other remedies available to such Party, exercise its rights under the Escrow, as contemplated by Article 17, or
terminate this Agreement by a written notice to the defaulting Party. A Party may not continue to exercise its rights under the Escrow if it terminates this Agreement. 
 15.3. Termination on Liquidation. Either Party may terminate this Agreement at any time after the involuntary institution of any
proceedings for the liquidation or winding up of the other Party’s business which have not been terminated within 180 days after institution. 
 15.4. Rights Upon Termination. In the event of any valid termination of this
Agreement [under Section 15.2 (“Termination for Breach”) or 15.3 (“Termination on Liquidation”),] each the breaching or liquidating Party’s rights under this Agreement shall be terminated except as follows: 
 15.4.1. No termination of this Agreement shall terminate or otherwise impact LABS’ rights under Sections 2.1.1, 2.1.2, 2.1.4, 2.3 or
any sublicenses and private label patient monitoring company contracts under 2.1.3. 
 15.4.2. No termination shall effect the
rights of customers that have already purchased products to continue to use such products, or the rights of the licensee to continue to sell sensors and accessories to meet the needs of such purchased products. 
  

 25 

 15.4.3. No termination shall impact either Party’s rights to collect for accrued
royalties or the licenses granted in this Agreement, which continue after termination on the terms and conditions existing upon termination. 
 15.4.4. For any termination for breach, only the rights of and licenses to the breaching Party are terminated, and rights and licenses to the non-breaching Party remain in effect, as well as the obligations of the
breaching Party to the non-breaching Party. 
 15.5. Survival. The rights and obligations of the Parties hereto under
Sections 10 (“Confidentiality”), 11 (“Proprietary Rights”), 12 (“Indemnification”), 13 (“Regulatory Compliance”), 14 (“Incident Reporting”), 2.1.1, 2.1.2, 2.1.4, and 2.3 ( “Trademarks, Legends
and Logos”), or any sublicenses and private label patient monitoring company contracts under 2.1.3, and 4 (“Masimo Option”) of this Agreement shall survive and continue after termination of this Agreement and shall bind the Parties
and their representatives, successors, heirs and assignees. 
 16. DISPUTE. If any dispute or difference shall arise between the
Parties concerning the construction of this Agreement or the rights or obligations of either Party, the Parties shall strive to settle the same amicably. If LABS and MASIMO have the same CEO, and the common CEO determines that a conflict exists that
he cannot resolve due to the diverging interests of Labs and Masimo, the common CEO at his option, will either 1) appoint an independent board member (if one exists) to represent each Party to discuss and negotiate resolutions to conflicts arising
under this Agreement, with the CEO, or 2) the common CEO will resolve the issue to his best capability to balance the needs of both Masimo and Labs and seek Board approval of both Masimo and Labs for his decision. If the Parties are unable to reach
agreement or amicably settle the dispute or difference within ninety (90) days after such dispute or difference has arisen, such dispute will be resolved through binding arbitration, applying the AAA rules. The prevailing Party will be entitled
to recover, in addition to any other award of the arbitrators, its attorney’s fees and costs associated with the arbitration. 
 17.
ESCROW 
 17.1. Escrow Deposit. When LABS and MASIMO no longer have the same CEO, either Party may request that
each of MASIMO and LABS place in escrow with an independent third party copies of the LABS Technology and MASIMO Technology, respectively, pursuant to the terms of an escrow agreement on commercially reasonable and standard terms. Such escrow
agreement will be negotiated and agreed to by the Parties at such time as either party makes a written request upon the other. Each Party will pay its own fees and costs to establish the escrow, except that the Party requesting the escrow shall pay
all costs of the escrow agent during the term of the escrow, notwithstanding the fact that both Parties will have technology placed in the escrow and both Parties will have rights to technology under the escrow. The escrow will include drawings and
all necessary information available to each such Party for use of the technology pursuant to the License in Section 17.2. Each Party shall update its deposit in accordance with the escrow agreement. 
 17.2. License upon Release. In the event that a Party is in breach of an obligation under this Agreement that inhibits the other
Party’s ability to make, use, offer for sell or sell products licensed under this agreement, and such breach is not cured within the time period provided herein, the nonbreaching Party is granted by the 

  

 26 

 
breaching Party a revocable, license to use, maintain, develop and improve the technology in escrow for the intended purposes of this Agreement, provided
that, the other Party shall have no right to access, maintain, develop or possess the deposited technology except in accordance with the terms of the escrow agreement; and provided further, that all royalties and other obligations due under this
Agreement shall not be reduced, waived or eliminated in any way during the time period that such license remains in effect. The license under this paragraph shall only apply during the continuation of the breach, and not after it has been cured,
except that where significant investment of funds was made by the licensed Party, the period of license shall run until the investing party has recovered the amount invested, or the breaching party reimburses the licensed Party for its out of pocket
costs associated with establishing its own manufacturing due to the failure to supply. 
 17.3. Intentions of Escrow.
As a matter of clarity, the purpose of the escrow is only to reduce the risk of unavailability of necessary information to allow a licensed Party to continue to achieve the purposes anticipated by this Agreement by having the temporary license to
such information in situations where there has been an uncured breach of this Agreement, and not alter existing economic or other obligations under this Agreement, or allow or provide for any permanent transfer of any rights or assets from one Party
to the other as a result of a release of information from the escrow contemplated in this Article 17. 
 18. MISCELLANEOUS 

18.1. Nonassignability. Neither MASIMO nor LABS may assign this Agreement except in connection with the sale of all or
substantially all of the assets or business of such Party to which this Agreement relates. This Agreement will inure to the benefit of and bind each Party’s successors and assigns. 
 18.2. Failure to Enforce. The failure of either Party to enforce at any time or for any period of time the provisions of this
Agreement shall not be construed to be a waiver of such provisions or of the right of such Party to enforce each and every such provision. 
 18.3. Governing Law. This Agreement shall be deemed to have been made in the State of California, United States of America, and shall be governed by and construed according to the laws of the State of
California. 
 18.4. Severability. In the event that any of the provisions of this Agreement shall be held by a court
or other tribunal of competent jurisdiction to be unenforceable, such provisions shall be deleted from this Agreement and the remaining portions of this Agreement shall remain in full force and effect, except where the economic equity of both
Parties hereto is materially affected by such unenforceability. 
 18.5. Notice. Except as either Party may hereafter
notify the other in writing with respect to itself, the addresses of the Parties for all purposes of this Agreement shall be: 
  

											
	 MASIMO:
	  	MASIMO CORPORATION	  		  		  	
		  	40 Parker	  		  		  		  	
		  	Irvine, CA 92618	  		  		  	
		  	Attention: Chief Executive Officer	  		  		  	

  

 27 

											
	 LABS:
	  	MASIMO LABORATORIES	  		  		  	
		  	50 Parker	  		  		  		  	
		  	Irvine, CA 92618	  		  		  		  	
		  	Attention: Chief Executive Officer	  		  		  	

 All notices and communications pursuant to this Agreement shall be addressed as set forth above
and shall be delivered to the Party for whom intended by hand or by postage prepaid, first class, registered or certified mail, return receipt requested. Such notices and communications shall be deemed to have been given and delivered as of the date
of receipt. 
 18.6. Force Majeure. Neither Party shall be liable to the other Party hereto for any loss, injury,
delay, damages or other casualties suffered or incurred by such other Party due to strikes, riots, storms, fires, acts of God, or war or any other cause beyond the reasonable control of either Party. 
 18.7. Headings. Headings to paragraphs and sections of this Agreement are to facilitate reference only, do not form a part of this
Agreement, and shall not in any way affect the interpretation hereof. 
 18.8. Exhibits. All exhibits to which this
Agreement refers are hereby incorporated into and made a part of this Agreement. 
 18.9. Entire Agreement. This
Agreement constitutes the entire agreement between LABS and MASIMO, and expressly supersedes the Original Agreement and all previous amendments , and there are no other understandings, agreements or representations, express or implied, written or
oral, not specified herein. This Agreement may only be amended by express written agreement and signed by authorized representatives of both Parties. 
 18.10. Bankruptcy. Each of MASIMO and LABS is a licensee under 11 U.S.C. §365(N) and is entitled to the protections as a licensee provided therein. 
 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date set forth above. 
  

							
	MASIMO CORPORATION	 	MASIMO LABS
				
	By	 	 /s/    BRAD LANGDALE
	 	By	 	 /s/    JOE E. KIANI

		 	Brad Langdale, EVP, Marketing	 		 	Joe E. Kiani, Chief Executive Officer

  

 28 

 EXHIBIT A 
 MASIMO SET® DEFINITION 
 MASIMO SET® includes the following MASIMO Technology, as it relates to pulse oximetry: 
 LNOP®, AutoProCalTM, ProCalTM, DSTTM, FSTTM Technology, SST, Proprietary Engine number 4, APOD, PVI, PI, FastSat, and Parallel Engines; 
 Transducers (sensor/probe) designed to reduce cost, reduce noise and improve accuracy; 
 The technique of building a reference generator for
calculating substantially a noise or signal reference; 
 Use of a noise reference or signal reference to minimize the effect of unwanted noise components
(e.g., motion artifacts) from physiological waveforms (e.g., photo-plethysmographic waveforms); 
 Use of a reference generator along with a correlation
canceler (e.g., Joint Process Estimator) to map natural photo-plethysmographic waveforms into oxygen saturation space; 
 Use of a saturation transform,
which is the technique of mapping plethysmographic waveforms into saturation space (e.g., saturation vs. power or probability and saturation vs. frequency or pulse rate); and/or 
 Use of transducers, circuitry, general digital signal processing techniques, mathematical algorithms for processing physiological signals and providing one or more final results (e.g., arterial blood oxygen
saturation, pulse rate and/or photo-plethysmographic wave forms). 
  

 29 

 EXHIBIT B 
 Exhibit B1: to include Masimo Licensed Trademarks. See 1.20. 
 Panatone Red / PMS Black 
 1850 MAT 
 (MASIMO WILL PROVIDE CAMERA READY ARTWORK UPON REQUEST) 
 NO IMPLIED LICENSE LABEL 
  

 30 

 EXHIBIT C 
 Price of Products 
 Price for MASIMO Boards: MASIMO’s transfer prices to LABS for the MS2000
Boards shall be $175.00: 
 Price for Rainbow Boards: 
 All
Rainbow Boards and Rainbow sensors at cost of goods sold up to 10% of MASIMO’s anticipated annual volume, determined on an annual basis. Thereafter, Labs will manufacture such Rainbow Boards or Rainbow sensors itself, or may purchase from
Masimo at COGS plus Masimo’s regular margin. When Labs wishes to manufacture, Masimo will provide reasonable assistance consistent with this Agreement, including providing Labs with access to Masimo vendors (Masimo vendors will be instructed to
transfer to Labs the products at the same price they supply them to Masimo), tools, manufacturing process procedures and training. 
 Transfer Price for Sensors and Accessories: MASIMO’s initial baseline transfer prices to LABS for the SpO2 Sensors and Accessories delivered in accordance with this Agreement shall be at the most favored OEM prices. 
 LABS shall receive
the best price offered by MASIMO to any other person or entity for Products. In the event that MASIMO provides more favorable pricing to another person or entity, MASIMO shall notify LABS of such better pricing within thirty days, and LABS shall
have the option of accepting the more favorable pricing, effective immediately. 
  

 31 

 EXHIBIT D 
 End-User License Agreement 
 THIS DOCUMENT IS A LEGAL AGREEMENT BETWEEN YOU, THE
“PURCHASER”, AND LABS. IF YOU DO NOT AGREE TO THE TERMS OF THIS AGREEMENT, PROMPTLY RETURN THE ENTIRE PACKAGE, INCLUDING ALL ACCESSORIES, IN THEIR ORIGINAL PACKAGE, WITH YOUR SALES RECEIPT TO LABS FOR A FULL REFUND. 
 1. Grant of License 
 In consideration
of payment of the license fee, which is part of the price paid for this product, LABS grants to Purchaser a nonexclusive, nontransferable license, without right to sublicense, to use the copy of the incorporated software/firmware, and documentation
in connection with Purchaser’s use of the Products for their labeled purpose. LABS reserves all rights not expressly granted to Purchaser. 
 2. Ownership of MASIMO Software/Firmware 
 Title to, ownership of, and all rights and interests in, any MASIMO software
and/or firmware and the documentation, and all copies thereof, remain at all times vested in MASIMO Corporation, licensor to LABS, and they do not pass to Purchaser. 
 3. Assignment 
 Purchaser shall not assign or transfer this License, in whole or in part, by operation
of law or otherwise, without LABS’ prior written consent; any attempt without such consent, to assign any rights, duties or obligations arising hereunder shall be void. 
 4. Copy Restrictions 
 The
software/firmware and the accompanying written materials are copyrighted. Unauthorized copying of the software, including software that has been modified, merged, or included with other software, or other written materials is expressly forbidden.
You may be held legally responsible for any copyright infringement that is cause or incurred by your failure to abide by the terms of this license. Nothing in this license provides any rights beyond those provided by 17 U.S.C. § 117.

 5. Use Restriction 
 As
the Purchaser, you may physically transfer the products from one location to another provided that the software/firmware is not copied. You may not electronically transfer the software/firmware from the products to any other device. You may not
disclose, publish, translate, release or distribute copies of the software/firmware or accompanying written materials to others. You may not modify, adapt, translate, reverse engineer, decompile, disassemble, or create derivative works based on the
software/firmware. You may not modify; adapt, translate, or create derivative works based on the written materials without the prior written consent of LABS. 
 6. Transfer Restrictions 
 The software/firmware is licensed to the Purchaser, and may not be
transferred to anyone, except other end-users, without the prior written consent of LABS. In no event may you transfer, assign, rent, lease, sell, or otherwise dispose of the software/firmware or the products on a temporary basis. 
  

 32 

 7. Beneficiary  
 MASIMO Corporation is a Beneficiary of this Agreement and has the right to enforce its provisions. 
 RESTRICTED RIGHTS LEGEND 
 The software/firmware and documentation is commercial computer software as defined in DFARS §
252.277.7014(a)(1). The Government shall have only those rights specified in this Agreement. DFARS § 227.7202-3(a). 
  

 33

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]